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Proteins are large size molecules (macromolecules) that are involved in every 
aspect of life. Every protein has a specific job to accomplish in the cell. The 
shape (structure) that proteins adopt depends on the tasks they have to perform. 
Most proteins can bind many different molecules and for this reason it cannot 
have a rigid structure but it has to be able to shift from a configuration to 
another. Therefore, proteins are dynamic macromolecules and studying the 
structural basis of these movements is important to understand how they work.  
Until recently, two main techniques, called X-ray crystallography and nuclear 
magnetic resonance (NMR), were used to determine the structure of proteins. 
However, the use of these “traditional” methods in isolation has some limitations. 
For example, X-ray crystallography can be used to resolve the structure of 
compact proteins and the three-dimensional reconstruction obtained only 
represent a snapshot of the protein in a particular state. On the other hand, 
nuclear magnetic resonance allows to obtain a series of structures, each of them 
representing an individual conformation adopted by the protein, therefore 
allowing the analysis of biologically relevant protein flexibility. However, NMR 
has the disadvantage that it can be used only for relatively small proteins.  
Nowadays, the efforts of the scientific community has led to the development 
of new techniques that can be combined in order to allow the structural 
characterization of “difficult” proteins, meaning those that cannot be 
characterized with traditional methods. Gathering structural information from 
different methods helps to obtain a more complete representation of the 
conformations adopted by proteins, not only in isolation but also as part of a 
biological network. In this study, the combination of several techniques was used 
to study the shape of Staufen: a small, flexible protein, which is difficult to study 
using only conventional methods. Additionally, this strategy is also beneficial to 
understand the dynamic behavior of large macromolecular complexes, such as 
the one formed by the protein MCM. Understanding the structure of proteins 
allows to uncover the molecular basis of their functions, not only in healthy cells 
but also in abnormal ones. Consequently, this knowledge is necessary to design 







Proteins are the ultimate effectors of biological mechanisms and are involved in 
every aspect of cellular life. The functional properties of proteins depend on their 
three-dimensional structure. Indeed, proteins are not rigid entities and internal 
motions, on a wide range of timescales and distances, are necessary to 
accomplish a specific function. While certain proteins adopt a compact 
conformation and undergo small-scale rearrangements, others are more flexible 
and withstand more dramatic movements. Proteins that exhibit a regulatory role 
function by binding multiple partners, such as small molecules, DNA, RNA, other 
proteins. Increased levels of flexibility favour this binding promiscuity. 
A long-standing goal in molecular biology has been the development of new 
methods to enable the determination of three-dimensional structures of proteins 
that exhibit a high level of dynamic complexity. In fact, it is becoming clearer 
every day that individual structural techniques have several limitations. An 
integrative structural biology approach provides the tools to decipher the 
dynamic configuration of proteins by combining information from multiple 
sources, including biochemical, bioinformatics and biophysical methods.  
In this thesis, an integrated approach is used to structurally characterize two 
extremely different nucleic acids binding proteins, the human Staufen1 protein 
and the archaeal Pyrococcus abyssi MCM complex. In this study, I show that an 
integrated structural biology approach is not only essential to determine the 
architecture of small, flexible proteins, which are traditionally difficult targets for 
conventional approaches, but it is also beneficial to understand the dynamic 
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1.1   The evolutionary advantage of multidomain proteins 
 
Proteins mediate every aspect in life. They are made of domains, which represent 
their fundamental building blocks. A domain can be defined as an independent 
evolutionary unit (single-domain protein) or be a module of a larger construct 
(multidomain proteins). Domains are not only the structural elements of proteins, 
but also their functional components as they often retain an independent function 
or act in cooperation with other domains to contribute to the function of a 
multidomain protein (Vogel et al., 2004). The majority of proteins are formed of at 
least two domains, whose nature and interactions govern the function of the 
protein. In multidomain proteins, the connecting linkers play an essential role in 
maintaining cooperative inter-domain interactions (Gokhale and Khosla, 2000) 
and display different degrees of flexibility to perform their particular biological 
purpose. However, loops and linkers do not act only as flexible connectors within 
and between distinct domains of a protein, but they have an important role in 
protein function and allostery (Papaleo et al., 2016). The formation of new domain 
combinations, in a well-defined architecture governed by linkers, is an important 




1.2   Flexibility as a functional “tool”  
 
Protein flexibility is essential for biochemical function and it allows proteins to 
adapt, and subsequently bind, to their target ligands. However, not all proteins are 
equally flexible and the degree of flexibility varies between proteins. For example, 
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some proteins behave as they were relatively rigid or compact. Conversely, many 
proteins undergo very large conformational changes, for example upon binding to 
a substrate or a ligand. In particular, the higher degree of flexibility of regulatory 
proteins, when compared to other functional categories, has been shown to relate 
to increased binding promiscuity allowing specificity towards multiple binding 
partners (Liu et al., 2009). Structural and proteomic research over the past decade 
has expanded the traditional structure-function paradigm by establishing the 
functional relevance of protein dynamics (Pabon and Camacho, 2017). In this 
perspective, particular efforts have been put towards the study of intrinsically 
disordered proteins (IDPs) or regions (IDRs), which exhibit large structural 
rearrangements, including the formation or loss of secondary structure elements, 
triggered by environmental changes or interactions with partners (Craveur et al., 
2015). Functional and evolutionary flexibility in protein-protein interaction 
networks are considerably enhanced by IDPs and IDRs, as their interaction profile 
can be fine-tuned with alternative splicing and post-translational modifications 
(PTMs), which may result in allostery and promiscuity (Tompa et al., 2015). The 
continuously increasing amount of research in this field is motivated by the 
involvement of IDPs and IDRs in several crucial biological functions (Dunker et 
al., 2000, Dunker and Obradovic, 2001). In fact, intrinsically disordered proteins 
or regions of proteins play key roles in regulatory and signalling processes of the 
cell (Wright and Dyson, 2015, Tompa, 2011). 
 
 
1.3   Protein complexes  
 
Every biological process requires the assembly of individual proteins into 
functional complexes. In particular, molecular machines are complexes that 
perform the major biological processes in the cell and consist of multiple 
components, whose activities are largely sequential and independent. These units 
retain their individual functions, but act in a more coordinate way because they 
are part of the same complex. Therefore, the formation of protein complexes is 
evolutionary favourable as it allows to bring together diverse functions by reducing 
the additional regulatory potential that would be required if the different 
polypeptide chains were not part of a complex (Marsh and Teichmann, 2015). 
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Additionally, proteins can self-assemble into homomeric complexes. In this case, 
the evolutionary benefit is obviously not an increase in the number of concerted 
different activities and several functional advantages linked with homo-
multimerization have been suggested. Self-assembly is directly related to protein 
function because the interface between two monomers could generate an active 
site or a ligand-binding site, it is a simple mechanism to achieve cooperative 
function and increased protein stability and it is “economically” favourable for the 
cell because it allows to form large assemblies using less genetic material (Perica 
et al., 2012, Goodsell and Olson, 2000). For what concerns the dynamics of 
protein complexes, the conformational changes observed upon protein-protein 
interactions largely depend on the nature of individual components. In general, if 
a protein exhibits a high degree of flexibility as a monomer, it will undergo a large 
conformational change upon binding. An extreme example of this phenomenon is 
represented by intrinsically disordered proteins, which have been shown to be 
able to form highly ordered structures when part of a complex (Hegyi et al., 2007, 
Dyson and Wright, 2002). As previously discussed for monomeric proteins, also 
protein complexes present movements on a wide range of time-scales and 
locations. In several energy-dependent molecular machines, large coordinated 
motions of different subunits are necessary for carrying out a specific function. For 
example, the rotary movement of the stalk of ATP synthase, caused by the 
movement of protons through the membrane-bound region, induces a 
conformational change of the b-subunits, which triggers ATP synthesis from ADP 
and phosphate (Stock et al., 1999). A different category of dynamic complexes is 
represented by “fuzzy complexes”, which are formed by intrinsically disordered 
proteins that remain partially unfolded (Tompa and Fuxreiter, 2008).  
 
 
1.4   Nucleic acid-binding proteins   
 
Nucleic acid-binding proteins are fundamental for the life of every organism. DNA-
binding proteins (DBPs) are key effectors of all aspects of genetic activity in the 
cell, such as transcription, packaging, rearrangement, replication and repair. 
RNA-binding proteins (RBPs) are involved in splicing, polyadenylation, RNA 
stability, RNA localization and protein translation. The physical interactions 
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between proteins and nucleic acids rely on hydrogen bonds, hydrophobic 
interactions and water-mediated contacts. Many DBPs and RBPs contain multiple 
nucleic acid binding domains, which can act together to recognize different 
regions of their targets, leading to an increase in affinity and specificity. 
 
 
1.4.1   DNA-binding proteins 
 
DNA-binding proteins (DBPs) bind DNA using a wide range of DNA binding 
domains (DBDs), such as homeodomain (HD), helix-turn-helix (HTH), zinc finger 
(ZF) and high-mobility group box (HMG). The mechanisms by which DBPs bind 
their targets are historically known as “direct readout” and “indirect readout” 
(Otwinowski et al., 1988). “Direct readout”, also known as “base readout”, occurs 
when the side chains of the amino acids of a protein directly interact with specific 
bases of the DNA. On the other hand, “indirect readout” is triggered by specific 
conformation of the DNA, such as DNA bending and kinks, and it is therefore 
referred as “shape readout”. Even though direct recognition, through a conserved 
DBD, is the common end-point in a protein-DNA complex, their interaction can 
depend on other factors. For example, DNA binding can be mediated by protein 
disordered regions. This mechanism is adopted by many transcription factors in 
order to facilitate protein diffusion along the DNA and regulate the transition from 
non-specific to specific binding (Doucleff and Clore, 2008). Moreover, DNA 
recognition can be mediated by cooperative binding when protein-protein 
interactions between multiple polypeptide chains are required to alter or stabilize 
protein-DNA contacts (Slattery et al., 2011). 
 
 
1.4.2   RNA-binding proteins 
 
RNA-binding proteins (RBPs) are generally considered as proteins that bind RNA 
with high affinity and specificity, through one or more globular RNA-binding 
domains (RBDs) (Lunde et al., 2007). Moreover, it is a common idea that RBPs 
interact with RNA targets in order to modify their fate or function in the cell 
(Gebauer et al., 2012). Even though these statements are true for many RBPs, 
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recent proteomic analysis have uncovered a variety of proteins that lack 
conventional RBDs (Tsvetanova et al., 2010, Castello et al., 2012, Baltz et al., 
2012), such as RNA recognition motif (RRM), hnRNP K homology domain (KH) 
and DEAD box helicase domain, but are able to bind RNA using different 
strategies. RNA recognition can be mediated by shape complementarity. An 
example of this binding mechanism is represented by the internal ribosome entry 
site of hepatitis C virus, which adopts a complex “key-lock” interaction mode to 
interact with the 40S ribosome (Quade et al., 2015). RNA binding can also be 
mediated by protein disordered regions, which are highly enriched in RBPs and 
conserved from yeast to humans (Beckmann et al., 2015). Consequently, IDRs 
could represent plastic, multifunctional RNA-binding motifs, which are involved in 
both non-selective and highly specific protein-RNA interactions, often by triggering 
co-folding (Varadi et al., 2015). An example of this binding mechanism is 
represented by the intrinsically disordered Arg-Gly-Gly repeat motif of fragile X 
mental retardation protein, which co-folds with its RNA target resulting in a b-turn 
that recognizes a G-quadruplex RNA (Vasilyev et al., 2015, Phan et al., 2011). 
The variety of protein-RNA interactions reported suggests that RNAs may also 
regulate the function of proteins. It follows that there must be a functional cross-
talk between proteins and RNAs, which allows both macromolecules to regulate 
each other’s fate (Hentze et al., 2018, Beckmann et al., 2016). For example, the 
antiviral protein PKR is activated upon binding to double stranded RNAs (dsRNAs) 
produced during viral replication, and subsequently phosphorylates the subunit a 
of the eukaryotic translation initiation factor elF2, severely inhibiting cellular and 
viral protein synthesis (Balachandran and Barber, 2007).  
 
 
1.5   The importance of structural biology 
 
A fundamental axiom of biology is that the three-dimensional structure of a protein 
determines its function. Understanding function through structure is a primary goal 
of structural biology. In particular, the structural study of how proteins interact with 
DNA, RNA, small molecules and other proteins is necessary to gain a deeper 
knowledge of all biological processes. Many factors can impact the correct 
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performance of molecular machines in the cell and lead to the development of 
diseases. Deciphering the results of these changes on the physiological structure 
of proteins and their complexes helps to reveal the role they play in diseases. 
Consequently, structural biology is of extreme importance for other fields, such as 
biotechnology, drug discovery and the design of “intelligent” therapeutics.  
 
 
1.6   Limitations of conventional structural biology techniques 
 
The vast majority of the structures deposited in the Protein Data Bank (PDB) have 
been solved by X-ray crystallography and nuclear magnetic resonance (NMR) 
spectroscopy. Therefore, we can refer to them as “conventional” structural biology 
techniques. Electron microscopy (EM) is the third major method represented in 
the PDB, followed by hybrid approaches. The continuous increase in the number 
of deposited structures solved by EM studies and hybrid methods is a clear 
indication of how the field of structural biology is evolving. In fact, even though X-
ray crystallography and NMR are extremely powerful techniques that allow 
obtaining atomic resolution structures and are still widely used, they present 
several limitations that are being overcome by embracing other methods. The 
main disadvantages of X-ray crystallography consist in the difficulty of studying 
flexible proteins and in the impossibility of looking at dynamics. In fact, increasing 
flexibility generally corresponds to more difficult crystallization and, when this is 
achieved, to lower resolution crystal structures or “invisible” linkers or missing 
parts of the proteins (Yu et al., 2000). The strategies that are usually adopted to 
overcome these issues consist in producing polypeptide constructs depleted of 
extremely flexible portions and in mutating particular residues in order to enhance 
the rigidity of a protein or “lock” it in a specific conformation. Moreover, a crystal 
structure represents a “snapshot” of the protein in the particular configuration that 
is adopted in the crystal lattice, therefore in a non-physiological environment. On 
the other hand, in NMR experiments the protein is in solution and this allows 
studying its structure in more physiological conditions. Moreover, using this 
technique, it is possible to obtain an ensemble of the conformations that the 
protein adopts, allowing the characterization of flexible and dynamic systems. 
However, the limiting factor of NMR studies is the size of the protein or complex 
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of interest. In fact, the upper size limit corresponds to ~40 kDa and this comes 
from the fact that the width of resonances increases with molecular weight, 
causing assignment to become impossible because of spectral overlaps 
(Campbell, 2002).  
 
 
1.7   The power of integrative structural biology  
 
A deeper understanding of the dynamic nature of macromolecular machines and 
their role in biological processes can be obtained through an integrative structural 
biology approach. As discussed in the previous section, the number of structures 
deposited in the PBD, which have been solved by EM studies and hybrid methods, 
has been continuously increasing in the last few years. The characterization of 
more complicated systems, which cannot be studied solely by conventional 
techniques, requires a multi-angle approach that provides information at different 
levels of detail. Employing several biochemical, bioinformatical and biophysical 
tools allows to obtain an all-round model of the system of interest. Over the last 
few years, integrative structural biology has been able to model the architecture 
of extremely important complexes, whose structural determination seemed 
impossible by adopting individual techniques. A striking example of the success 
of this approach is the RNA polymerase II (RNAPII) transcription initiation 
machinery, whose architecture has been resolved by using small angle X-ray 
scattering, cryo-EM, cross-linking mass spectrometry, affinity pull-downs, labelling 
and co-localization experiments, combined with atomistic structural information in 
the form of homology models or crystal structures available for some of the 
domains (Trnka et al., 2019). Another example is represented by the aerolysin 
pore formation complex, where a hybrid method combining cryo-EM, X-ray 
crystallography and molecular dynamics analysis showed the transition from 
monomer to a heptameric pre-pore state and finally to a functional toxin pore 
inserted in the target membrane (Degiacomi et al., 2013). These two examples 
represent a clear indication that the structure of macromolecular machines and 





In this thesis, an integrated approach is used to structurally characterize two 
extremely different nucleic acids binding proteins, the human Staufen1 protein 
and the archaeal Pyrococcus abyssi MCM complex.  
Staufen1 is a dsRNA-binding protein involved in many aspects of RNA regulation, 
such as mRNA transport along the microtubules (Vessey et al., 2008, Martel et 
al., 2010, Brendza et al., 2000, Ramasamy et al., 2006, Martel et al., 2006), mRNA 
decay (Park, 2013, Park and Maquat, 2013, Kim et al., 2005, Kim et al., 2014, 
Gong et al., 2013, Gong and Maquat, 2011, Gong et al., 2009, Cho et al., 2012, 
Cho et al., 2013) and regulation of protein translation (Ravel-Chapuis et al., 2012, 
Elbarbary et al., 2013, Bonnet-Magnaval et al., 2016).  
MCM is a highly conserved DNA helicase complex involved in replication (Tye, 
1999, Costa et al., 2008, Costa and Onesti, 2008), genome repair (Bailis and 
Forsburg, 2004) and transcriptional regulation (Hubbi et al., 2011). Archaeal 
MCMs have proven to be powerful tool to elucidate essential features of the 
functions of this protein in Eukaryotes, thanks to their simplified structural 
organization (Miller and Enemark, 2015).   
A more detailed introduction to the role of Staufen1 and MCM proteins and on 
their structural characterization can be found in Chapter 3 and Chapter 4, 
respectively. 
These two proteins are used in this study to show how an integrated structural 
biology approach is not only essential to determine the architecture of small, 
flexible proteins, which are traditionally difficult targets for conventional 
techniques, but it is also beneficial to understand the dynamic behaviour of large, 









2.1   Size exclusion chromatography coupled with multi-angle 
laser light scattering 
 
Size exclusion chromatography coupled with multi-angle laser light scattering 
(SEC-MALLS) is a technique widely used for protein characterization. SEC-
MALLS allows to evaluate sample purity and stability, as well as to determine 
proteins oligomeric state during purification (monomers, dimers, trimers etc.) and 
their size.   
The physical phenomena at the basis of SEC-MALLS is that small species do 
not present variation in their scattering intensity and are therefore referred to as 
“isotropic scatterers”. On the other hand, the light scattered by big biomolecules 
is different in every direction and its intensity depends on the scattering angle. It 
follows that detectors located at different angles perceive different amount of light 
scattering and this can be used to calculate the molar mass of the species. 
In order to perform a SEC-MALLS experiment, an HPLC system equipped with 
a size exclusion chromatography (SEC) column is connected to a multi-angle light 
scattering detector and to a differential refractive index detector (Figure 2.1). The 
sample is loaded onto the SEC column and subsequently passes through the 
MALLS detector. The resulting chromatogram is complemented with the molar 
mass distribution of the sample, allowing to determine the exact molecular weight 
of the species in a particular peak. Consequently, SEC-MALLS allows to 
overcome conflicting results from size exclusion chromatography alone. Indeed, 
in a SEC experiment, the separation is based on the hydrodynamic size of the 
biomolecules and this could resolve in an erroneous interpretation of the 












Figure 2.1: Schematic representation of SEC-MALLS experiment. A HPLC system 
equipped with a size exclusion chromatography (SEC) column is connected to a UV detector, 
a multi-angle light scattering detector and a differential refractive index detector. The sample 
is loaded onto the SEC column and subsequently passes through the detectors. The resulting 
chromatogram is complemented with the molar mass distribution of the sample, which allows 






2.2   Analytical ultracentrifugation 
 
Analytical ultracentrifugation (AUC) is a powerful technique that allows to 
determine the molecular weight, hydrodynamic and thermodynamic properties of 
a protein or other macromolecules in solution. Moreover, it allows to study protein 
interactions, such as oligomerization states and complexes formation, their 
stoichiometry and association constants.  
An analytical ultracentrifuge is a high-speed centrifuge equipped with optical 
systems (UV-Vis absorbance and Rayleigh interference) that enable to record the 
behaviour of molecules in solution as they undergo sedimentation (Figure 2.2). As 
the rotor spins, scans are generated when the cell, containing the sample, passes 
through an optical detector’s path. Sequential scans allow to monitor the change 




Figure 2.2: Schematic representation of AUC system and sedimentation velocity 
experiment. Left: High-speed centrifuge equipped with optical systems (a Xenon flash lamp 
generates a high-intensity light that is directed to the cell by a toroidal diffraction grating; light 
is diffracted by inhomogeneity in the cell and recorded by an imaging system connected to a 
photomultiplier tube). Right: Sedimentation velocity experiment showing the movement of 
macromolecules upon sedimentation, represented by the shift of boundaries, from the top to 
the bottom of the cell. (Adapted from [(Ralston, 2004)]) 
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There are two approaches that can be used in analytical ultracentrifugation: 
sedimentation velocity and sedimentation equilibrium. Sedimentation velocity is 
technique in which the macromolecules of interest sediment during the duration 
of the experiment, ultimately pelleting at the bottom of the cell. On the other hand, 
in a sedimentation equilibrium experiment the particles reach a perfect equilibrium 
between sedimentation and diffusion and do not sediment. 
Thanks to the shorter duration of the experiment and to the development of 
softwares that allow to model complex systems, sedimentation velocity AUC is 
generally considered the primary method of choice for most current applications 
of analytical ultracentrifugation, including the analysis of protein oligomerization 
state and hetero-complexes formation, conventional targets of sedimentation 
equilibrium AUC experiments.  
In a sedimentation velocity experiment, a series of sequential scans is used to 
monitor in real-time how the macromolecules move through the solution, thanks 
to snapshots that describe their position in the cell in a specific moment in time. 
The rate of sedimentation of the particles provides information about their 






where M is the molar mass of the macromolecule, ?̅? its partial specific volume, 𝜌 
the density of the solvent and 𝑓 the frictional coefficient.  
It follows that the sedimentation coefficient is proportional to the size of the 
macromolecule and inversely proportional to the frictional coefficient, which is 
related to the overall dimensions of the particle. In other words, if two proteins 
have the same molar mass but different shapes, i.e. different frictional ratios, they 
will sediment at different Svedberg (S) units (10-13 seconds).  
In an ideal mono-disperse system, the rate of sedimentation can be calculated 
by plotting the midpoint of each curve generated by individual scans, therefore 
monitoring the progression of the “boundary”. However, in real experimental 
condition, this simple approach is often not applicable because of the presence of 
extremely small molecules or of several species in solution, even when highly 
purified samples are employed. To overcome these limitations, several 
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computational approaches have been developed in order to analyse 
sedimentation data. For example, the programs generally used to analyse multi-
species systems are UltraScan and Sedfit, which are based on the c(s) analysis 
and allow to obtain the sedimentation coefficient s (S). Moreover, these softwares 
allow to determine the steepness of the boundaries, which relates to the frictional 
ratio f/f0 that represents the comparison between the frictional coefficient of the 
sedimenting particle (f) and the one of an ideal sphere of identic volume (f0). It 
follows that it is possible to extrapolate the molecular weight of the species in 
solution by calculating the sedimentation coefficient and the frictional ratio.  
 
 
2.3   Microscale thermophoresis 
 
Microscale thermophoresis (MST) is a biophysical technique that allows to 
determine the strength of inter-molecular interactions based on the dispersion of 
biomolecules upon heating, in solution.  
Thermophoresis is the movement of the molecules across a temperature 
gradient and it is affected by their size, charge and hydration shell. Consequently, 
the change in any of these properties, upon binding to a partner, can be monitored 
using this technique and it allows to determine the dissociation constant (Kd) of 
the complex. 
In a MST experiment, an infrared (IR) laser is used to heat a small portion of a 
capillary tube containing the sample, as shown in Figure 2.3. Upon laser 
stimulation, molecules can move away from the heat (“positive” thermophoresis) 
or towards it (“negative” thermophoresis). In both cases, once the laser is turned 
off, the molecules diffuse back to their original equilibrium state. The difference in 
the molecular diffusion of a complex and of an unbound protein is measured as a 
change in fluorescence. Indeed, one of the biomolecules (“target”) is labelled with 
a fluorophore, while the other molecule is unlabelled and mixed to the target in 
different concentrations, acting as a “ligand”. Upon heating, if the ligand is 
interacting with the target molecule, the complex will diffuse at a different rate 
relatively to the individual components, giving rise to a difference in fluorescence 
(Figure 2.3, bottom left). The change in fluorescence amongst the capillaries, 
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containing different concentrations of ligand, allows to directly determine the 
dissociation constant of the complex (Figure 2.3, bottom right). 
MST presents several advantages compared to the conventional techniques 
traditionally used to study kinetics. In contrast with Isothermal Titration Calorimetry 
(ITC) and Surface Plasmon Resonance (SPR), the amount of sample required is 
limited to few microliters. In fact, each capillary contains only 4-5 µl of sample and 
a 16-capillaries titration curve is generally sufficient to observe the complex 
formation and obtain a precise measure of the Kd. Moreover, this method does 
not require immobilization of the target protein and it is performed in solution, 
therefore in native-like conditions. Using this technique, any size of biomolecules 





Figure 2.3: Schematic representation of Monolith Nanotemper system and principles of 
MST experiment. Top: IR laser is used to heat a small portion of a capillary tube containing 
the sample and the heat generated causes the molecules to move; once the laser is turned 
off, the molecules diffuse back to their original equilibrium state. Bottom: A complex will diffuse 
at a different rate when heated up relatively to the individual components, giving rise to a 
difference in fluorescence that allows to directly determine the dissociation constant of the 
complex. (Adapted from [(Jerabek-Willemsen et al., 2014)])  
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2.4   Nuclear magnetic resonance spectroscopy 
 
Nuclear magnetic resonance spectroscopy (NMR) is one of the techniques that 
has been traditionally used to study the three-dimensional structure of proteins at 
atomic resolution, together with x-ray crystallography. NMR allows to determine 
the solution structure of relatively small proteins or complexes, generally in the 
range of 5-40 kDa. However, this method can also be used to yield information 
about the chemical properties of macromolecules and their folding state, or to 
measure the kinetics of complex formation. 
The NMR phenomenon is based on the fact that nuclei of some atoms (1H, 13C, 
15N, ...) have magnetic properties, which can be used to gain chemical information 
on the geometry of a molecule. Indeed, those atoms possess a “non-zero” overall 
spin because the number of the protons and neutrons in their nucleus is different.  
When an external magnetic field B0 is applied, the nuclear magnetic momentum 
of an NMR-active atom will align to it, either in an energetically favourable parallel 
orientation (with spin 𝑚 =	+ !
"
 ) or in an higher energy anti-parallel orientation 
(with spin 𝑚 =	− !
"
 ) as shown in Figure 2.4 A. 
However, the rotational axis of the spinning nucleus is not perfectly parallel (or 
anti-parallel) to the applied magnetic field B0, but it rotates at an angle. The 
angular velocity, also called Larmor frequency, can be described as: 
 
𝜔# = 𝛾𝐵# 
 
where g is the magnetogyric ratio and it is characteristic of each nucleus as it 
relates to its magnetic momentum µ and spin number I. 
Conceptually, the NMR experiment consists in irradiating the sample with a 
pulse of electromagnetic radiation of frequency 𝜔#  (in the MHz range) and 
duration t. In this way, a nucleus can be induced to transition from a low energy 
parallel orientation to a higher energy anti-parallel state and this absorption of 
energy is at the basis of the NMR method. It follows that, after the pulse, the 
sample nuclei magnetic moments are in a non-equilibrium condition, as they are 
not anymore aligned to the applied magnetic field B0. Subsequently, the nuclei 
magnetic moments initiate a process called “relaxation”, in which they return to 
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equilibrium and therefore aligned to the external magnetic field. The time-
dependent relaxation signal is recorded as a FID (free induction decay) spectrum 
and then Fourier transformed in order to obtain a frequency domain spectrum 




Figure 2.4: Schematic representation of NMR experiment. A: Schematic representation of 
the rearrangement of the nuclear magnetic momentum of NMR-active atoms upon application 
of magnetic field (spin m= ±1/2); the rotational axis of the spinning nucleus is not perfectly 
parallel (or anti-parallel) to the applied magnetic field B0, but it rotates at an angle. B: The 
sample is irradiated with a pulse of electromagnetic radiation that induces the nuclei to 
transition from a low-energy to a high-energy state; this absorption of energy causes the nuclei 
magnetic moments to be in a non-equilibrium condition and subsequently to return to 
equilibrium via a process called “relaxation”: the time-dependent relaxation signal is recorded 
as a FID (free induction decay) spectrum and then Fourier transformed in order to obtain a 




The power of the NMR method is given by the fact that it allows to distinguish 
between chemically different protons, which experience a slightly different applied 
magnetic field depending on the electronic environment in which they are located. 
The electrons around the nuclei generate a magnetic field, which is anti-parallel 
to the external one and attenuates its effect on the atoms. It follows that protons 
are electronically shielded and the Larmor frequency can be re-written as:  
 
𝜔# = 𝛾(𝐵# − 𝑆) 
 
where S represents the change in magnetic field caused by the electrons, and it 
depends on the chemical structure and geometry of the molecule.  
The NMR spectra provides information on the “chemical shifts” of all the 
protons of the examined molecule, in comparison to the signal given by 
tetramethylsilane (TMS) or by 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS), 
which are used as reference standards for NMR experiments of organic solvents 
or proteins, respectively.  
When analysing proteins by NMR it is useful to introduce one or more NMR-
active atoms, such as 15N and 13C. The labelled recombinant protein can be 
expressed in micro-organisms grown in minimal growth medium supplemented 
either with 15N-labelled ammonium salts or with 13C-labelled glucose. The 
advantage of using heteronuclear NMR analysis is that the nuclei spins are almost 
all connected by one-bond couplings. In particular, the 1H-15N coupling is the most 
important starting point for NMR analysis of proteins since this bond is present in 
every amino acid residue, except for N-terminus and proline residues.  
The simplest method used to record this coupling is called 1H-15N HSQC 
(heteronuclear single quantum correlation). However, when analysing larger 
proteins or complexes, it is generally preferred to perform a TROSY experiment 
(transverse relaxation optimized spectroscopy) in order to obtain sharper peaks 
in the NMR spectra and higher resolution.   
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2.5   Small angle scattering  
 
Small angle scattering (SAS) is a powerful technique that has been extensively 
used to structurally characterize biological systems over a broad range of 
macromolecular sizes, from small peptides to large macromolecular assemblies. 
This method can be used on its own to obtain low-resolution models (10-20 Å) of 
biological macromolecules in solution, however it is more often used in 
combination with other structural, hydrodynamic, computational and biochemical 
techniques.  
A schematic representation of a scattering experiment is illustrated in Figure 
2.5. It is conceptually very simple, with many instruments being essentially pinhole 
cameras, and requires only a source, a sample and a detector, combined with 
focussing and collimation devices, such as mirrors and slits. Scattering is a 
physical process where a beam of radiation, in this case either X-rays or neutrons, 
is deviated from its initial incident trajectory by inhomogeneities in the medium 
through which it passes. 
 
 
            
 
 
Figure 2.5: Schematic representation of SAS experiment. A beam of radiation is produced 
by a source and deviated by its incident trajectory by inhomogeneities of the sample; the 
scattered beam hits the detector and the scattering only depends on the momentum transfer 





X-rays and neutrons are both used as probes for diffraction, spectroscopy and 
scattering, but they interact with matter in different ways. X-rays interact largely 
with electrons, while neutrons interact with atomic nuclei. It follows that the 
magnitude of X-ray scattering depends solely on the constituent atoms electron 
density. Consequently, heavier atoms are stronger X-ray scatterers, as they 
contain more electrons. On the other hand, neutron scattering is due to nuclear 
and spin densities and it does not depend exclusively on atomic number, but also 
on the isotopic composition of the sample.  
In spite of these different scattering mechanisms, however, the theories for data 
analysis are similar and therefore they will be described together in this section.  
The first assumption that needs to be made to examine small angle scattering 
is that the energy and wavelength (λ) of the incident and the scattered radiations 
are identical; thus, we are only considering the ideal case of elastic scattering of 
X-rays and neutrons.  
The scattering from aqueous solutions of biological macromolecules is 
assumed to be isotropic and only depends on the momentum transfer q, which is 






where 2θ is the scattering angle between the incident beam and the scattered 
radiation. 
Since each atom contributes to the total scattering intensity, it is important that 
every measurement of the scattering of a solution of macromolecules is always 
accompanied by that of the corresponding solvent, in order to perform background 
subtraction. For both x-ray and neutron instruments, there are a variety of 
instrumental corrections and normalizations that are performed as part of data 
reduction, such as detector efficiency correction, scaling to absolute units and slit 
smearing.  
The resulting scattering pattern Itotal(q) is given by the interference of scattered 
waves and can be described as: 
 




where I(q) is the form factor and S(q) is the structure factor. 
While the form factor I(q) originates from the scattering of individual particles in 
solution and contains information about their structure, the structure factor S(q) 
results from the interference of the scattered waves emitted by different particles 
and contains information about the structure of the solution, meaning inter-particle 
interactions. However, in the range of concentrations generally employed in a 
scattering experiment (μM, mM), we can assume that there are no inter-particle 
interactions. It follows that the assumption of working with an ideal (non-
interacting) system can be made (S(q)=1), therefore only I(q) is necessary to fully 
describe the scattering pattern. 
Using small angle scattering it is possible to quickly obtain general information 
about the size and the shape of a macromolecule is solution, thanks to the direct 
computation of overall parameters from scattering data, which will be described in 
this section. 
The initial slope of a scattering curve from a monodisperse solution of identical 






where Rg is the radius of gyration.  
This approximation (Guinier’s law) is valid at small q values, typically in the 
range qRg<1.3, and allows to extrapolate the scattering intensity at zero angle I(0) 
which cannot be determined experimentally because it is masked by the 
beamstop on the detector. The beamstop protects both X-ray and neutron 
detectors from damage or overload by the intense direct beam. Rg and I(0) can 
therefore be calculated using the Guinier plot (ln[I(q)] versus q2), where the slope 
gives Rg and the intercept with the ordinate axis gives I(0).  
The linearity of the Guinier region represents the first indication of sample 




Additional information about the macromolecule is provided by the pair-distance 
distribution function p(r), which is computed by a Fourier transformation of the 












p(r) represents the scattering data in real space and contains information on 
distances within the particle. For this reason, it cannot be determined directly 
using this equation as I(q) is not known over the full interval 0 £ q £ ¥ and it can 
only be obtained with statistical and systematic errors. 
However, using an indirect Fourier transform, the pair-distance distribution 
function can be approximated by a limited series of functions ji in real space. 
Therefore, the resulting approximated distance distribution function pa(r) can be 
described as: 
 
𝑝-(𝑟) = 	F𝑐.𝜑. 	(𝑟)					for
/#
.0!
	0 ≤ 𝑟 ≤ 𝐷1-2 
 
where ns is the number of functions ji and Dmax is the maximal dimension in the 
particle.  
Since the pair-distance distribution function contains information on distances 
within the particle, it follows that macromolecules with different shapes are 
described by different distribution functions. Figure 2.6 shows how geometrical 
bodies with the same maximum dimension Dmax, but different shapes, exhibit 








Figure 2.6: Scattering profile and pair distribution function of objects with same Dmax 
but different shapes. The scattering profile and the pair distribution function of a solid sphere 
are described by a red line, the ones of a long rod by a green line, the ones of a flat disk by a 
yellow line, the ones of a hollow sphere by a blue line and the ones of a dumbbell shape 






Information on the folding state of proteins, or on the compactness of the 
macromolecules, can be obtained directly from the scattering data using the 
Kratky plot (q2I(q) versus q).  
As shown in Figure 2.7, the Kratky plot of a folded globular (or compact) protein 
shows a peak which intensity usually decays at q-4. Conversely, unfolded proteins 
do not present any peak and instead show a plateau and a slow continuous 
increase at high q. 
Particular attention should be taken with the interpretation of the Kratky plot of 
flexible systems. An extremely flexible protein will appear to have a scattering 
pattern similar to the one of a random coil, exhibiting a decay of the intensity as q-
1 at high angles. However, this does not mean that the protein is present in solution 
as a random coil and further experiment should be performed to assess its folding 
state.  
Qualitative analysis of the Kratky plot is also a very important step in the 
identification of the most appropriate tools to generate reliable low-resolution 
models of the macromolecule, based on its level of flexibility. 
 
               
Figure 2.7: Characteristic Kratky plots of proteins exhibiting different levels of 
flexibility. The Kratky plot of a compact globular protein is represented by a continuous blue 
line, the one of a multidomain protein by a continuous red line, the one of a multidomain protein 
with flexible linker by a dashed orange line, the one of a partially flexible protein by a dashed 




Three-dimensional shape determination of biological systems from their scattering 
pattern can be achieved by different computational analysis methods. The choice 
of the most appropriate modelling approach depends not only on the state of the 
object in solution (compact or flexible), but also on a priori knowledge of its 
association state (monomer, dimer or higher order assemblies) and on the 
availability of high-resolution structures for specific portions of a macromolecule 
or complex.   
When no a priori structural information is available and the analysis of the Katky 
plot shows that the macromolecule of interest is highly compact, an ab initio bead 
modelling approach is the most straightforward method to obtain a low-resolution 
model of the particle.  
One of the most widely used programs based on this approach is DAMMIN 
(Svergun). Its algorithm represents the particle as a sphere (called “search 
volume”), of diameter Dmax, made of densely packed beads, where each bead in 
the search volume can be assigned to the solvent or to the macromolecule. 
Starting from a random configuration and through steps of simulated annealing, 
where one bead of the model is changed at each time, the algorithm calculates 
the theoretical scattering pattern from the generated bead model and calculates 
the discrepancy (C2) from the experimental data. The optimal configuration of 
densely packed beads, chosen as final model, is the one that minimise the C2 
function (Figure 2.8). 
Even though the final model generated by DAMMIN is one, ab initio methods 
do not provide a unique solution, as different models are obtained when the 
program is run several times on the same dataset. To reduce this intrinsic 
ambiguity, several utilities that allow the building of different models, and their 
comparison, have been developed. In particular, the workflow has been 
implemented by a preliminary ab initio bead modelling using DAMMIF, which is 
based on the same principles of DAMMIN but it is run several times. The models 
generated out of each run of DAMMIF are then compared with DAMAVER, which 












   
 
 
Figure 2.8: Schematic representation of ab initio bead modelling (DAMMIN). DAMMIN 
algorithm considers the particle as a sphere (“search volume”), of diameter Dmax, made of 
densely packed smaller beads. Each bead in the search volume can be assigned to the solvent 
or to the macromolecule. One bead of the model is changed at each time through iterative 
steps of simulated annealing, in which the algorithm calculates the theoretical scattering 
pattern from the generated bead model and calculates the discrepancy (C2) from the 
experimental data. The optimal configuration of densely packed beads, chosen as final model, 













When the macromolecule of interest exhibits significant flexibility, the scattering 
data cannot be analysed in terms of a single beads model, as this model would 
represent the average of very different conformations. 
Ensemble-based methods have been developed in order to account for the 
coexistence of multiple configurations adopted by a macromolecule in solution.  
One tool based on this approach is EOM (Ensemble Optimization Method). 
This program also allows to use available high-resolution structures of individual 
subunits or domains of a protein as constraints (called “rigid bodies”) for the 
generation of the EOM models. 
As described in Figure 2.9, this program first generates a pool of n independent 
models, based on the protein sequence and on structural information. After the 
creation of the pool of models, EOM runs a genetic algorithm that compares the 
average theoretical scattering intensity from the ensemble of n conformations with 
the experimental scattering data and selects the models that best describe the 
experimental data.  
 
            
 
Figure 2.9: Schematic representation of ensemble optimization method (EOM). EOM 
generates a pool of n independent models, based on the protein sequence and on constraints 
(rigid bodies). After the creation of the pool, EOM runs a genetic algorithm that compares the 
average theoretical scattering intensity with the experimental data and selects the models that 
best describe the experimental scattering profile. 
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2.6   Transmission electron microscopy 
 
Transmission electron microscopy (TEM) is a powerful tool that allows to 
determine the three-dimensional structure of biological macromolecules in native-
like conditions. Recent innovations in TEM instrumentations, in particular the 
development of direct electron detectors and phase plates, and improvement of 
image processing methods, led to a “resolution revolution” with the establishment 
of electron microscopy as a tool to obtain near-atomic resolution structures, 
previously achieved only by X-ray crystallography or NMR spectroscopy.  
Figure 2.11 shows the main components of an electron microscope. Electrons 
are generated by an electron gun (cathode) and then accelerated by an anode. 
The electron beam is focused onto the specimen by a condenser system and the 
image is subsequently produced and magnified by a set of electrostatic and 
electromagnetic lenses. The electron image is then transformed into something 
perceptible by the human eye and then recorded by a digital camera or by a direct 
electron detector. 
 
                              
Figure 2.10: Schematic representation of TEM microscope. The beam of electrons is 
generated by an electron gun and it is focused into a small coherent beam by the use of lenses. 
The beam hits the specimen and its transmission generates the image, which is then recorded 
and used for image processing. 
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Since electrons interact strongly with matter, electron microscopy is performed 
under vacuum conditions and for this reason the sample must be in the solid state 
for imaging.  
There are two approaches that allow to achieve this. The first method is called 
“negative staining” and it consists in embedding the sample in a thin heavy metal 
salt layer, traditionally uranyl acetate, which allows to visualize the envelope of 
the macromolecule of interest by exclusion (Figure 2.12). The protein suspension 
is firstly deposited on an EM copper grid covered with a 5-10 nm carbon film and 
then incubated with 2% uranyl acetate solution, which is subsequently blotted and 
allowed to dry. This method is quick and simple, and it allows to obtain a low-
resolution model of the macromolecule of interest, for this reason it is usually 
adopted as first step in electron microscopy studies. However, this technique 
presents some difficulties because some protein complexes cannot withstand the 
drying process and they collapse. Also, the models obtained from negative 
staining electron microscopy might not reflect the real conformation of the protein 
in solution because of the distortion induced by the metal layer.  
 
                  
 
Figure 2.11: Schematic representation of negative staining principle. The protein 
suspension is deposited on an EM copper grid covered with a 5-10 nm carbon film, let sit for 
2 minutes and then incubated with 2% uranyl acetate solution for 5 minutes, which is 




A second method, cryo-electron microscopy (cryo-EM), has been developed in 
order to overcome these limitations (Figure 2.13). Cryo-EM allows to obtain more 
accurate high-resolution models. This method consists in applying the protein 
suspension on a holey (Quantifoil) copper or gold EM grid, which can be also 
covered by a very thin layer of carbon (1-2 nm) or graphene oxide to allow better 
sample distribution. The sample is then blotted, allowing the macromolecules to 
enter the grid holes, and subsequently plunge-frozen in liquid ethane, which is 
kept cold by liquid nitrogen. Fast freezing allows to bring the sample to the solid 
state in native-like conditions, where its hydration state is maintained in vitrified 
ice, and prevents the formation of ice crystals, which would be detrimental to 
sample quality. Moreover, the specimen needs to be maintained at low 
temperature throughout the whole process, from sample preparation to imaging, 
which reduces the effect of radiation damage. Contrary to negative staining, cryo-
EM is a time-consuming technique which requires extensive screening of different 
sample preparation conditions in order to optimise particles distribution and ice 
thickness. 
 
                          
 
Figure 2.12: Schematic representation of cryo-EM principle. The protein suspension is 
deposited on a holey (Quantifoil) copper or gold EM grid (with or without a thin (1-2 nm) layer 
of carbon or graphene oxide. The sample is then blotted and subsequently plunge-frozen in 
liquid ethane, which is kept cold by liquid nitrogen. 
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Single-particle analysis (SPA) coupled to cryo-EM allows to achieve high-
resolution structural information of individual proteins or complexes. A substantial 
part of a single-particle project consists on processing the acquired images. To 
simplify data processing, several softwares have been developed for SPA, such 
as EMAN2 and RELION. Even though these packages are based on different 
approaches and algorithms, they share the same basic concepts. The typical SPA 
workflow is illustrated in Figure 2.14.  
The development of direct electron detectors allows to record movies in which 
the electron dose is fractionated into a series of frames, which can be then aligned 
and averaged. This allows not only to account for initial stage drifting and beam-
induced movements and correct it by excluding the first frames, but also to 
optimise the signal-to-noise ratio by excluding the last frames that will have a 
lower quality due to radiation damage. 
Moreover, CTF estimation allows to further evaluate image quality. CTF 
parameters depend on instrument features (voltage and spherical aberration) and 
microscopy settings used during the data collection (astigmatism, defocus and 
amplitude contrast). The subsequent correction for these parameters allows to 
additionally improve the quality of the dataset by selecting the micrographs which 
contain high-resolution information. 
In single-particle analysis, individual reprojections of the object in different 
orientations are picked and then extracted from the micrographs. Particles are 
then grouped in 2D class averages by iterative alignments, which allows to divide 
the dataset in homogeneous subsets with increased signal-to-noise ratio.  
A limited number of 2D class averages, representing different particle 
orientations, is then used to obtain an initial 3D model where angles and 
relationships between the reprojections are calculated through computational 
methods. The resulting model that best describe the object is then used as low-







Figure 2.13: Schematic representation of single particle analysis. Individual particles are 
picked from micrographs, which have been previously aligned and CTF corrected. Particles 
are then extracted to obtain individual reprojections that are successively subjected to several 
rounds of alignments in order to generate 2D class averages. These are then used to obtain 
an initial 3D model, for which angles and relationships between the reprojections are 
calculated through computational methods. The resulting model that best describe the object 




The improvement of the refinement can be monitored by evaluation of the Fourier 
Shell Correlation (FSC) curve, which provides information on the signal-to-noise 
ratio as a function of spatial frequency and resolution of the 3D density map. 
However, the “resolution” of cryo-EM maps cannot be univocally defined as 
several criteria are used for its determination. For example, the resolution can be 
defined as the spatial frequency at which the FSC curve is 0.5 or 0.143, the latter 
threshold being selected based on correlation studies between results obtained in 
EM and in x-ray crystallography.  
The interpretation of low/intermediate resolution EM maps is highly enhanced 
by the availability of atomic resolution structures of some portions of the protein 
or some components of a complex. Indeed, structures from NMR spectroscopy or 
X-ray crystallography studies, can be fitted in EM density map to validate the 
model and provide detailed information on feature localisation. On the other hand, 
caution should be taken with the interpretation of low-resolution EM maps. In fact, 
they only reveal the overall architecture of a protein (or complex) and no additional 
information, other than domains arrangement or components localisation, can be 







Human Staufen protein 
 
3.1   Introduction 
 
Staufen (Stau) is a dsRNA binding protein, which was originally identified in 
Drosophila melanogaster, where it plays an essential role in oocyte development 
(St Johnston et al., 1991, St Johnston and Nusslein-Volhard, 1992). It is well 
conserved from nematodes to humans and, depending on the species, it is 
composed of four or five dsRNA-binding domains (RBDs) (Wickham et al., 1999b). 
In humans, there are two Staufen paralogs: Stau1 and Stau2. The hStau1 gene 
encodes two main isoforms (55 and 63 kDa) and an additional isoform with six 
residues inserted into hStau1 RBD3 (Duchaine et al., 2000), whereas the hStau2 
gene encodes at least four isoforms (52, 56, 59 and 62 kDa): all these isoforms 
are generated by alternative pre-mRNA splicing and/or polyadenylation (Park and 
Maquat, 2013). Much of our knowledge on human Stau1 is based on the study of 
its hStau155 isoform. The hStau155 isoform is associated with 40S and 60S 
ribosomal subunits and co-localises with the rough endoplasmic reticulum (Luo et 
al., 2002, Wickham et al., 1999b, Marion et al., 1999). Besides the biochemical 
studies on its ribosome association, hStau155 has been characterised 
biochemically in the context of mRNA decay (Kim et al., 2005) and cell cycle 
control (Boulay et al., 2014). Whilst Stau2 is expressed only in the neuromuscular 
system and it is mostly involved in mRNA transport at particular sites of the post-
synaptic muscles, Stau1 is ubiquitously expressed (Bélanger et al., 2003, Lebeau 
et al., 2008, Vessey et al., 2008, Ravel-Chapuis et al., 2012, Peredo et al., 2014). 
Even though Stau1 and Stau2 exhibit different tissue localization, they have been 
shown to be involved in the same mechanisms of RNA regulation, such as mRNA 
transport (Martel et al., 2010, Martel et al., 2006, Ramasamy et al., 2006, Vessey 
et al., 2008, Ravel-Chapuis et al., 2012, Ferrandon et al., 1994), Staufen-mediated 
mRNA decay (Cho et al., 2013, Cho et al., 2012, Kim et al., 2014, Park and 
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Maquat, 2013, Gong et al., 2009, Gong and Maquat, 2011, Gong et al., 2013, Kim 
et al., 2005, Park, 2013) and regulation of protein translation (Ravel-Chapuis et 
al., 2012, Elbarbary et al., 2013, Bonnet-Magnaval et al., 2016). Among the 
several cellular processes in which Stau protein is involved we can include 
myogenic differentiation (Ravel-Chapuis et al., 2014), stress granule formation 
(Ravel-Chapuis et al., 2016), regulation of adipogenesis (Cho et al., 2013, Cho et 
al., 2012), progression of the cell cycle (Boulay et al., 2014) and cellular 
differentiation (Kretz, 2013, Gautrey et al., 2005, Gautrey et al., 2008, Peredo et 
al., 2014). Stau1 and Stau2 are also central players in virology: they play a role in 
HIV infection by favoring vRNA encapsidation (Banerjee et al., 2014, Chatel-Chaix 
et al., 2008, Chatel-Chaix et al., 2004, Mouland et al., 2000), in hepatitis C 
infection by transporting viral RNA to the site of translation and replication in the 
cells (Blackham and McGarvey, 2013, Dixit et al., 2016) and they are also required 
for efficient multiplication of influenza A virus (de Lucas et al., 2010). The variety 
of cellular processes in which Staufen is implicated suggests that this protein 
might adopt different binding modes with its diverse RNA targets and that 
structurally distinct RNA-Staufen complexes mediate the recruitment of effectors 
via protein-protein and/or protein-RNA interactions.  
The interaction between Stau1 and its RNA substrates has been initially 
characterised using molecular and cellular biology tools on hStau155. The 
evidence that multiple copies of hStau155 can bind a single dsRNA is based on 
studies showing that two hStau155 molecules bind the hARF1 RNA in cells, which 
is a target of Staufen-mediated mRNA decay (SMD) (Martel et al., 2010) and 
mRNA containing as many as 250 CUG repeats that typify patients with myotonic 
dystrophy in vitro (Ravel-Chapuis et al., 2012). Furthermore, hStau155 stabilizes 
relatively large imperfect base-pairing regions formed between mRNAs and long 
noncoding RNAs (Gong and Maquat, 2011). Additionally, multiple hStau1 
molecules bind in tandem to the same dsRNA to efficiently recruit the ATP-
dependent helicase hUPF1. Genome-wide analysis (Furic et al., 2008, Laver et 
al., 2013) and hiCLIP (RNA hybrid and individual-nucleotide resolution ultraviolet 
cross-linking and immunoprecipitation) (Fernandez Moya and Kiebler, 2015) of 
Staufen-associated mRNAs identified secondary structures that confer target 
specificity (Ricci et al., 2014). The hiCLIP experiments confirmed Arf1 RNA as a 
substrate for Stau1, adding evidence for the presence of a sbsRNA on the 3' UTR 
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of the X-box binding protein 1 (XBP1) mRNA (Fernandez Moya and Kiebler, 
2015). However, the molecular mechanism of Staufen/RNA recognition is still 
unclear (de Lucas et al., 2014), since even the recent structure of the RBD3-RBD4 
in complex with dsRNA does not provide a conclusive answer to whether or not 
this is sequence specific (Lazzaretti et al., 2018).  
Staufen is characterized by two conserved consensus amino acid motifs that 
fold into functional double-stranded RNA binding domains (RBD3, RBD4); hStau1 
contains two other RBDs (RBD2, RBD5) that are unable to bind RNA and, relative 
to hStau1, hStau2 has an additional RBD1 and only a partial RBD5 (Allison et al., 
2004, Wickham et al., 1999a, Furic et al., 2008, Buchner et al., 1999, Duchaine et 
al., 2002). The tubulin-binding domain (TBDs), which is involved in mRNA 
transport on the cytoskeleton, shares only 18% identity between hStau1 and 
hStau2 (Park and Maquat, 2013). The functional activation of a number of dsRNA-
binding proteins requires that they self-associate or associate with other dsRNA-
binding proteins (Park et al., 2013). A Staufen swapping motif (SSM) has been 
identified between the TBD and RBD5. The SSM is necessary for the 
homodimeric or heterodimeric interactions between Stau1 and Stau2. This 
dimerization is indispensable for Staufen activity during Staufen-mediated mRNA 
decay (Park, 2013, Martel et al., 2010, Gleghorn et al., 2013). RBD5 was also 
identified as the major determinant for protein–protein interaction in vivo, 
contributing to ∼50% of the Stau1 self-interaction. A recent SEC-MALLS report on 
purified protein also shows that, in the absence of RNA, SSM/RBD5 promotes 
dimerization (Lazzaretti et al., 2018). The importance of RBD2 in dimerization is 
less clear. BRET assays aimed at the study of hStau155 multimerization show that 
RBD2 (amino acids 37–79, isoform hStau155) interacts with full-length hStau1 
(Martel et al., 2010). On the other hand, recombinant purified RBD2-RBD3 
suggests that the contribution of RBD2 to hStau155 dimerization, while existing, is 
relatively minor (Martel et al., 2010, Park et al., 2013).  
To date, the analysis of the three-dimensional structure of Stau proteins has 
focused on studies of truncated versions of the protein in isolation or in complex 
with either short RNA sequences or truncated versions of interacting proteins 
(Figure 3.1). The NMR structure of Drosophila RBD3 in isolation first confirmed 
that this construct is organised in the typical α-β-β-β-α fold (PDB ID: 1STU) 
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(Bycroft et al., 1995). Mouse Stau2 RBD4 in the absence of dsRNA also showed 
the α-β-β-β-α fold (PDB ID: 1UHZ). The structure of human Stau1 SSM/RBD5 
solved by X-ray crystallography revealed a domain swapped dimer, which is 
responsible for mediating hStau1 dimerization (PDB ID: 4DKK) (Gleghorn et al., 
2013). The X-ray crystal structure of the complex between RBD5 and Miranda, a 
multi-domain scaffold protein involved in Drosophila neuroblast asymmetric 
division, showed two RBD5 domains symmetrically bound to the Miranda dimeric 
coiled coil region through their exposed β-sheet faces, revealing a previously 
unrecognized protein interaction mode for dsRBDs (PDB ID: 5CFF) (Jia et al., 
2015). The solution structure of Drosophila melanogaster Stau RBD3 bound to a 
12-bp stem-loop RNA, determined by NMR spectroscopy, revealed the interaction 
of the canonical α-β-β-β-α dsRBD fold with dsRNA (PDB ID: 1EKZ) (Ramos et al., 
2000b, Ramos et al., 2000a). The crystallographic structure of the RBD3-RBD4 
construct, bound to dsRNA as a dimer (monomers A and B), shows that the 
interaction surface with the RNA spans the major groove and the two adjacent 
minor groove surfaces. Furthermore, RBD3B is bound on the opposite side of the 
RNA molecule, in an antiparallel orientation to RBD3A, whereas density for the 




Figure 3.1: Domains organization of hStaufen1 (isoform 55 kDa) and available structural 
information. hStaufen155 domains are shown as coloured rectangles (RBD2: blue, RBD3: 
orange, RBD4: teal, TBD: purple, SSM: yellow, RBD5: pink). Available structures of individual 
and tandem domains, in complex with RNA or polypeptide molecules, are represented in 




Human, Drosophila, and C. elegans Stau bind dsRNA without apparent sequence 
specificity in vitro (St Johnston et al., 1992, Marion et al., 1999, Wickham et al., 
1999a, Ramos et al., 2000b, LeGendre et al., 2013, Wang et al., 2015). Yet, in all 
these systems, Stau proteins associate with specific RNA targets (St Johnston 
and Nusslein-Volhard, 1992, Ferrandon et al., 1994, Li et al., Mallardo et al., 2003, 
Kim et al., 2005, Kim et al., 2007, Furic et al., 2008, Heraud-Farlow et al., 2013, 
Laver et al., 2013, LeGendre et al., 2013, de Lucas et al., 2014, Ricci et al., 2014, 
Sugimoto et al., 2015), challenging the hypothesis that the binding of a dsRBDs 
to dsRNA has generally been considered to be dependent on the target RNA 
structure, rather than sequence. On the other hand, Bono and co-workers recently 
showed that, in addition to the interactions with the sugar–phosphate backbone 
previously shown for RBD3 (Ramos et al., 2000c), both domains of hStau1 directly 
contact RNA bases in the minor groove of ARF1 SBS. Indeed they also show that 
specific base recognition is relevant in vivo and may therefore contribute to the 
overall sequence selectivity by Stau, possibly together with additional regions of 
the protein or with other regulators (Lazzaretti et al., 2018). The macromolecular 
interaction events that happen downstream of Staufen RNA binding are still 
unknown. 
We used an integrated structural biology approach, combining homology 
modelling, small angle X-ray scattering, NMR, hydrodynamic methods and cryo-
EM, to characterize the structure of the human full-length Staufen1 protein to 
better understand the structural basis for  its functional plasticity. More specifically, 
we aim to decipher the structural components that play a role in the ability of this 
protein to interact in vivo with a wide variety of RNA substrates and protein 
interactors in order to mediate many diverse functions in RNA metabolism. To 
interpret this structure, we also studied its truncation mutant hStau155_DRBD2, its 
individual domains and several tandem domain fragments. We confirmed that 
RBD2 has an important role in protein oligomerization, as well as reporting for the 
first time its effect on protein solubility. Our data show for the first time that 
hStau155 adopts an elongated conformation in solution. Furthermore, in the 
absence of RNA, RBD3 and RBD4 are connected by a linker that is very flexible 




3.2   Materials and Methods 
 
 
3.2.1   Staufen proteins 
 
 
3.2.1.1   Cloning of individual and tandem domains  
 
Individual and tandem hStau155 domains were amplified by Polymerase Chain 
Reaction (PCR) from pRSET-B-Stau155 vector (Kim et al., 2005) as described in 
Table 3.1. Different annealing temperatures were used for primers corresponding 
to different constructs (shown as “*” in Table 3.1). Primers sequences and 
constructs boundaries are indicated in Table 3.2. PCR products for RBD2, RBD2-
RBD3, RBD3, RBD3-RBD4, RBD4 and TBD were purified using the QIAquick 
PCR Purification Kit (QIAGEN). PCR products for RBD4-TBD, SSM/RBD5 and 
TBD-SSM/RBD5 were purified from 2% agarose gel run in TBE using the MinElute 
Gel Extraction Kit (QIAGEN). Purified PCR products and pET28-a vector were 
digested with NdeI and HindIIIHF (NEB) for 3 hours at 37°C. Digested vector was 
purified from 1% agarose gel run in TBE using the MinElute Gel Extraction Kit 
(QIAGEN), whereas digested inserts were purified using the QIAquick PCR 
Purification Kit (QIAGEN). Ligations between the vector and the individual inserts 
(in ratio 1:3) were performed using the Quick Ligation Kit (NEB) for 5 minutes at 
RT. E. coli XL1-Blue cells were transformed by heat-shock method with 2.5 μl of 
the ligation reactions and plated in LB agar plates containing 50 μg/ml kanamycin. 
After overnight, for each of the transformations, 15 ml of LB, supplemented with 
50 μg/ml kanamycin, were inoculated with a single colony and the cultures were 
grown at 37°C o/n. Subsequently, plasmid DNA was purified using the Wizard 
Plus SV Minipreps DNA Purification Systems and sequenced. 
 





Table 3.1: PCR program used to amplify individual and tandem domains. Primers 
annealing temperature is indicated in the table by “*” and it varies as following for the 
constructs: RBD2 and RBD2-RBD3 (62°C), RBD3 and RBD3-RBD4 (60°C), RBD4 (65°C), 









3.2.1.2   Proteins overexpression and purification for SAXS, AUC and EM 
experiments 
 
Recombinant proteins were overexpressed in E. coli Rosettaä(DE3) pLysS cells 
transformed by heat-shock with pRSET-B vectors containing hStau155_FL (Kim et 
al., 2005) and hStau155_ΔRBD2 or with pET28a containing individual domains 
(RBD2, RBD3, RBD4, TBD, SSM/RBD5) and tandem domains (RBD2-RBD3, 
RBD3-RBD4, RBD4-TBD, TBD-SSM/RBD5). Starting cultures were grown in LB 
medium containing 50 μg/ml ampicillin (for hStau155_FL and hStau155_ΔRBD2) or 
50 μg/ml kanamycin (for individual and tandem domains) and 34 μg/ml 
chloramphenicol at 37°C o/n. 1 ml of overnight culture was inoculated in 1 L of TB 
medium supplemented with antibiotics and cells were grown to an OD600=0.6. 
Protein overexpression was induced by adding 0.5 mM IPTG and culturing the 
cells at 27°C overnight. Cells were harvested by centrifugation at 5000 rpm on a 
Beckman AvantiTM J-20 XP centrifuge with JLA 8.1000 rotor for 20 minutes and 
washed once with PBS; cell pellets were aliquoted and stored at -80°C. Frozen 
aliquots were thawed and lysed by sonication in 20 ml lysis buffer (25 mM HEPES 
pH 7.5, 1 M GndCl, 20 mM imidazole, 1% Triton X-100, 400 μl Complete EDTA-
free protease inhibitors (50X) and 2 μl benzonase) followed by 30 min of 
incubation on ice. Soluble protein extracts were separated from cell pellets by 
centrifugation at 15000 rpm for 30 min. 6-His tagged Staufen1 proteins were 
purified by nickel chromatography using HisTrap FF columns (GE Healthcare) 
equilibrated in washing buffer (25 mM HEPES pH 7.5, 1 M GndCl, 20 mM 
imidazole). Elution was performed with a 20 mM-1 M imidazole gradient. Fractions 
containing the protein of interest were pooled and concentrated to 10 mg/ml prior 
to size exclusion chromatography on a Superdex 200 Increase 10/300 GL 
(hStau155_FL and hStau155_ΔRBD2) or a Superdex 75 Increase 10/300 GL 
(individual and tandem domains) gel filtration column (GE Healthcare) in buffer A 
(25 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg HCl). 
Overexpression and purification efficiency were monitored by SDS-PAGE 
analysis on 12% or 18% gels stained with SimplyBlue SafeStain (Invitrogen). 
Fractions were also analyzed by Western Blot: the membrane was incubated o/n 
at 4°C with anti-His antibody conjugated with alkaline phosphatase (1:4000) and 
developed using the SIGMA-FASTTM BCIP/NBT reagent.  
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3.2.1.3   Proteins overexpression and purification for NMR analysis 
 
E. coli Rosettaä(DE3) pLysS cells were transformed by heat-shock with vectors 
carrying inserts for hStau155_FL, hStau155_ΔRBD2, individual domains (RBD2, 
RBD3, RBD4, TBD, SSM/RBD5) and tandem domains (RBD2-RBD3, RBD3-
RBD4, RBD4-TBD, TBD-SSM/RBD5). Starting cultures were grown as described 
above and the following day cells were cultured in TB medium supplemented with 
antibiotics to OD600=2. Cells were harvested by centrifugation at 5000 rpm on a 
Beckman AvantiTM J-20 XP centrifuge with JLA 8.1000 rotor for 20 minutes, 
resuspended in M9 minimal medium (1x M9, 2 mM MgSO4, 0.1 mM CaCl2) and 
grown for 30 min at 37°C. Successively, the minimal medium was supplemented 
with 400 μl Thiamine [50 mg/ml], filter-sterilized glucose [3 g/L] and filter-sterilized 
ISOGRO®-15N Powder-Growth Medium [1 g/L]. Protein overexpression was 
induced by adding 0.5 mM IPTG and culturing the cells at 27°C overnight. 
Purification of Staufen proteins was performed as described above, but replacing 
HEPES with 20 mM potassium phosphate buffer pH 7.5 in all buffers used. To 




3.2.1.4   Analytical ultracentrifugation (AUC)   
 
Sedimentation velocity experiments were performed at 50,000 rpm, using a 
Beckman Optima analytical ultracentrifuge equipped with an An-50Ti rotor. Data 
were recorded using both the absorbance (at 280 nm and 260 nm) and 
interference optical detection systems. The density and viscosity of the buffer 
were measured experimentally using a DMA 5000M densitometer equipped with 
a Lovis 2000ME viscometer module. The partial specific volume for the protein 
was calculated using SEDNTERP from the amino acid sequence. Data were 
processed using SEDFIT, fitting to the c(s) model. Figures were made using 






3.2.1.5   SEC-MALLS 
  
SEC-MALLS experiments were performed using a Superdex 200 10/300 Increase 
column (GE Healthcare) connected to an AktaPure 25 System (GE Healthcare). 
The protein sample (100 μL) was loaded onto the gel filtration column and eluted 
with one column volume (24 mL) of buffer A, at a flow rate of 0.7 ml/min. The 
eluting protein was monitored using a DAWN HELEOS-II 18-angle light scattering 
detector (Wyatt Technologies) equipped with a WyattQELS dynamic light 
scattering module, a U9-M UV/Vis detector (GE Healthcare), and an Optilab T-
rEX refractive index monitor (Wyatt Technologies). Data were analysed by using 
Astra (Wyatt Technologies) using a refractive increment value of 0.185 mL/g. 
 
 
3.2.1.6   Small Angle X-ray Scattering (SAXS) and Modelling  
 
SAXS data for hStau155_FL and hStau155_ΔRBD2 were collected on a Nano-
inXider instrument (1x106 ph/s) (Xenocs SA, Grenoble, France), at the ISIS 
Neutron and Muon Source (Harwell, UK). 80 μl of sample (hStau155_FL at 40 μM 
and hStau155_ΔRBD2 at 60 μM), were loaded using the Xenocs “low noise” flow 
cell chamber connected to an auto-sampler unit, and data were acquired in high 
resolution mode every 10 minutes for 120 seconds, for a total of 2 hours. SAXS 
data for Staufen1 proteins were reduced to 1D curves and buffer-subtracted using 
the Foxtrot package and then input to EOM 2.0 (Tria, 2015) (ATSAS suite). High-
resolution structures of individual domains were used as rigid bodies and 
constraints in the model generation. In our analysis, the modelled structures of the 
individual domains of Staufen1 were obtained using the Phyre2 web portal (Kelley 
et al., 2015). Human Staufen1 RBD3 was modelled by homology based on the 
NMR structure of Drosophila melanogaster Staufen RBD3 (PDB ID: 1EKZ) 
(Ramos et al., 2000b, Ramos et al., 2000a). The structure of human Staufen1 
RBD4 was obtained by homology modelling based on the mouse RBD4 (PDB ID: 
1UHZ). The structures of SSM and RBD5, were extracted from the structure 
solved by X-ray crystallography (PDB ID: 4DKK) (Gleghorn et al., 2013) and 
treated as two separate domains in this analysis, allowing complete inter-domain 
loop flexibility. To obtain a more complete set of structural information to use as 
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constraints for the interpretation of the SAXS data, the sequences of the 6-
His+linker+RBD2 domain of hStau155_FL, the 6-His+linker of hStau155_ΔRBD2 
and the TBD were modelled using the Phyre2 server (Kelley et al., 2015).  The 
program EOM 2.0 (Tria, 2015) was used to obtain the SAXS models of 
hStau155_FL protein and deletion mutants. A pool of 10,000 independent models 
was generated, based on the sequence of hStau155_FL, or hStau155_ΔRBD2, and 
on constraints we generated by homology modelling.  
SAXS data for individual domains and tandem domains were collected at B21, 
Diamond Light Source (Harwell, UK). 55 μl of each protein sample (~10 mg/ml) 
was loaded onto a Superdex 75 Increase 10/300 GL column (GE Healthcare), 
controlled by an Agilent HPLC system, coupled to an in-vacuum SAXS flow cell. 
HPLC-SAXS traces were processed using ScÅtter. Data were analysed using 
different strategies depending on their flexibility level. Models for individual 
domains RBD3 and RBD4 were obtained using ScÅtter and DAMMIN and the 
tandem domain TBD-SSM/RBD5 was modelled using BUNCH (ATSAS). All the 
other domains, showing higher degree of flexibility, were modelled with EOM 
using homology models obtained from Phyre2, as described above. 
 
 
3.2.1.7   NMR spectroscopy 
 
hStau155_FL, hStau155_ΔRBD2, individual and tandem domains were studied by 
NMR spectroscopy. 30 μl of D2O were added to 570 μl of protein in 20 mM 
potassium phosphate pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg.HCl, 2 
mM TCEP at a suitable concentration for NMR experiments (Table 3.3).  2D 15N 
TROSY experiments (trosyf3gpphsi19; Czisch et al., 1998; Pervushin et al.,1998) 
were recorded at 298 K on a Bruker AVANCE IIIHD spectrometer operating at 
14.1 T equipped with a 5 mm TCI cryoprobe and running TopSpin software. 
Spectra of hStau155_FL and hStau155_ΔRBD2 were recorded with 1024 and 128 
complex points and sweep widths of 10775.862 Hz and 1823.747 Hz in 1H 
and 15N, respectively. The data were processed by applying Lorentz to Gauss 
(GM; LB=-7.72; GB=0.1667) window function and zero filled to 2048 complex 
points before Fourier transformation in the 1H dimension. In the 15N dimension, 
linear prediction with 48 coefficients was applied extending the data to 512 
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complex points. This was followed by a sinebell squared (QSINE; SSB=2.25) 
window function and Fourier transformation. Spectra of the shorter Staufen 
fragments were acquired and processed similarly, except that only 78 complex 
points were recorded in the 15N dimension. Data were processed using the Bruker 
TopSpin software and figures were generated using CCPN analysis 2.4 (Vranken 
et al., 2005). 
                                	
Table 3.3: Protein concentration used for NMR experiments.	
 
 
3.2.1.8   Cryo-EM 
 
Cryo-EM data for hStau155_FL, purified at 1.3 mg/ml in buffer A (25 mM HEPES 
pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg HCl) as per section 3.2.1.2, 
were collected by Dr G. Cannone (LMB, Cambridge) and analysed by Dr Laura 
Spagnolo. The low-resolution EM map for Staufen full-length was used to interpret 
SAXS scattering curves. 
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3.2.2   ARF1 RNA 
 
 
3.2.2.1 ARF1 RNA preparation 
 
ARF1 DNA was amplified by PCR from vector pCR2.1-TOPO_Arf1_SBS, gift of 
Dr Michael L. Gleghorn and Prof Lynne E. Maquat, using forward primer (5’-
GTAATACGACTCACTATAGGGAGAGGCAAACGTGCGGCTCGTGG-3’) and 
reverse primer (5’-GCTGAGTAATATTGCATAGG-3’) as described in Table 3.4. 
The PCR product was purified from 0.8% agarose gel run in TBE using the 
MinElute Gel Extraction Kit (QIAGEN). The DNA was dried using a speed vacuum 
system and then resuspended in 30 μl of DEPC water. In vitro transcription was 
carried out for 6 hours at 37°C, supplementing the reaction mix with 
pyrophosphatase inorganic (NEB) and RNasin® Ribonuclease Inhibitors 
(Promega). ARF1 RNA was purified by phenol-chloroform extraction (3 washes 
with phenol:chloroform:isoamyl alcohol 25:24:1 followed by 3 washes with 
chloroform) and precipitated o/n at -20°C by addition of 2.5 volumes of EtOH and 
0.1 volumes of 3 M potassium acetate. The following day, the sample was spun 
down at maximum speed in a pre-cooled bench-top centrifuge for 30 minutes at 
4°C. The pellet was washed twice with 1 ml of 70% EtOH and then dried using a 
speed vacuum system. The RNA pellet was then resuspended in RNA storage 
buffer (40 mM HEPES, 100 mM KCl), aliquoted in PCR tubes, flash-frozen and 
stored at -80°C. Prior to use, RNA aliquots were thawed and boiled at 95°C for 10 
minutes and then transferred into boiling water, allowing a slow and constant 
decrease in temperature. When the temperature was below 60°C, 1 mM MgCl2 




        	
 




3.2.2.2 Microscale thermophoresis (MST) of ARF1 RNA and Staufen proteins 
complexes 
 
hStau155_FL and hStau155_ΔRBD2 were fluorescently labeled via the His-tag 
using NT-647. NT-647 labeled protein concentration was kept constant (10 nM), 
while the concentration of the non-labeled Arf1 RNA was varied between 33 μM 
and 1 nM. The samples were incubated for 30 minutes at room temperature and 
then loaded into MST NT.115 premium glass capillaries. MST analysis was 




3.2.2.3   Purification of Staufen proteins and Arf1 RNA complex 
 
100 μl of hStau155_FL or hStau155_ΔRBD2 proteins (10 μM) were incubated with 
100 μl of Arf1 RNA (87 μM) for 30 minutes at room temperature before being 
applied on top of a 24 ml glycerol gradient (5-70% glycerol in buffer 25 mM HEPES 
pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg HCl). hStau155_FL (10 μM), 
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hStau155_ΔRBD2 (10 μM), Arf1 RNA (87 μM) and gel filtration standards were 
individually loaded as controls. The gradient was run for 45 hours at 4°C at 28000 
rpm on a Sorvall ultracentrifuge with swing-out rotor Surespin (Sorvall). The 
gradients were manually fractionated in fractions of 500 μl and separation was 
checked with SDS-PAGE analysis of 12% gels stained with SimplyBlue SafeStain 
(Invitrogen) and 0.8% agarose gel run in TBE.  
 
 
3.2.2.4 Negative staining of hStau155_ΔRBD2/Arf1 complex 
  
Negative staining EM and single particle analysis (SPA) were coupled to study 
hStau155_ΔRBD2/Arf1 complex. 5 μl of the fraction from the glycerol gradient 
purification containing both hStau155_ΔRBD2 protein and Arf1 RNA were 
deposited on an EM copper grid 400 mesh (Agar Scientific) covered with a ~10 
nm layer of carbon and incubated for 2 minutes. The grid was washed and blotted 
3 times with 10 μl of ultra-pure water and 3 times with 10 μl of 2% uranyl acetate. 
The grid was then incubated for 5 minutes with 5 μl of 2% uranyl acetate, blotted 
and then dried and stored at room temperature. The data collection was carried 
out at nominal magnification of 50,000x, at a final sampling of 1.9 Å/pixel at the 
specimen level, using a Jeol2200 200kV FEG microscope, equipped with a Gatan 
UltraScan 4000 (4096x4096) CCD camera. Data were processed using EMAN2 
and RELION softwares. From the micrographs dataset, ~290,000 single particles 
(SP) were auto-picked with EMAN2 using 250 Å masks; the single particles 
images were extracted into boxes 128x128 pixels and band-pass filtered. The 
dataset was subjected to sequential rounds of alignments and classification in 
RELION, using a 200 Å mask, in order to polish the dataset and improve the 
resulting class-average images. ~43,000 particles were then sorted with RELION 
into three 3D classed using as reference an ab initio initial model generated with 






3.2.3   Upf1 protein 
 
 
3.2.3.1   Cloning of hUpf1 
 
Oligos containing the sequence for STREP-tag (Table 3.5) were annealed to form 
dsDNA: 50 μl of each oligos (100 μM) were added into a PCR tube and mixed 
before being boiled at 95°C for 10 minutes, annealing was achieved o/n by 
incubation of the PCR tubes into boiling water, allowing a slow and constant 
decrease in temperature. dsDNA containing Strep-tag and pTWO-E vector were 
digested with XbaI and HindIIIHF (NEB) for 2 hours at 37°C. Digested vector was 
purified from 1% agarose gel run in TBE using the MinElute Gel Extraction Kit 
(QIAGEN), whereas digested Strep-tag insert was purified using the QIAquick 
PCR Purification Kit (QIAGEN). Ligations between the vector and the insert (in 
ratio 1:3) were performed using the Quick Ligation Kit (NEB) for 5 minutes at RT. 
E. coli XL1-Blue cells were transformed by heat-shock method with 2.5 μl of the 
ligation reaction and plated in LB agar plates containing 50 μg/ml ampicillin. After 
overnight, 15 ml of LB, supplemented with 50 μg/ml ampicillin, were inoculated 
with a single colony and the cultures were grown at 37°C o/n. Subsequently, 
plasmid DNA was purified using the Wizard Plus SV Minipreps DNA Purification 
Systems and sequenced. pTWO-E_Strep-tag and pGEX-hUpf1 vectors were 
digested with NotIHF and HindIIIHF (NEB) for 3 hours at 37°C. Digested hUPF1 
insert and pTWO-E_Strep-tag vector were purified from 1% agarose gel run in 
TBE using the MinElute Gel Extraction Kit (QIAGEN). Ligations between the 
vector and the insert, transformation and plasmid DNA extraction were performed 
as described above and sequenced.  
 
        	
 
Table 3.5: Oligos used to introduce Strep-tag sequence in pTWO-E vector using XbaI 
and HindIIIHF restriction enzymes. 
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3.2.3.2   hUpf1 overexpression and purification  
 
Recombinant hUpf1 protein was overexpressed in E. coli Rosettaä(DE3) pLysS 
cells transformed by heat-shock with pTWO-E_Strep-tag vectors containing 
hUpf1, which were obtained as described in 3.2.2.1. Starting culture was grown in 
LB medium containing 50 μg/ml ampicillin and 34 μg/ml chloramphenicol at 37°C 
o/n. 4 ml of overnight culture was inoculated in 4 L of TB medium supplemented 
with antibiotics and cells were grown to an OD600=0.6. Protein overexpression was 
induced by adding 0.25 mM IPTG and culturing the cells at 23°C for 4 hours. Cells 
were harvested by centrifugation at 5000 rpm on a Beckman AvantiTM J-20 XP 
centrifuge equipped with JLA 8.1000 rotor for 20 minutes and washed once with 
PBS; cell pellets were aliquoted and stored at -80°C. Four frozen aliquots, from 1 
L of culture each, were thawed and lysed by sonication in 30 ml of lysis buffer (25 
mM HEPES pH 7.4, 1 M NaCl, 1mM MgCl2, 1μM ZnCl2, 20 mM imidazole, 1% 
Triton X-100, 600 μl Complete EDTA-free protease inhibitors 50X). Soluble 
protein extracts were separated from cell pellets by centrifugation at 15000 rpm 
for 30 min. 6-His tagged hUpf1 protein was purified by nickel chromatography 
using HisTrap FF columns (GE Healthcare) equilibrated in washing buffer B (25 
mM HEPES pH 7.4, 1 M NaCl, 1 mM MgCl2, 1 μM ZnCl2, 20 mM imidazole). 
Elution was performed with a 20 mM-1 M imidazole gradient. Fractions containing 
the protein of interest were pooled and incubated o/n at 4°C with 2 ml of streptactin 
resin, previously equilibrated with buffer B. The following day, the resin was 
transferred to a gravity column and washed with 5CV of buffer B. Elution was 
performed in buffer B supplemented with 2.5 mM desthiobiotin. The elution from 
the streptactin resin was concentrated to 500 μl [2 mg/ml] and loaded into a 
Superdex 200 Increase 10/300 GL SEC column, previously equilibrated in buffer 
C (25 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2). Overexpression and 
purification efficiency were monitored by SDS-PAGE analysis on 8% gels stained 
with SimplyBlue SafeStain (Invitrogen). Fractions were also analyzed by Western 
Blot: the membrane was incubated o/n at 4°C with anti-His antibody conjugated 






3.2.3.3 Interaction between Staufen proteins, Arf1 RNA and                            
hUpf1 protein 
 
70 μM of purified hStau155_FL or hStau155_ΔRBD2 proteins were firstly incubated 
with 70 μM of Arf1 RNA for 30 minutes at room temperature. 70 μM of purified 
hUpf1 were then added to the reaction mix and incubated at room temperature for 
1 hour, in a final volume of 21 μl in buffer C (25 mM HEPES pH 7.5, 100 mM KCl, 
10 mM MgCl2). Control reactions were set up with single components and protein-
protein and protein-RNA pairs. 7.5 μl of each reaction was loaded on a 4-16% Bis-
Tris NativePAGE (Invitrogen) with 0.5 μl of NativePage 5% G-250 sample additive 
(Invitrogen). Dark blue BN-PAGE was run for 1 hour at 150 V. Gel was de-stained 




3.3   Results and Discussion 
 
 
3.3.1   Staufen proteins  
 
 
3.3.1.1   Solution studies of Staufen domains 
 
Individual and tandem hStau155 domains were purified to homogeneity by 
immobilized nickel chromatography followed by size exclusion chromatography 
using a Superdex 75 Increase 10/300 GL column. The SEC traces and SDS-
PAGE analysis of individual domains are shown in Figure 3.2A-B, while the ones 
for tandem domains are shown in Figure 3.2C-D. For each construct, SEC peaks 
are consistent with the molecular weight of a monomer and correspond to ~10-12 
KDa for individual domains and to ~20-24 KDa for tandem domains. 
Interestingly, a higher molecular weight species can be observed in the SEC 
trace of RBD3 and RBD3-RBD4 and, in smaller amount, in the one of RBD4. SDS-
PAGE analysis and A260/280 measurements confirmed these species to be nucleic 
acid contaminants, previously co-purified during the affinity chromatography step. 
Their removal was successfully achieved by buffer exchange. Fractions from 
individual and tandem domains SEC peaks were concentrated to ~30 μM using 3 
K MWCO spin-concentrators and analytical ultracentrifugation (AUC) experiments 
were performed in order to address whether or not these constructs could form 
dimers in solution (Figure 3.2E-F). 
Our data for the SSM/RBD5 construct are consistent with that shown previously 
by X-ray crystallography (Gleghorn et al., 2013) and show that SSM/RBD5 is 
present in solution both as a monomer and as a dimer, likely to be a concentration-
dependent equilibrium. However, TBD seems to inhibit the dimerization of 
SSM/RBD5, as supported by the presence of a unique peak in the AUC data for 
the tandem domain TBD-SSM/RBD5. Moreover, the construct RBD3-RBD4 is 
mainly present in solution as a monomer, as previously shown (Lazzaretti et al., 





Figure 3.2: Purification and biophysical characterization of Staufen individual and 
tandem domains.  A: SEC trace of Staufen individual domains purified in buffer A (25 mM 
HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg HCl) using a Superdex 75 Increase 
10/300 GL SEC column at 0.7 ml/min. B: SimplyBlue SafeStain staining of 18% SDS-PAGE 
gel of SEC purified individual domains. C: SEC trace of Staufen tandem domains purified in 
buffer A (25 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg HCl) using a 
Superdex 75 Increase 10/300 GL SEC column at 0.7 ml/min. D: SimplyBlue SafeStain staining 
of 18% SDS-PAGE gel of SEC purified tandem domains. E: Analytical ultracentrifugation 
(AUC) of individual domains (~30 μM). F: Analytical ultracentrifugation (AUC) of tandem 
domains (~30 μM). 
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Individual and tandem domains were studied by SAXS and 2D NMR (Figure 3.3 
and Figure 3.4, respectively). 15N,1H-TROSY spectra were recorded for individual 
and tandem domains, with the exception of TBD, for which the concentration was 
too low.  
The presence of peaks only in the central area of the spectra of RBD2 indicates 
that this domain is unfolded in isolation. RBD3 and RBD4 are folded domains in 
isolation and peaks corresponding to amino acids in regions with a well-defined 
secondary structure and the ones corresponding to amino acids in disordered 
regions (loops) can be seen in their NMR spectra. SSM/RBD5 construct appears 
to be structured, however, some buffer contribution and possibly monomer-dimer 
equilibrium interfere with further investigations.  
Additionally, the similar lineshapes and lack of significant chemical shift 
perturbations between the spectra recorded for individual and tandem domains 
(Figure 3.3 and 3.4, respectively) show that interactions between adjacent 
domains are very limited and that each of the domains constituting the tandem 
constructs tumbles independently in solution, thanks to the intervening linkers’ 
flexibility. This is also confirmed by SAXS analysis of individual and tandem 
domains, with representative models shown appended to NMR spectra. SAXS 
profiles, Kratky analysis and the ensemble of models obtained for each construct 
are shown in Figures 3.5-3.13.  
Different modelling approaches were adopted based on the flexibility level of 
each construct. RBD2 was modeled using EOM in “compact chain” mode, out of 
10,000 models initially generated based on its sequence, seven were selected as 
final output that satisfy the experimental data and the dimensional parameters of 
the models are Rgensemble=37.3 Å, Dmaxensemble=112.64 Å, (Χ2=0.98). RBD3 
and RBD4 were modeled using DAMMIN as they appeared to be more compact. 
RBD3 dimensions are Rg=18.74 Å and Dmax=58.08 Å (Χ2=0.835), while RBD4 has 
Rg=17.15 Å and Dmax=51.37 Å (Χ2=0.5314). The same approach used for the 
unstructured RBD2 in isolation was used for TBD and EOM generated eight 
models (Rgensemble=31.74 Å, Dmaxensemble=97.24 Å (Χ2=1.29). The other 
domains were modeled using either EOM or BUNCH and feeding the software 
homology models obtained for RBD3, RBD4 and SSM/RBD5 as constraints. Four 
models were generated for SSM/RBD5 (Rgensemble=25.55 Å, 
Dmaxensemble=83.44 Å (Χ2=1.405), for RBD2-RBD3 (Rgensemble=37.86 Å, 
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Dmaxensemble=120.74 Å (Χ2=1.16) and for RBD3-RBD4 (Rgensemble=36.15 Å, 
Dmaxensemble=114.96 Å (Χ2=1.342). Eight models were generated for TBD-RBD4 
(Rgensemble=36.46 Å, Dmaxensemble=121.16 Å (Χ2=1.253). The model obtained 
with BUNCH for TBD-SSM/RBD5 shows a Rg=41.24 Å and a Dmax=129.65 Å 
(Χ2=1.28).  
              
	
Figure 3.3: NMR of Staufen individual domains and representative SAXS models. For 
NMR experiments, 30 μl of D2O were added to 570 μl of each protein in 20 mM potassium 
phosphate pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg.HCl, 2 mM TCEP and 15N,1H-
TROSY-HSQC spectra were acquired at 298 K using a Bruker AVANCE IIIHD 600 MHz 
spectrometer equipped with a 5 mm TCI cryoprobe. Data were processed using the Bruker 
TopSpin software and figures were generated using CCPN analysis 2.4. SAXS data collected 
at B21, Diamond Light Source (Harwell, UK). 55 μl of each protein sample (~10 mg/ml) was 
loaded onto a Superdex 75 Increase 10/300 GL column (GE Healthcare), controlled by an 
Agilent HPLC system, coupled to an in-vacuum SAXS flow cell and HPLC-SAXS traces were 
processed using ScÅtter. RBD3 and RBD4 were modelled with DAMMIN, RBD2 and 








Figure 3.4: NMR of Staufen tandem domains and representative SAXS models. For NMR 
experiments, 30 μl of D2O were added to 570 μl of each protein in 20 mM potassium phosphate 
pH 7.5, 100 mM KCl, 10 mM MgCl2, 200 mM L-Arg.HCl, 2 mM TCEP and 15N,1H-TROSY-
HSQC spectra were acquired at 298 K using a Bruker AVANCE IIIHD 600 MHz spectrometer 
equipped with a 5 mm TCI cryoprobe. Data were processed using the Bruker TopSpin software 
and figures were generated using CCPN analysis 2.4. SAXS data collected at B21, Diamond 
Light Source (Harwell, UK). 55 μl of each protein sample (~10 mg/ml) was loaded onto a 
Superdex 75 Increase 10/300 GL column (GE Healthcare), controlled by an Agilent HPLC 
system, coupled to an in-vacuum SAXS flow cell and HPLC-SAXS traces were processed 
using ScÅtter. TBD-SSM/RBD5 was modelled with BUNCH and all the other tandem domains 












Figure 3.5: Small angle X-ray scattering (SAXS) of RBD2. SAXS curve, Kratky analysis 
and EOM models generated for RBD2. Rg ensemble= 37.3 Å, Dmax ensemble= 112.64 Å, 
Χ2=0.98, Rsigma= ~85.78% (~86.70%). 
  















Figure 3.6: Small angle X-ray scattering (SAXS) of RBD3. SAXS curve, Kratky analysis 












Figure 3.7: Small angle X-ray scattering (SAXS) of RBD4. SAXS curve, Kratky analysis 












Figure 3.8: Small angle X-ray scattering (SAXS) of TBD. SAXS curve, Kratky analysis 
and EOM models generated for TBD. Rg ensemble= 31.74 Å, Dmax ensemble= 97.24 Å, Χ2= 












Figure 3.9: Small angle X-ray scattering (SAXS) of SSM/RBD5. SAXS curve, Kratky 
analysis and EOM models generated for SSM/RBD5. Rg ensemble= 25.55 Å, Dmax ensemble= 











Figure 3.10: Small angle X-ray scattering (SAXS) of RBD2-RBD3. SAXS curve, Kratky 
analysis and EOM models generated for RBD2-RBD3. Rg ensemble= 37.86 Å, Dmax 












Figure 3.11: Small angle X-ray scattering (SAXS) of RBD3-RBD4. SAXS curve, Kratky 
analysis and EOM models generated for RBD3-RBD4. Rg ensemble= 36.15 Å, Dmax 









Figure 3.12: Small angle X-ray scattering (SAXS) of RBD4-TBD. SAXS curve, Kratky 
analysis and EOM models generated for RBD4-TBD. Rg ensemble= 36.46 Å, Dmax ensemble= 











Figure 3.13: Small angle X-ray scattering (SAXS) of TBD-SSM/RBD5. SAXS curve, Kratky 
analysis and BUNCH models generated for TBD-SSM/RBD5. Rg ensemble= 41.24 Å, Dmax 






3.3.1.2   RBD2 influences both solubility and oligomeric state of Staufen1 
 
Staufen proteins were purified to homogeneity by immobilized nickel 
chromatography followed by size exclusion chromatography.  
Additive screening to discover conditions that would allow the protein to 
achieve high concentration and good homogeneity for subsequent structural 
studies was performed using 10 K MWCO spin-concentrators (Rambo, 2017). The 
addition of L-Arg HCl to the buffer proved necessary for maintaining the solubility 
of the full-length protein to enable further experiments. Interestingly, the solubility 
of hStau155_ΔRBD2 is not affected by the presence (or absence) of L-Arg HCl in 
the buffer. However, this additive was used for all constructs for consistency with 
the purification requirements of hStau155_FL.  
Size exclusion chromatography (SEC) traces show that the hydrodynamic 
volumes of hStau155_FL and of hStau155_ΔRBD2 (~130-140 kDa) are higher than 
expected for globular proteins with corresponding molecular weights, suggesting 
that the two proteins might have an elongated shape or might form homo-
multimers (Figure 3.14).  
 
	
Figure 3.14: Domains organization and purification of hStau155_FL and 
hStau155_∆RBD2. A: Size exclusion chromatography trace of hStau155_FL (continuous line) 
and of hStau155_∆RBD2 (dashed line) in buffer A (25 mM HEPES pH 7.5, 100 mM KCl, 10 
mM MgCl2, 200 mM L-Arg HCl) using a Superdex 200 Increase 10/300 GL column at 0.5 
ml/min flow-rate (BioRad GF markers appended to the chromatogram). B: SimplyBlue staining 
of 12% SDS-PAGE analysis of purified hStau155_FL and hStau155_∆RBD2. 
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SEC-MALLS analysis of hStau155_FL (Figure 3.15A) shows the presence of 
multiple assemblies. In contrast to the recently published SEC profile for 
hStau163_FL (Lazzaretti et al., 2018), both SEC profiles for hStau155_FL and 
hStau155_ΔRBD2 described in this study present symmetrical peaks.  
MALLS analysis of the eluting species highlights the different behaviour of 
hStau155_FL and hStau155_ΔRBD2. Measurements were performed at three 
different concentrations (20, 100 and 200 μM). The samples used for this analysis 
had not been subject to the final SEC purification, hence small amounts of species 
other than hStau155_FL and hStau155_ΔRBD2 were seen to be present, however, 
the predominant peak in the hStau155_ΔRBD2 sample had a molecular weight 
consistent with that of a monomer (Figure 3.15B). The main SEC peak for 
hStau155_FL appears with a molecular weight consistent with the one of a dimer, 
but the high poly-dispersity seen across the peak suggests that this is an 
equilibrium species been a monomer and higher order oligomers. This is 
consistent with the previous observation that RBD2 mediates hStau155_FL self-
association (Martel et al., 2010, Lazzaretti et al., 2018), showing that its presence 
is fundamental for the formation of a stable oligomer in solution. The recent report 
describing hStau163 did not contain SEC-MALLS analysis for the full-length 
protein (Lazzaretti et al., 2018). 
To resolve the oligomeric assemblies of the species eluting in the main SEC 
peak, analytical ultracentrifugation (AUC) experiments were performed. AUC 
analysis of the peak fraction from hStau155_FL SEC (Figure 3.15C) confirms the 
co-existence of a number of species with molecular weights consistent with that 
of the monomer (major species in solution) and higher oligomers. Measurements 
were performed at three different concentrations (4, 25 and 100 μM). We chose 
to analyse a wide range of concentrations to address the role of concentration in 
the oligomeric state of the protein. The number of oligomers increases with 
increasing sample concentration, and the position of the peaks also shifts to a 
higher sedimentation co-efficient. Both of these phenomena indicate 
concentration-dependent self-association equilibrium for hStau155_FL.  
On the other hand, both SEC-MALLS (Figure 3.15B) and AUC (Figure 3.15D) 
analysis of hStau155_ΔRBD2 show that the truncated protein is only present in 










Figure 3.15: Biophysical characterization of Staufen proteins. A: SEC-MALLS of 
hStau155_FL at 20,100 and 200 μM. B: SEC-MALLS of hStau155_∆RBD2 at 20,100 and 200 
μM. C: Analytical ultracentrifugation (AUC) of hStau155_FL at 4, 25 and 100 μM. D: Analytical 






3.3.1.3   Staufen adopts distinct elongated structures in solution   
 
The first indication that Staufen protein and its hStau155_ΔRBD2 mutant adopt 
elongated structures in solution is given by their average hydrodynamic volume, 
which is much higher than expected for the estimated molecular weight of the 
monomeric protein. This is in agreement with the Rg and Dmax obtained from SAXS 
measurements for both the full-length (Rgensemble= 48.11 Å, Dmaxensemble= 
155.2 Å) and truncated ΔRBD2 (Rgensemble= 50.26 Å, Dmaxensemble= 166.96 
Å) proteins. The higher Rg and Dmax for hStau155_ΔRBD2 can be explained by a 
higher degree of conformational heterogeneity in the FL protein. Importantly, 
SAXS shows that both these systems are characterized by a high degree of 
flexibility, as shown by their Kratky plot in Figure 3.16.  
The three-dimensional models of hStau155_FL protein and of its truncation 
mutant hStau155_ΔRBD2 were obtained by combining homology modelling 
analysis and small angle X-ray scattering data.  
The models obtained for hStau155_ΔRBD2 show that the protein adopts a 
range of conformations (Figure 3.16A), from highly extended to more compact, 
where RBD3 and RBD5 are in closer proximity. The relative positions of RBD4, 
TBD and SSM show only minor differences among the models obtained, due to 
the flexibility of the loops. On the other hand, the high level of flexibility of the loops 
between RBD3 and RBD4 and between SSM and RBD5 seems to be the main 
factor that contributes to the co-existence of a more distended and a more closed 
conformation of hStau155_ΔRBD2. These models show that all the individual 
domains do not coalesce to form a compact structure.  
The models obtained for hStau155_FL, represented in Figure 3.16B, show more 
inter-domain flexibility, resulting in the presence of elongated, as well as more 
compact, conformations. The major differences between the co-existing 
conformations are due to the disordered loops between RBD2 and RBD3, 
between RBD3 and RBD4 and between RBD4 and TBD. Thanks to the 
malleability of these linkers, hStau155_FL seems to be able to transition in solution 





Figure 3.16: Small angle X-ray scattering (SAXS) of Staufen proteins. A: SAXS curve, 
Kratky analysis and EOM models generated for hStau155_ΔRBD2 [Rg ensemble= 50.26 Å, 
Dmax ensemble= 166.96 Å, Rsigma= ~80.2% (~85.68%)/ Χ2=2.30]. B: SAXS curve, Kratky 
analysis and EOM models generated for hStau155_FL [Rg ensemble= 48.11 Å, Dmax 




The structural information gathered from the SAXS models for hStau155_FL and 
hStau155_ΔRBD2 were validated using 2D NMR (Figure 3.17).  
15N,1H-TROSY spectra were recorded for individual and tandem domains, as 
well as for the full-length protein and its truncation mutant ΔRBD2. The large 
number of peaks in the central area of the spectra of both hStau155_FL and 
hStau155_ΔRBD2 indicates the presence of a large number of amino acids in 
disordered regions. This agrees well with the presence of long unstructured linkers 
that confer flexibility to the proteins.  
Moreover, the similar lineshapes and lack of significant chemical shift 
perturbations between the spectra recorded for individual and tandem domains 
(Figures 3.3 and 3.4) show that any interactions between adjacent domains are 
very limited and that each of the domains constituting the tandem constructs 
tumbles independently in solution, thanks to the intervening linkers’ flexibility. In 
addition, it is possible to reconstitute the spectra of hStau155_FL and 
hStau155_ΔRBD2 almost entirely by overlaying those obtained for individual 
domains, proving that the domains tumble independently in the full-length protein.  
Together, our data suggest that hStau155 is an extremely flexible protein and 
its domains can adopt several positions relative to each other, without inter-
domain interactions. Thanks to the flexibility of the linkers, the protein adopts an 
elongated conformation in solution and its domains behave as beads on a string. 
Connector regions are crucial players in Staufen allostery and conformational 
changes are in line with recent studies on the role of dynamic linkers in the 


















Figure 3.17: NMR of Staufen proteins. A: NMR spectra of hStau155_FL. B: NMR spectra of 
hStau155_ΔRBD2. C: Reconstitution of hStau155_FL spectra by overlapping of RBD2, RBD3-
RBD4 and TBD-SSM/RBD5 NMR spectra. D: Reconstitution of hStau155_ΔRBD2 spectra by 





3.3.1.4   Linker flexibility mediates RBD3 and RBD4 rearrangement   
 
The fitting of a representative subset of SAXS models for individual or tandem 
domains in the SAXS models of hStau155_ΔRBD2 and hStau155_FL is shown in 
Figure 3.18 and 3.19, respectively. The SAXS data and models obtained for 
individual and tandem domains have been previously discussed in section 3.3.1.1 
(Figures 3.5-3.13). A representative subset of solution scattering models of 
individual and tandem domains (Figure 3.18B) was chosen in order to interpret 
the domain rearrangement observed in the models corresponding to the different 
conformations that hStau155_ΔRBD2 adopts in solution (Figure 3.18A). From the 
fitting proposed in Figure 3.18C, it is possible to observe that in hStau155_ΔRBD2 
the linker connecting RBD3 to RBD4 can be completely or partially distended. 
SAXS models obtained for the construct RBD3-RBD4 well describe the behaviour 
of these two domains also when they belong to hStau155_ΔRBD2, showing that 
the presence of TBD and SSM/RBD5 does not have a great impact on RBD3-
RBD4 rearrangements.  
On the contrary, the models obtained for the construct RBD3-RBD4 cannot be 
used for the interpretation of domains rearrangements in hStau155_FL (Figure 
3.19A) and a different subset of solution scattering models (Figure 3.19B) needs 
to be used in the fitting to describe the conformational changes of the full-length 
protein (Figure 3.19C). In fact, the solution models obtained for the tandem 
domain RBD3-RBD4 in isolation (Figure 3.11) show that a long linker, which is 
extremely elongated, connects these two domains. On the other hand, our 
hStau155_FL models show the coexistence of three main conformations in 
solution for which it is interesting to notice the relative movement of RBD3 and 
RBD4 and their closer proximity, possibly in order to elicit the binding of RNA 
targets (Figure 3.20). In the most elongated model of the full-length protein (model 
1), RBD3 and RBD4 are in an ‘open’ conformation that resembles the one adopted 
by the tandem domain on its own. However, in the other two models (models 2 
and 3), RBD3 and RBD4 are ‘pulled’ towards each other by conformational 
changes of the connecting linker, interestingly resembling the recently deposited 
structure of the hStau163 RBD3-RBD4 construct bound to Arf1 SBS (Lazzaretti et 








Figure 3.18: Fitting of SAXS models for Staufen1 domains in the SAXS models obtained 
for hStau155_ΔRBD2. A: EOM models generated for hStau155_ΔRBD2. B: Subset of selected 
domains and tandem domains models. C: Fitting of representative models for domains and 
















Figure 3.19: Fitting of SAXS models for Staufen1 domains in the SAXS models obtained 
for hStau155_FL. A: EOM models generated for hStau155_FL. B: Subset of selected domains 
and tandem domains models. C: Fitting of representative models for domains and tandem 













Figure 3.20: RBD3 and RBD4 rearrangements in hStau155_FL can explain its plasticity 
in the binding of diverse dsRNA targets. The SAXS models obtained for hStau155_FL show 
that RBD3 (orange) and RBD4 (cyan) transit from an ‘open’ to a ‘more closed’ conformation. 
A direct comparison of our models with the crystal structure of the hStau163 RBD3-RBD4 
construct bound to Arf1 SBS43 (RBD3 displayed in red and RBD 4 in blue) shows that RBD3 
and RBD4 are ‘pulled’ towards each other by conformational changes of the connecting linker, 




Cryo-EM coupled to single particle analysis was exploited in order to gather more 
information about the architecture of Staufen protein and, in particular, about the 
role of RBD2 in triggering the domains rearrangement observed in the full-length 
models obtained from small angle scattering analysis.  
The continuous advances in the electron microscopy field, and in particular the 
use of phase plate and direct electron detector, allowed us to directly visualise the 
monomeric hStau155_FL protein. Importantly, Staufen is just below the limit of size 
of protein that is possible to study using cryo-EM analysis (to date) and this 
represents a major difficulty in both microscopy and image processing stages. The 
data collection was carried out at the LMB-MRC (Cambridge, UK) by Dr Giuseppe 
Cannone and the data was processed by Dr Laura Spagnolo (Figure 3.21).  
Nevertheless, the low-resolution cryo-EM density map obtained for 
hStau155_FL is in agreement with our SAXS studies and shows that Staufen is an 
elongated protein with dimensions 126x63x43 Å (Figure 3.22, top).  
As shown in Figure 3.22, the protein can be described to have an L-shaped 
architecture, which can be divided into three main portions: a “head”, a “body” and 
a “foot”. Moreover, it is possible to observe a thin element between the “head” and 
the “body”, which can be described as a “neck”.  
Even though the SAXS models obtained for hStau155_FL show that the protein 
could adopt at least three major different conformations in solution, cryo-EM 
analysis reveals only an extended architecture, which resembles the one 
represented by the most elongated SAXS model (hStau155_FL EOM model 1). In 
fact, the calculated SAXS curve of the DAMMIN model generated from the cryo-
EM density map (using EM2DAM) is extremely similar to the curve calculated for 
the most extended hStau155_FL SAXS model (using CRYSOL), which represents 
the scattering contribution of this conformation to the total scattering intensity 
(Figure 3.22, bottom). 
The discrepancy between the several conformations revealed using SAXS 
studies and the single architecture obtained with cryo-EM analysis, could be due 
to an effect of cryo-EM experimental condition during sample preparation (e.g. 
surface tension and freezing) or to the fact that more compact architectures are 
extremely difficult to distinguish from the background during particle picking, due 





Figure 3.21: Cryo-EM single particle analysis of hStau155. A: Representative micrograph. 
B: CTF for the representative micrograph. C: Representative 2D classes from 2245 manually 
picked single particles, boxsize = 208 Å. D: Representative 2D classes from 198,088 












Figure 3.22: Architecture of hStau155 full-length protein. Top: Cryo-EM structure of full-
length Staufen1. Bottom left: DAMMIN model calculated on the EM density map (EM2DAM). 
Bottom right: Theoretical SAXS curve calculated for the cryo-EM map (grey, continuous) 
overlaid to the experimental SAXS curve for the ensemble of conformations (black) and to the 




The domain arrangement observed in the cryo-EM density map is consistent with 
the beads-on-a-string model, as supported also by NMR analysis.   
SAXS studies of hStau155_FL show that RBD2 and RBD3 can be in close 
proximity to each other. Therefore, we fitted the more compact SAXS model 
obtained for the tandem domain RBD2-RBD3 (Figure 3.10) at the foot of the cryo-
EM map. The remaining density allows space for the other domains (RBD4, TBD, 
SSM and RBD5) to be fitted within the map (Figure 3.23B). As previously 
described, the solution models obtained for the tandem domain RBD3-RBD4 
(Figure 3.11) show that a long linker, which is extremely elongated, connects 
these two domains. However, in our hStau155_FL SAXS models, RBD3 and RBD4 
are in closer proximity. In the cryo-EM density map, the electron density 
corresponding to RBD4 is fitted according to the spatial domains organization of 
the more compact SAXS model obtained for the tandem domain RBD4-TBD 
(Figure 3.12). It follows that RBD4 must undergo a spatial reorganization, as 
described in Figure 3.23A. Moreover, since Staufen dimerization is mediated by 
the domain swapping motif SSM, the arrangement proposed by the fitting of one 
of the SAXS models obtained for SSM/RBD5 (Figure 3.9) within the “neck” and 
“head” of the density map, respectively, would allow the SSM of each monomer 
to be accessible for homo-dimerization. 
Taken together, these data show that not only the presence of RBD2 triggers 
a spatial reorganization of RBD3 and RBD4, which is indeed mediated by the 
linker between these last two domains, but also the importance of RBD3-RBD4 
relative position and rearrangements on dsRNA binding. Therefore, we propose 
that these two domains can change mutual orientation depending on the structure 
of the RNA target, in order to effectively bind different substrates in distinct 
biological contexts. Moreover, dsRBDs that are not involved in the binding of 
RNAs, such as RBD2 and RBD5, can adopt multiple conformations in the full-
length protein, not only to elicit protein dimerization, but also to regulate Staufen 
structural plasticity and multi functionality in vivo. All in all, our solution studies 
demonstrate that Staufen protein can adopt several conformations thanks to long 
linkers that facilitate domains rearrangement, providing a clue on the structural 














Figure 3.23: Fitting of SAXS models for Staufen1 domains in the cryo-EM density map 
of the full-length protein. A: Fitting of representative models for the ensemble of the SAXS 
models generated by EOM for the tandem domains RBD3-RBD4 (orange and turquoise) and 
RBD4-TBD (for clarity, only RBD4 is shown in teal) showing RBD4 rearrangement in the full-
length protein. B: Fitting in the EM density map of representative models for the ensemble of 
the SAXS models generated by EOM for the tandem domains RBD2-RBD3 (blue and orange), 
RBD4-TBD (teal and purple) and SSM/RBD5 (yellow and magenta).  
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3.3.2   Staufen/Arf1 RNA interaction  
 
 
3.3.2.1   RBD2 is important in the stabilization of Staufen/Arf1 complex 
 
Previous studies have shown that Staufen-binding sites (SBSs) are located in 
intra-molecular double-stranded regions, typically between 9 and 12 bp, at the 
5’UTR or 3’UTR of mRNAs and that Staufen binding mediates their translation or 
decay, respectively (Dugre-Brisson et al., 2005, Kim et al., 2005). Moreover, SBSs 
can be located in inter-molecular double-stranded regions formed between 
mRNAs and long noncoding RNAs via Alu element base-pairing (Gong and 
Maquat, 2011).  
Human ADP-Ribosylation Factor 1 (ARF1) mRNA represents the best 
characterized Staufen target to date, together with D.melanogaster oskar (osk) 
and bicoid (bcd) mRNAs (Ferrandon et al., 1997, Irion et al., 2006, Micklem et al., 
2000). The 3’UTR of Arf1 (~300 bp) forms an apex structure and mutagenesis 
analysis showed that the 19 bp stem is required for Staufen binding (Kim et al, 
2007) (Figure 3.24).  
	
Figure 3.24: Structure prediction of ARF1 3’UTR. Model of the secondary structure of ARF1 
showing nucleotides 1 through 300 and mutagenesis studies, which confirmed the 19bp stem 
to be the major SBS. The plot was generated using Sfold v2.0 software (Wadsworth 
Bioinformatics Center) by Kim et al, 2007. (Adapted from [Kim et al, 2007]) 
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Consequently, the Arf1 mRNA bound to Staufen is targeted for degradation 
through Staufen-mediated decay. On the other hand, the 19 bp stem is not the 
only Staufen-binding site within the 3’UTR of Arf1. In fact, two additional shorter 
SBSs have been identified, by high-throughput studies, in shorter double-stranded 
regions within the apex (Sugimoto et al., 2015). Lazzaretti et al, using 
fluorescence anisotropy and X-ray crystallography, recently characterized the 
interaction between hStau163 proteins and the 19 bp stem of Arf1 mRNA. The 
crystal structure, at 2.9 Å resolution, shows that the tandem RBD3-RBD4 of 
hStau163 recognizes A-form RNA, mainly through electrostatic interactions with 
the RNA backbone (Lazzaretti et al., 2018). 
In our study, the interaction between hStau155 proteins and the entire 3’UTR of 
its RNA target Arf1 was investigated with microscale thermophoresis (MST) 
analysis, during a demonstration of the Monolith NT.115Pico instrument by 
NanoTemper. As represented in Figure 3.25, MST analysis shows that 
hStau155_FL/Arf1 complex (Kd = 5 nM) is more stable than hStau155_ΔRBD2/Arf1 
complex (Kd = 28 μM), even though the latter is probably under-estimated in this 
analysis as the reaction has not reached saturation. Our data on the interaction 
between hStau155_FL protein and Arf1 RNA are in agreement with the 
fluorescence anisotropy measurements by Lazzaretti et al, which show that 
purified recombinant hStau163_FL interacts with the 19 bp stem of Arf1 with high 
affinity (6 ± 1 nM). Moreover, an N-terminal deletion of hStau163, removing RBD2, 
only minimally affects the RNA-binding affinity (9 ± 3 nM) (Lazzaretti et al., 2018). 
On the other hand, our MST data show that RBD2 deletion in hStau155 
dramatically reduces the affinity of the protein to Arf1 RNA (Kd: from 5 nM to 28 
μM). However, the fact that we used the entire 3’UTR of Arf1, instead of the 19 bp 
stem only, might be the basis of this apparent discrepancy. In fact, several Staufen 
monomers could bind at three different sites in the 3’UTR of Arf1, and this 
interaction could be stabilized by RBD2 via protein-protein interactions, as this 




                              
Figure 3.25: MST assay to study the interaction of Staufen proteins with Arf1 RNA. Top: 
Titration curve of NT-647 labeled hStau155_FL protein (10 nM) and Arf1 RNA (33 μM-1 nM), 
previously incubated for 30 minutes at room temperature. Bottom: Titration curve of NT-647 
labeled hStau155_ΔRBD2 protein (10 nM) and Arf1 RNA (33 μM-1 nM), previously incubated 
for 30 minutes at room temperature. MST analysis was performed in premium glass capillaries 




3.3.2.2   Negative staining of hStau155_ΔRBD2 /Arf1 complex 
 
Negative staining coupled to single particle analysis was employed in order to 
gather more information about the architecture of Staufen protein in complex with 
its RNA target Arf1.  
Data collection was carried out for both hStau155_FL/Arf1 and for 
hStau155_ΔRBD2/Arf1 complexes purified from glycerol gradient. However, the 
higher percentage of glycerol (~45-50%) in the sample of the full-length 
protein/RNA complex interfered with signal-to-noise ratio and no further image 
processing analysis were undertaken. 
From the micrographs of the hStau155_ΔRBD2/Arf1 complex dataset (Figure 
3.26A), ~290,000 single particles (SP) were auto-picked with EMAN2, using 250 
Å masks. The single particle images were extracted into boxes (128x128 pixels) 
and band-pass filtered (Figure 3.26B). The dataset was subjected to sequential 
rounds of alignments and 2D classification in RELION, using a 200 Å mask, in 
order to polish the dataset and improve the resulting class-average images 
(Figure 3.26C). ~43,000 particles were then sorted with RELION into three 3D 
classed (Figure 3.26D) using as reference an ab initio initial model generated with 
EMAN2. 
As shown in Figure 3.26D, the three 3D classes generated for 
hStau155_ΔRBD2/Arf1 are fairly dissimilar and this could be due to partial 
assembly and/or dissociation of the complex. This heterogeneity can also be 
observed in the 2D classification (Figure 3.26C), as the class averages show 
smaller and bigger assemblies. Moreover, the stoichiometry of the complex is not 
known, and this limits the possibility of further interpretation of the low-resolution 
electron density map obtained from negative staining.  
Nevertheless, the 3D class “class 1” shows some common features with one of 
our SAXS model for the monomeric hStau155_ΔRBD2 (Figure 3.27). In fact, it is 
possible to notice that the protein/RNA complex shows some “triangular” 
densities, which could be assigned to RNA-binding domains. Moreover, the 
volume of the density map (143.6 Å3) suggests that at least two hStau155_ΔRBD2 
monomers (41.08 Å3) might be bound to Arf1 RNA and that the structured RNA 





Figure 3.26:	 Single particle analysis of negative stained grids of hStau155_ΔRBD2 
protein and Arf1 RNA complex purified from glycerol gradient. A: Characteristic 
micrograph of hStau155_ΔRBD2 protein and Arf1 RNA complex, red circles are used to show 
single particles. B: Subset of individual particles extracted from auto-picking (128x128 pixels, 
1.9 Å/pixel). C: Class averages obtained from 2D classification using a 200 Å mask. D: 3D 













Figure 3.27:	 Segmented map of hStau155_ΔRBD2/Arf1 complex and representative 
SAXS model of hStau155_ΔRBD2. Left: Segmented electron-density map of 3D class n.1 of 
hStau155_ΔRBD2 protein and Arf1 RNA complex obtained with single particle analysis coupled 
to negative staining electron microscopy. Right: Representative SAXS model of 
hStau155_ΔRBD2 obtained with EOM showing characteristic domains organization of 
monomeric protein (RBD3 in orange, RBD4 in teal, TBD in purple, SSM in yellow, RBD5 in 






3.3.3   hUpf1 protein  
 
 
3.3.3.1   Overexpression and purification of hUpf1 protein 
 
E. coli Rosettaä(DE3) pLysS cells were transformed by heat-shock method with 
pTWO-E_Strep-tag vector. To test overexpression conditions for the production 
of recombinant hUpf1, cells were treated with different concentrations of IPTG 
(0.25 mM and 0.5 mM) and aliquots were taken at different time-points (2,4 hours 
and o/n). The overexpression was carried out at 23°C, in order to allow proper 
folding of this relatively big (~125 kDa) human protein in E. coli. Protein production 
was assessed by SDS-PAGE and Western Blot analysis (Figure 3.28A). Protein 
overexpression was induced by adding 0.25 mM IPTG and culturing the cells at 
23°C for 4 hours. In fact, after o/n induction the amount of protein was extremely 
low, likely because of protein degradation.  
Four litres of culture were grown in order to obtain enough soluble protein. Cells 
were lysed by sonication and soluble protein extracts were separated from the cell 
pellets by centrifugation. Strep-hUpf1-6His protein was firstly purified by nickel 
chromatography in high-salt buffer in order to remove nucleic acid contamination. 
Elution was performed with an imidazole gradient and the fractions containing 
protein were analysed by 8% SDS-PAGE analysis (Figure 3.28B). Subsequently, 
the fractions containing STREP-hUpf1-6His were pooled and incubated with 
streptactin resin, hUpf1 full-length protein was eluted by addition of desthiobiotin 
and analysed in an 8% SDS-PAGE gel (Figure 3.28C). The elution from the 
streptactin resin was then subjected to size exclusion chromatography (SEC) 
using a Superdex 200 Increase 10/300 GL column. The SEC trace and SDS-
PAGE analysis of the elutions are shown in Figure 3.28D. The yield of purified 
hUpf1 full-length protein was extremely low and further studies were limited to 
biochemical assays in order to investigate the interaction between Staufen 




         
Figure 3.28: Overexpression and purification of hUpf1.  A: SimplyBlue SafeStain staining 
of 10% SDS-PAGE gel of overexpression test in E. coli Rosettaä(DE3) pLysS cells grown in 
TB and induced at 23°C with 0.25 mM and 0.5 mM IPTG for 2,4 hours and o/n (left). Western 
Blot analysis of 10% SDS-PAGE gel of overexpression test: the nitrocellulose membrane was 
incubated o/n at 4°C with anti-His antibody conjugated with alkaline phosphatase (1:4000) and 
developed using the SIGMA-FASTTM BCIP/NBT reagent (right). B: SimplyBlue SafeStain 
staining of 8% SDS-PAGE gel of nickel chromatography purification step in buffer B (25 mM 
HEPES pH 7.4, 1 M NaCl, 1 mM MgCl2, 1 μM ZnCl2, 500 mM imidazole). C: SimplyBlue 
SafeStain staining of 8% SDS-PAGE gel of streptactin purification step in buffer B 
supplemented with 2.5 mM desthiobiotin. D: SEC trace of hUpf1 full-length purified in buffer C 
(25 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2) using a Superdex 200 Increase 10/300 
GL SEC column at 0.7 ml/min (left) and SimplyBlue SafeStain staining of 8% SDS-PAGE gel 
of SEC purification step (right).  
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3.3.3.2   Study of the interaction between Staufen proteins, Arf1 RNA and                            
hUpf1 protein 
 
Previous in vivo studies showed that Stau1 binds directly to Upf1 and elicits mRNA 
decay when bound downstream of a termination codon, via SMD pathway instead 
of the conventional NMD, which would require Upf2 and Upf3 to recruit Upf1 and 
consequently to elicit RNA decay (Kim et al., 2005). 
The interaction between hStau155_FL or hStau155_ΔRBD2 protein, Arf1 RNA and 
hUpf1 protein was studied by incubating an equimolar concentration of each 
component. Subsequently, complex formation was evaluated by BN-PAGE 
analysis (Figure 3.29).  
While an extra band, likely to correspond to the protein/RNA complex, can be 
observed when hStau155_ΔRBD2 protein is incubated with Arf1 RNA, it is not 
possible to detect any difference in the bands pattern of hStau155_FL when in 
absence or presence of RNA. In fact, the full-length protein shows several bands, 
corresponding to monomer, dimer and higher order assemblies, which are 
particularly smeary, indicating the presence of different conformations. This 
makes it difficult to detect whether a band corresponding to hStau155_FL/Arf1 
complex is present.  
Moreover, the incubation of hUpf1 and Arf1 results in the appearance of an extra 
band in the gel, suggesting that purified recombinant hUpf1 is active and can bind 
RNA. However, the band corresponding to hUpf1/Arf1 complex is also present 
when Staufen proteins were in the reaction mix. This suggests that, in the 
Staufen/Arf1 mix, free RNA is present in solution and it is then bound by hUpf1.  
Furthermore, using this technique, it is not possible to observe whether or not a 
Staufen/Arf1/hUpf1 complex is assembled and further experiments should be 













Figure 3.29: BN-PAGE analysis of Staufen proteins, Arf1 RNA and hUpf1 protein. 70 μM 
of each component were incubated at room temperature for 90 minutes in a final volume of 21 
μl in buffer C (25 mM HEPES pH 7.5, 100 mM KCl, 10 mM MgCl2). 7.5 μl of each reaction 
were loaded in a 4-16% Bis-Tris NativePAGE and BN-PAGE was run for 1 hour at 150 V. Gel 
was de-stained o/n in 30% ethanol and 10% acetic acid. 
  
hUpf1 / Arf1 complex 
hStau155_DRBD2 / Arf1 complex 
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3.4   Conclusions 
 
Canonical dsRBDs are composed of an α1-β1-β2-β3-α2 secondary structure that 
folds in three dimensions to recognize dsRNA. Recently, structural and functional 
studies of divergent dsRBDs revealed adaptations that include intra- and/or 
intermolecular protein interactions, sometimes in the absence of detectable 
dsRNA-binding ability (Gleghorn and Maquat, 2014, Krovat and Jantsch). The 
number of canonical dsRBDs per polypeptide is highly variable in dsRBD-
containing proteins (Barraud and Allain, 2012, Thomas and Beal, 2017, Macrae 
et al., 2006), ranging from one to five. There is no clear correlation between the 
number of dsRBDs and dsRNA binding affinity. Moreover, the extent of the 
contribution of specific dsRBDs to RNA substrate specificity is still an open 
question. Structural information reported on dsRBPs carrying one or more 
canonical dsRBD, such as Dicer (Macrae et al., 2006) and ADARs (Thomas and 
Beal, 2017, Barraud and Allain, 2012) highlights the importance of neighbouring 
domains for substrate specificity and enzymatic activity. Conformational flexibility 
of Dicer protein is also proposed to play a central role in dsRNA recognition and 
processing (Macrae et al., 2006) and this could be extended to other RBD-
containing proteins, such as Staufen. The lack of structural information on this 
protein, for which to date we only had three-dimensional models of Staufen 
truncation mutants, in isolation or in complex with short RNA sequences or 
truncated protein interactors (Gleghorn et al., 2013, Ramos et al., 2000a, Ramos 
et al., 2000b, Jia et al., 2015, Lazzaretti et al., 2018) made its functional 
understanding particularly challenging. Here, we provided for the first time 
structural information on the full-length Staufen1 protein, using an integrated 
structural biology approach. Combination of hydrodynamic methods, homology 
modelling, small angle X-ray scattering, NMR and cryo-EM allowed us to show 
that Stau1 is a highly flexible protein, that recoils in solution from an elongated to 
a compact conformation in which the domains are in closer proximity but not 
interacting with each other. In this perspective, we propose that the flexible inter-
domain loops possess a regulatory role in Staufen activity, allowing a high degree 
of freedom for recognition and binding of diverse RNA and protein targets and for 
the subsequent involvement of Staufen in very diverse aspects of RNA 
metabolism and regulation. As far as the dimerization of Stau1 is concerned, we 
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show that this is dependent on the presence of RBD2 and on protein 
concentration. Consistently with what was shown crystallographically, the SSM-
RBD5 construct dimerized in solution. SAXS experiments show that the full-length 
protein adopts at least three main conformations in solution, which therefore can 
explain its ability to bind diverse RNA targets and protein partners. Our data 
provide the first structural insight into the mechanism adopted by Stau155 protein 
to elicit sometimes contrasting biological functions. Staufen seems to be able to 
re-arrange its domains thanks to long and disordered linkers, which confer 
plasticity to the protein, probably in order to increase the number of different 
mRNA targets and protein partners it can bind to. We can therefore think of 
Staufen as a “Swiss Knife” multi-tool. Furthermore, our preliminary negative 
staining EM studies provide the first structural information on a near-full-length 
Staufen protein (ΔRBD2) in complex with the 3’UTR of Arf1 RNA, which suggests 
that indeed Staufen undergoes domain rearrangements in order to elicit RNA 
binding, as suggested by our solution studies (Figure 3.30).  
However, the question about whether or not Staufen/Arf1 complex is directly 
bound by hUpf1 in order to elicit mRNA decay, still remains unanswered and 
further experiments should be used to address this matter. 
 
	
Figure 3.30: Model for the dimerization of Staufen1 protein and dsRNA recognition. Two 
Staufen1 monomers assemble through the SSMs and the resulting dimer is stabilised by 
RBD2a-RBD2b interactions. RBD5a and RBD5b undertake a spatial rearrangement from the 
position they assume in the monomer (EM density map) to the position they assume in the 
crystallographic structure of the dimer SSM-RBD5 (Gleghorn et al., 2013) (PDB ID: 4DKK). In 
each monomer, RNA binding is mediated by RBD3 and stabilised by RBD4 (Lazzaretti et al., 
2018) (PDB ID: 6HTU). Each RBD3 and RBD4 could bind two individual molecules of dsRNA 





P. abyssi Mini-chromosome Maintenance 
protein 
 
4.1   Introduction 
 
Precise duplication of genetic material is required for the correct progression of 
the cell cycle and for cell division. Multiple proteins act together to separate the 
parental DNA and synthetize two new strands of complementary DNA. The set of 
proteins, whose concerted activities are necessary for a complete and high-fidelity 
genome duplication, is known as replisome.  
Eukaryotes and Archaea employ a tightly regulated series of events to ensure 
correct DNA duplication, which must occur only once per cell cycle. The high 
degree of similarity between eukaryotic and archaeal proteins, involved in the 
replisome formation, allowed to study the archaeal DNA replication system as a 
model to provide a deeper understanding of the eukaryotic replication machinery.  
In Eukaryotes, at the beginning of S-phase, the origin recognition complex 
(ORC), Cdc6, Cdt1 and MCM helicase come together to form the pre-replication 
complex (pre-RC), which initiates DNA melting at the origins of replication spaced 
along the chromosomes. After Cdc45 and GINS are incorporated into an 
intermediate pre-initiation complex (pre-IC) (Zou et al., 1997), the CDK and DDK 
protein kinases activate the Cdc45-MCM-GINS (CMG) complex (Aparicio et al., 
2006, Aparicio et al., 2009, Costa et al., 2011, Ilves et al., 2010). Once activated, 
the two CMG complexes separate and the resulting replication forks travel in 
opposite directions unwinding genomic dsDNA to expose ssDNA template.  
Mini-chromosome maintenance proteins (MCM) are AAA+ (ATPases 
associated with diverse cellular activities) superfamily members, which are known 
primarily as DNA helicases (Tye, 1999). However, their function is not limited to 
unwinding DNA and they have also been shown to be involved in origin melting 
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(Costa and Onesti, 2008), genome repair (Bailis and Forsburg, 2004, Bailis et al., 
2008) and transcriptional regulation (Hubbi et al., 2011). 
MCMs are replicative helicases highly conserved between Eukaryotes and 
Archaea; these proteins were first identified in yeast when mutations in their genes 
resolved in defective mini-chromosome maintenance, hence their name (Maine et 
al., 1984). Archaeal MCMs can be used as a simplified powerful tool for 
deciphering fundamental structural and functional features of the eukaryotic MCM 
complex since the MCM complexes of many Archaea form homohexamers from 
a single gene product, while eukaryotic MCM2-7 is a heterocomplex made of 
different polypeptide chains (Miller and Enemark, 2015, Brewster and Chen, 
2010). 
MCM proteins contains three domains, as shown in Figure 4.1A: a N-terminal 
domain, an AAA+ domain, and a C-terminal domain. The N-terminal domain is 
known to play roles in protein oligomerization, DNA binding, and the processivity 
of the helicase. The AAA+ domain is responsible for ATPase function and DNA 
unwinding. The small domain at the C-terminus may play a role in DNA-stimulated 
ATPase activity. 
From the structural point of view, the N-terminal domain is divided in three 
subdomains (A, B and C). Subdomain A forms a compact bundle, mainly 
composed by helices, which hangs off the outside of the ring-shaped complex. 
EM analysis suggests that this domain changes conformation, depending on its 
phosphorylation state (Chen et al., 2005, Fletcher and Chen, 2006). Subdomain 
B forms a compact domain, made of three antiparallel β-sheets, which contains a 
zinc-binding site (Fletcher et al., 2003). Subdomain C contains five antiparallel β-
sheets, which form a β-barrel like structure, and represents the core of the N-
terminal domain and it is connected to the AAA+ domain through a flexible linker 
(Fletcher et al., 2003, Liu et al., 2008, Brewster et al., 2008). 
The MCM AAA+ domain is constituted of five parallel β-sheets flanked on each 
side by α-helices, and retains structural features that are common to all AAA+ 
proteins: a canonical P-loop motif, which contains a conserved Walker A lysine 
that coordinates and binds the γ phosphate of the ATP, and a Walker B motif, 
which coordinates Mg++ and water to catalyze the hydrolysis of ATP to ADP and 
phosphate (Brewster et al., 2008, Bae et al., 2009, Erzberger and Berger, 2006).  
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The C-terminal domain is connected to the AAA+ domain through a flexible 
linker and adopts a winged helix-turn-helix fold (Barry et al., 2007). 
As mentioned before, archaeal MCM proteins have proven to be powerful tools 
to elucidate essential features of MCM functions and this is linked to their 
structural organization (Miller and Enemark, 2015).  
The eukaryotic MCM2-7 ring might present difficulties in the crystallization 
process due to multiple orientations that can be adopted in the crystallographic 
lattice which might look similar at macroscopic level, but not at atomic level 
because the ring is formed by six different polypeptide chains. On the other hand, 
archaeal MCM complexes often consist of six identical subunits, meaning all the 
permutations are identical, at both macroscopic and atomic level, and potentially 
facilitating crystallization. For this reason, two archaeal MCM proteins, one from 
the thermophilic archaeon Sulfolobus solfataricus (SsoMCM) (Liu et al., 2008, 
Brewster et al., 2008) and another one from Methanothermobacter 
thermautotrophicus (MtMCM) (Fletcher et al., 2003), represent the best studied 
examples to date. Crystal structures from these two Archaeons provide the vast 
majority of high-resolution structural information available.  
Some archaeal MCM proteins are polymorphic, both hexameric and 
heptameric architectures have been reported for the same polypeptide, moreover 
both these assemblies can be found as single rings, double rings or filaments 
(Figure 4.1B). Electron microscopy reconstruction provide low resolution maps of 
single hexameric and heptameric full-length MCM rings, as well as double rings 
and filament from several species of Archaea (Costa et al., 2006a, Costa et al., 
2006b, Costa et al., 2008, Gomez-Llorente et al., 2005, Fletcher et al., 2003, 
Slaymaker et al., 2013). The question on whether all these different assemblies 
can be present in vivo or if they are solely artefacts of overexpression and 
purification conditions, still remain unsolved and further experiments need to be 





Figure 4.1: Archaeal MCM proteins. A: Homology model for PabMCM obtained using 
Phyre2; the N-terminal domain is shown in blue, the AAA+ catalytic domain in orange and the 
C-terminal domain in cyan. Inter-domains linkers are represented in grey. B: Polymorphism of 
archaeal MCM complex; double hexameric, double heptameric assemblies and filaments were 
reported by Fletcher et al., Yu et al., and Slaymaker et al., respectively. [Adapted from Fletcher 




Available evidences suggest that MCMs are commonly associated in a head-
to-head double ring configuration and, after origin melting, the double hexamer 
can separate into two single rings that translocate unwinding the DNA (Remus et 
al., 2009, Takahashi et al., 2005). However, the mechanism by which MCM loads 
to origins of replication, melts them and transits from a melted origin to two viable 
replication forks remains unclear. It is a reasonable assumption that the 
conformation of MCM has to be dynamic so that the rings can open and reclose 
to bind DNA, as required at different stages of replication (Costa et al., 2011, 
Bochman and Schwacha, 2010). It follows that there are two possible scenarios 
in which MCM associates with genomic DNA. In the first one, MCM is loaded onto 
dsDNA at the origin of replication, which is subsequently melted (Remus et al., 
2009, Takahashi et al., 2005). Whereas, in the second scenario, other replication 
factors, such as ORC and Cdc6, melt the replication origin and MCM loads 
afterwards onto ssDNA (Samson et al., 2016, Samson and Bell, 2016, Fernandez-
Cid et al., 2013, Frigola et al., 2013, Frigola et al., 2017).  
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An approach that could be used to dissect the individual steps of MCM 
mechanism is to use distinct DNA molecules designed to mimic the shape 
adopted by genomic DNA during individual phases of replication. For instance, in 
order to examine the wrapping of the origin of replication by head-to-head double 
ring MCM complexes, we could use a long linear dsDNA as substrate. On the 
other hand, the configuration adopted by MCM during the process of origin melting 
could be studied using a “bubble”-shaped DNA and it could be compared to the 
one assumed during the progression of the replication fork by using a y-shaped 
DNA substrate which mimics DNA unwinding.   
In this chapter, we present the characterization of the archaeal Pyrococcus 
abyssi MCM assembly (PabMCM), in isolation or in complex with distinct DNA 
substrates, in order to provide a deeper understanding of the mechanism by which 
archaeal MCMs dynamically loads to origins of replication, melts them and transits 
from a melted origin to two viable replication forks. Additionally, in this study we 
want to further investigate the peculiar case of PabMCM, which represents the 
first evidence that MCM proteins can be found not only as hexamers and 
heptamers, but also as octameric assemblies (Cannone et al., 2017). 
Furthermore, in this chapter, PabMCM is used as a tool to provide technical 
insights on the characterization of heterogeneous and extremely large protein-
nucleic acid complexes, by using an integrated approach that combines electron 






4.2   Materials and Methods 
 
 
4.2.1   Protein overexpression and purification  
 
Recombinant PabMCM was overexpressed in E. coli Rosettaä(DE3) pLysS 
transformed by heat-shock method. A single colony was picked and used to 
inoculate a starting culture, which was grown in LB medium containing 50 μg/ml 
ampicillin and 34 μg/ml chloramphenicol at 37°C o/n. 1 ml of overnight culture was 
inoculated in 1 L of TB medium supplemented with antibiotics and cells were 
grown to an OD600=0.6. Protein overexpression was induced by adding 0.2 mM 
IPTG and culturing the cells at 30°C overnight. Cells were harvested by 
centrifugation at 5000 rpm on a Beckman AvantiTM J-20 XP centrifuge with JLA 
8.1000 rotor for 20 minutes and washed once with PBS; cell pellets were aliquoted 
and stored at -80°C. Frozen aliquots were thawed and lysed by sonication in 20 
ml of lysis buffer (20 mM HEPES pH 7.4, 500 mM NaCl, 400 μl Complete EDTA-
free protease inhibitors 50X) followed by 20 min of heat–denaturation at 70°C. 
Soluble protein extracts were separated from cell pellets by centrifugation at 
15000 rpm for 30 min. 6-His tagged PabMCM protein was purified by nickel 
chromatography using HisTrap FF columns (GE Healthcare) equilibrated in 
washing buffer (20 mM HEPES pH 7.4, 500 mM NaCl, 20 mM imidazole). Elution 
was performed with a 20 mM-500 mM imidazole gradient. Fractions containing 
the protein of interest were tested for DNA contaminations by measuring the 
Abs260/280 ratio. Only fractions with Abs260/280 ratio between 0.51 and 0.68 (99% 
protein) were pulled and concentrated by ultra-filtration using a 15R Vivaspin 
(30,000 MWCO), to a final concentration of 10 mg/ml prior to size exclusion 
chromatography on a Superose6™10/300 GL column in SEC buffer (20 mM 
HEPES pH 7.4, 150 mM NaCl). Overexpression and purification efficiency were 
monitored by SDS-PAGE analysis on 10% gels stained with SimplyBlue SafeStain 
(Invitrogen). Fractions were also analyzed by Western Blot: the membrane was 
incubated o/n at 4°C with anti-His antibody conjugated with alkaline phosphatase 




4.2.2   Helicase activity assay 
Purified PabMCM protein (2 μM) was incubated with annealed y-shaped FAM-
DNA (10 nM) at 65°C and 75°C for 30 minutes, 1,4 and 20 hours, in helicase 
buffer (20 mM HEPES pH 7.4, 5 mM MgCl2, 1 mM DTT, 0.1 mg/ml BSA, 3 mM 
ATP 150 mM NaCl and 100 mM K-glutammate). The sequences of the oligos 
forming y-shaped FAM-DNA can be found in Table 4.1. Temperature and protein-
DNA ratio were chosen according to experimental condition commonly used for 
helicase activity assays of SsoMCM. Adequate DNA concentration was previously 
tested in order to have sufficient detectable fluorescence. PabMCM helicase 
activity was tested by running the samples in a 10% native-PAGE and boiled y-
shaped FAM-DNA was used as positive control. Imaging was performed using a 




Table 4.1: Oligos used to form y-shaped FAM-DNA. The sequence of the fluorescent tag 
(FAM) at the 5’ end of OLIGO_1 is underlined. OLIGO_2 is partially complementary to 
OLIGO_1, forming a y-shaped DNA that recreates the shape of the replication fork. 
 
 
4.2.3   Protein-DNA complex assembly 
DNA oligos (Table 4.2) were annealed to form different shapes of DNA substrates, 
dsDNA (OLIGO_A + OLIGO_B) and y-shaped DNA (OLIGO_A + OLIGO_C). 50 
μl of each oligo (100 μM), forming the DNA substrate, were added into a PCR 
tube and mixed before being boiled at 95°C for 10 minutes, annealing was 
achieved o/n by incubation of the PCR tubes into boiling water, allowing a slow 
and constant decrease in temperature. 500 μl of nickel-purified PabMCM (10 
mg/ml) were incubated with 100 μl of different DNA substrates (50 μM) for 1 hour 
at room temperature prior to size exclusion chromatography on a 
Superose6™10/300 GL column in SEC buffer (20 mM HEPES pH 7.4, 150 mM 
NaCl). Purification was monitored by SDS-PAGE analysis on 10% gels stained 
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with SimplyBlue SafeStain (Invitrogen) and changes into PabMCM assemblies 





Table 4.2: Oligos used to form DNA substrates. OLIGO_A and OLIGO_B were annealed 
to form dsDNA, while OLIGO_A and OLIGO_C were annealed to form y-shaped DNA. 
 
 
4.2.4   Small angle X-ray scattering (SAXS) and modelling  
 
SAXS data for PabMCM in isolation and in complex with distinct DNA substrates 
(in absence or presence of ATPγS) was collected at B21, Diamond Light Source 
(Harwell, UK). 55 μl of each protein sample (~10 mg/ml) was loaded onto a 
Superose6 column (GE Healthcare), controlled by an Agilent HPLC system, 
coupled to an in-vacuum SAXS flow cell. HPLC-SAXS traces were processed 
using ScÅtter. Data was analysed using different strategies. Ab initio bead models 
were obtained using ScÅtter and DAMMIN. Ensemble models of single hexameric 
rings in open conformation, closed single heptameric rings and single octameric 
rings were generated using EOM: a pool of 10,000 asymmetric independent 
models was generated, based on the sequence of PabMCM and on constraints 
we generated by homology modeling using Phyre2. The constraints used as input 
for EOM correspond to the three main PabMCM domains (N-terminal, AAA+ and 
C-terminal). Particular care was taken in order to build the ring assembly of N-
terminal domains formed by six, seven or eight subunits. Three independent N-
terminal rings models were built using Chimera by docking the N-terminal domains 
onto the EM density maps of PabMCM and onto the crystallographic structure of 
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SsoMCM. Theoretical SAXS curves of individual EOM models were calculated 
using CRYSOL. Figures were prepared using ScÅtter and SasView. 
 
 
4.2.5   200 kV cryo-electron microscopy (cryo-EM) 
 
Cryo-EM and single particle analysis (SPA) were coupled to study the structure of 
PabMCM. The cryo-EM data collection was performed on Quantifoil 1.2-1.3 
copper grids covered with a 2nm layer of carbon, plunge-frozen into liquid ethane 
using a Vitrobot instrument. The data collection was carried under low-dose mode 
at nominal magnification of 50,000x, at a final sampling of 1.51 Å/pixel at the 
specimen level, using a FEI F20 FEG microscope, equipped with a TemCam-
F816 (8kx8k) CCD camera. Data were processed using RELION and EMAN2 
softwares. From the micrographs dataset, ~34,000 single particles (SP) were 
manually picked using 250 Å masks; the single particle images were extracted 
into boxes 200x200 pixels, re-scaled at 96x96 pixels and band-pass filtered. The 
dataset was subjected to sequential rounds of alignments and classification in 
order to improve the resulting class-average images. The original dataset was 
divided into sub-datasets on the basis of the class-averages obtained with the 2D 
classification. Firstly, two sub-datasets were created for PabMCM in single ring 
conformation (~26,000 SP) and in double ring conformation (~8,000 SP). 
Secondly, the sub-dataset of the single ring PabMCM was split into two sub-
datasets grouping heptametric or octameric (~16,000 SP) single particles. Only 
the single particle images from the octameric single ring dataset were used for the 
following 3D reconstruction processes. Figures were prepared with UCSF 
Chimera and fitting copies of the crystallographic structure of SsoMCM of (PDB 
ID: 3F9V) into the cryo-EM density maps obtained.  
 
 
4.2.6   300 kV cryo-electron microscopy (cryo-EM) 
 
Cryo-EM and single particle analysis (SPA) were coupled to study the structure of 
PabMCM in complex with y-shaped DNA and 5 mM ATPγS. The cryo-EM data 
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collection was performed on Quantifoil 1.2-1.3 copper grids, plunge-frozen into 
liquid ethane using a Vitrobot instrument. The data collection was carried under 
low-dose mode at nominal magnification of 50,000x, at a final sampling of 1.06 
Å/pixel at the specimen level, using a FEI Titan Krios microscope, equipped with 
a Gatan Quantum K3 Summit image filter/detector. Data was processed using 








4.3   Results and Discussion 
 
 
4.3.1   PabMCM has no significant helicase activity in vitro 
 
E. coli Rosettaä(DE3) pLysS cells were transformed by heat-shock method with 
pTWO-E vector containing PabMCM insert. Protein overexpression was induced 
by addition of 0.2 mM IPTG and carried out o/n at 30°C. Cells were then lysed by 
sonication and the lysate was incubated at 70°C for 20 minutes.  
Heat-denaturation represents the first step in the purification protocol of PabMCM 
as this archaeal protein is highly thermo-stable and does not aggregate, whereas 
the majority of E. coli proteins become insoluble after heat treatment and the 
aggregates can be removed by a simple centrifugation step. PabMCM protein was 
then purified by nickel chromatography in high-salt buffer in order to remove 
nucleic acid contamination. Elution was performed with an imidazole gradient, the 
fractions containing protein were analysed by 10% SDS-PAGE analysis and then 
pooled and concentrated to 10 mg/ml prior to size exclusion chromatography 
(SEC) using a Superose6 column.  
From the SEC trace in Figure 4.2A it is possible to notice that the main peak, 
eluting after ~13.5 ml, is characterized by a shoulder on its left-hand side, 
indicating that a bigger assembly elutes after ~11.5 ml and the two peaks are not 
resolved. The apparent molecular weight of the main peak of the SEC profile of 
PabMCM is 575 kDa, suggesting that this protein is likely to form an octameric 
assembly. Moreover, the apparent molecular weight of the left-hand side shoulder 
peak (~ 1 MDa) is consistent with the one of a double ring assembly. From the gel 
in Figure 4.2B it is possible to observe that the main band corresponds to a 
molecular weight consistent to the one of the PabMCM monomer (74 kDa). 
However, a small amount of degradation products could be detected when the gel 
was overloaded. Removal of these contaminants was carried out using 100 K 
MWCO spin-concentrators before further experiments. 
The helicase activity of PabMCM was tested by incubating the purified protein with 
fluorescently labelled y-shaped DNA that mimics the replication fork, in the 
presence of ATP, and by native-PAGE analysis. More specifically, using this 
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assay, if the protein has helicase activity, we would observe a band-shift of the 
fluorescent DNA substrate at lower molecular weight compared to the one of free 
duplexed y-shaped DNA. Temperature and protein-DNA ratio, as well as buffer 
composition, were chosen accordingly to experimental condition commonly used 
for helicase activity assays of SsoMCM. Adequate DNA concentration was 
previously tested in order to have sufficient detectable fluorescence. As shown in 
Figure 4.3, PabMCM has very low helicase activity in vitro, detectable only after 
20 hours of incubation at 70°C. Moreover, it is possible to observe fluorescence 
at the bottom of the wells were protein and DNA are simultaneously present, 
indicating high-molecular weight complex assembly. P. abyssi is a hyper-
thermophilic archaeon and its optimal temperature habitat is 95°C. It follows that, 
since DNA is denaturated in vitro at 95°C, lower temperatures and longer 
incubation times had to be used in order to test PabMCM helicase activity in vitro. 
Consequently, the extremely low helicase activity detected for PabMCM protein 








Figure 4.2: SEC purification step of PabMCM. A: Size exclusion chromatography trace of 
PabMCM in SEC buffer (20 mM HEPES pH 7.4, 150 mM NaCl) using a Superose6™10/300 
GL column at 0.4 ml/min flow-rate. B: SimplyBlue SafeStain staining of 10% SDS-PAGE 
analysis of the elutions of SEC purification step of PabMCM. 
	
 
       	
 
Figure 4.3: Helicase activity assay of PabMCM protein. Purified PabMCM protein (2 μM) 
was incubated with y-shaped FAM-DNA (10 nM) at 65°C and 75°C for 30 minutes, 1,4 and 20 
hours, in helicase buffer (20 mM HEPES pH 7.4, 5 mM MgCl2, 1 mM DTT, 0.1 mg/ml BSA, 3 
mM ATP 150 mM NaCl and 100 mM K-glutammate) and loaded into a 10% native-PAGE. 




4.3.2   PabMCM is a heterogeneous complex  
 
Most archaeal MCM proteins are polymorphic and both hexameric and heptameric 
architectures have been reported for the same polypeptide. Moreover, both these 
assemblies can be found as single rings, double rings or filaments. PabMCM 
represents the first evidence that MCM proteins can be found not only as 
hexamers and heptamers, but also as octameric assemblies (Cannone et al., 
2017). 
As shown in Figure 4.4, PabMCM forms numerous assemblies. There are three 
main bands between 480 kDa and 720 kDa, which are likely to correspond to 
single ring assemblies in hexameric, heptameric and octameric configuration. 
However, other weaker bands can be detected at molecular weights consistent 
with the ones of single rings and these could correspond to different conformations 
of this dynamic complex.  
On the other hand, a single band is present between 720 kDa and 1048 kDa, 
which is likely to correspond to a double ring complex. The molecular weight would 
suggest a double hexameric assembly (888 kDa). However, the presence or 
absence of double heptamers and double octamers would be difficult to detect 
using this gel electrophoresis. It follows that, using this analysis, we cannot 
exclude the possibility that also PabMCM double ring is an heterogeneous 
complex, as demonstrated for the single ring assembly. 
 
	
Figure 4.4: Heterogeneity analysis of PabMCM. A: Size exclusion chromatography trace of 
PabMCM in SEC buffer (20 mM HEPES pH 7.4, 150 mM NaCl) using a Superose6™10/300 
GL column at 0.4 ml/min flow-rate. B: BN-PAGE analysis of the elutions from SEC purification 
step of PabMCM in a 4-12% Bis-Tris NativePAGE, gel was run for 3 hours at 150 V and de-
stained o/n in 30% ethanol and 10% acetic acid.  
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Cryo-EM and single particle analysis (SPA) were coupled to study the structure of 
PabMCM and its heterogeneity (Figure 4.5). From the CTF corrected micrographs 
dataset, ~34,000 single particles (SP) were manually picked using 250 Å masks; 
the single particle images were extracted into boxes 200x200 pixels, re-scaled at 
96x96 pixels and band-pass filtered. The dataset was subjected to sequential 
rounds of alignments and 2D classification in order to improve the resulting class-
average images. The original dataset was divided into sub-datasets on the basis 
of the class-averages obtained with the 2D classification. Firstly, two sub-datasets 
were created for PabMCM in single ring conformations (~26,000 SP) and in 
double ring conformation (~8,000 SP). Secondly, the sub-dataset of the single ring 
PabMCM was split into two sub-datasets grouping heptametric (~10,000 SP) or 
octameric (~16,000 SP) single particles. From the 2D class-averages obtained it 
is not clear whether or not single ring hexameric assemblies are present in our 
dataset. In fact, some of the class-averages belonging to the heptameric ring sub-
dataset might instead represent a hexameric ring in an open configuration. This 
derives from the fact that some densities are in different axial planes and they 
could be either single subunits or different domains of the same PabMCM 
monomer. For this reason, only the single particle images from the octameric 
single ring dataset and for the double ring were used for the following 3D 
reconstruction. Initial models were generated with EMAN2 without imposing 
symmetry and checked by inspecting the 3D model and the correspondence 
between the class averages and the re-projections of the initial models. The 
choice of avoiding to impose symmetries comes from the fact that previous EM 
structural studies of other MCM proteins from different organisms show that these 
proteins assemble as skewed rings (Lyubimov et al., 2012). The models for the 
single octameric ring and for the double ring, obtained after 3D classification and 
refinement in RELION, were manually fitted with copies of the 4.35 Å resolution 
crystallographic structure of a near full-length SsoMCM (PDB ID: 3F9V), whose 
AAA+ domain presents high sequence identity with the one of PabMCM. On the 
other hand, the N-terminal domain of PabMCM reveals low sequence similarity 
with previously reported S. solfataricus and M. Thermoautrophicus MCM proteins 
(Cannone et al., 2017), even though the secondary structure of the N-terminal 
domain is highly conserved amongst Archaea and Eukaryotes. The density map 
obtained for the single octameric ring shows that indeed eight copies of 3F9V can 
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be fitted into the EM map (Figure 4.6). Moreover, two subunits are in a different 
axial plane compared to the rest of the ring, which is indeed in a skewed 
configuration. The density map obtained for the double ring shows that sixteen 
copies of 3F9V could be fitted in the map, suggesting a head-to-head assembly 
of octameric rings (Figure 4.7). 
 
 
Figure 4.5: Cryo-EM coupled to single particle analysis of PabMCM. Micrographs were 
collected at nominal magnification of 50,000x at 1.51 Å/pixel, using a FEI F20 FEG microscope 
equipped with a TemCam-F816 (8kx8k) CCD camera. Micrographs were CTF corrected and 
~34,000 single particles were manually picked using 250 Å masks and subjected to several 
round of classification to then be divided into sub-datasets corresponding to PabMCM in single 






Figure 4.6: Cryo-EM density map of PabMCM single octameric ring. A: ~16,000 single 
particles were used to generate a 3D model of PabMCM in single octameric ring assembly. B: 
8 truncated SsoMCM monomers (PDB ID: 3F9V) were fitted into the cryo-EM density map. C: 







Figure 4.7: Cryo-EM density map of PabMCM double octameric ring. A: ~8,000 single 
particles were used to generate a 3D model of PabMCM in double octameric ring assembly. 
B: 16 truncated SsoMCM monomers (PDB ID: 3F9V) were fitted into the cryo-EM density map. 




4.3.3   PabMCM forms dynamic rings  
 
The first evidence that PabMCM can adopt several configurations in solution is 
given by the presence of multiple bands consistent with molecular weights of 
single ring assemblies. Moreover, cryo-EM coupled to single particle analysis 
shows that PabMCM can assemble as single octamers, heptamers and probably 
hexameric rings in open conformation. Small angle X-ray scattering was used in 
order to provide more information about the behaviour of the complex in solution. 
SAXS data were collected at B21, Diamond Light Source (Harwell, UK). The 
protein sample was loaded onto a Superose6 column (GE Healthcare), controlled 
by an Agilent HPLC system coupled to an in-vacuum SAXS flow cell. HPLC-SAXS 
traces were processed using ScÅtter. Particular care was taken when analysing 
the HPLC-SAXS traces, in order to avoid using frames with non-ideal separation 
of single and double ring assemblies. The low number of frames used, and 
therefore the low concentration, is the basis of the high noise of the data, 
especially at high q. 
The buffer subtracted experimental SAXS intensity curve of PabMCM in single 
ring assembly is shown in purple in Figure 4.8A and the correspondent ab initio 
bead model, represented in purple, was obtained using ScÅtter and DAMMIN. 
The Rg calculated from the Guinier analysis is 68.99 Å, whereas the one obtained 
in real space from the p(r) distribution is 70.01 Å. The Dmax is 283 Å and the C2 of 
the fitting is 0.37. Even though the DAMMIN model fits well to the SAXS data (C2 
= 0.71), it is possible to notice the presence of extra density compared to the bead 
model generated from the EM density map of the single ring in octameric 
assembly, represented in grey. Moreover, the theoretical SAXS curve calculated 
for the EM model, shown in black in the graph, presents more enhanced features 
compared to the experimental data. The same approach was used to study 
PabMCM in double ring assembly and its experimental SAXS intensity curve is 
shown in blue in Figure 4.8B. The Rg calculated from the Guinier analysis is 110.46 
Å, whereas the one obtained in real space from the p(r) distribution is 113.06 Å. 
The Dmax is 418 Å and the C2 of the fitting is 0.53. The DAMMIN model, shown in 
blue, fits well the SAXS data (C2 = 0.73), but also in this case it is possible to 
observe the presence of an extra density. 
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Additionally, the theoretical SAXS curve calculated for the EM model of PabMCM 
double ring, shown in black in the graph, also presents more distinct features 
compared to the experimental curve.  
The extra densities observed in the SAXS beads models for PabMCM single ring 
and double ring are not likely to derive from aggregation or inter-particle 
interference as fractions from SEC purification were previously assessed with DLS 
measurements, in order to identify regions of the peaks containing only one 
species. Consequently, we hypothesized that the dissimilarity between the 
solution scattering models and the cryo-EM models could be explained by the 
intrinsic difference in data processing of these two techniques. In fact, while 2D 
class averaging and further subsets selection of different conformations is 
possible in cryo-EM analysis, the SAXS profile is the result of the scattering 
pattern of all molecules in solution and the identification of different conformations 
in solution can be particularly challenging. Importantly, SAXS shows that both 
these systems are characterized by a certain degree of flexibility, as shown by 
their Kratky plot in Figure 4.8C, and this could be the reason why the DAMMIN 
models exhibit extra densities. 
In order to gather more information about these systems, the three-dimensional 
models of PabMCM protein in single ring assembly were obtained by combining 
homology modelling analysis and small angle X-ray scattering data.  
An Ensemble Optimization Method (EOM) approach was used in order to 
generate SAXS models for single rings in heptameric, octameric and open 
hexameric configuration. A pool of 10,000 asymmetric independent models was 
generated for each type of complex, based on the sequence of PabMCM and on 
constraints we generated by homology modeling using Phyre2. The constraints 
used as input for EOM correspond to the three main PabMCM domains (N-
terminal, AAA+ and C-terminal). Particular care was taken in order to build the 
ring assemblies of N-terminal domains formed by six, seven or eight subunits. 
This was achieved by using Chimera and by docking the N-terminal domains of 
PabMCM into the EM density maps of PabMCM and into the crystallographic 
structure of SsoMCM. In the EOM analysis, the N-terminal ring was fixed in the 
configuration obtained from the docking, while positions of AAA+ and C-terminal 
domains were allowed to be freely modelled by EOM, without imposing any 
symmetry.  Figure 4.9A shows the three EOM models obtained for the octameric 
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single ring assembly and their calculated SAXS curves, as well as their 
comparison with the experimental SAXS curve (in purple). Similarly, Figures 4.9B 
and 4.9C show the EOM models obtained for the heptameric and for the 
hexameric single ring assemblies, respectively. 
 
 
Figure 4.8: Comparison of SAXS and EM characterization of PabMCM in single and 
double ring assemblies. A: Experimental SAXS intensity curve of PabMCM in single ring 
assembly (purple) and theoretical SAXS curve calculated from the cryo-EM model of PabMCM 
in single ring octameric assembly (black), correspondent beads models are shown in purple 
and grey. B: Experimental SAXS intensity curve of PabMCM in double ring assembly (blue) 
and theoretical SAXS curve calculated from the cryo-EM model of PabMCM in double ring 
octameric assembly (black), correspondent beads models are shown in blue and grey. C: 
Kratky plot analysis of PabMCM in single (purple) and double (blue) ring assemblies. Figures 
were prepared using SasView and ScÅtter, beads size of the models increased post-analysis 
for clarity in figure.  
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Figure 4.9: EOM modelling of PabMCM in single ring assemblies. A: Experimental SAXS 
intensity curve of PabMCM in single ring assembly (purple) and theoretical SAXS curve 
calculated from the EOM models generated for PabMCM in single ring octameric assembly 
(blue, green, cyan), correspondent EOM models are shown in the figure. B: Experimental 
SAXS intensity curve of PabMCM in single ring assembly (purple) and theoretical SAXS curve 
calculated from the EOM models generated for PabMCM in single ring heptameric assembly 
(blue, green, cyan), correspondent EOM models are shown in the figure. C: Experimental 
SAXS intensity curve of PabMCM in single ring assembly (purple) and theoretical SAXS curve 
calculated from the EOM models generated for PabMCM in single ring hexameric assembly 
in open conformation (blue, green, cyan), correspondent EOM models are shown in the figure. 
Figures were prepared using SasView. 
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As shown in Figure 4.9, EOM generated three models for each single ring 
assembly and, for each of them, the model with the highest percentage in the 
scattering contribution was chosen to perform further analysis.  
The calculated scattering curves of the single rings in different configurations were 
compared to the experimental SAXS intensity curve (Figure 4.10). As previously 
described, BN-PAGE and cryo-EM analysis indicate that PabMCM is a 
heterogeneous complex and can assemble as single hexamers, heptamers and 
octamers. Moreover, our EOM models fit quite well with our experimental data 
(C2hexamer = 4.768, C2heptamer= 3.888, C2octamer = 10.87).  
Therefore, we decided to use OLIGOMER in order to obtain a quantification of the 
scattering contribution of each model to the total scattering intensity.  The software 
was fed with the nine EOM models obtained for PabMCM single ring (three for 
each type of complex) and the scattering data. Surprisingly, the output given by 
this software suggests that only the three EOM models for the single octameric 
ring contribute to the total scattering intensity, as simplified in Figure 9. 
Conversely, the calculated C2 of the three ensembles of EOM models calculated 
for PabMCM would suggest that the octameric assembly is the less reliable. 
Another discrepancy between the output from EOM and from OLIGOMER 
analysis consists in the different percentages of scattering contribution from the 
three models for the single ring in octameric assembly. Specifically, according to 
EOM analysis, the model that has the biggest impact on the scattering intensity is 
“model 01783” (71.5 %), whereas the other two models contribution is 14 % only. 
On the other hand, OLIGOMER analysis suggests that the “model 01076” is the 
major species in solution (1 ± 0.695), while the fraction of “model 01783” is only 0 
± 0.664 and the one for “model 06768” is 0 ± 0.693.  
Moreover, the Rg calculated with these softwares are inexplicably slightly different 
and this could be at the basis of the incongruity of the analysis.  
For what concerns the PabMCM double ring complex, an EOM approach could 
not be adopted given the complexity of the system. Instead, a simplified analysis 
has been performed by fitting two identical copies of each EOM model obtained 
for the octameric assembly in a head-to-head configuration into the EM density 
map of the double ring.  
SAXS curves were calculated from the models obtained and compared to the 
experimental data for PabMCM in double ring assembly (Figure 4.11). This 
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evaluation shows a good fitting with the experimental data. However, further 
modelling, where the two rings of a double ring assembly are in different 
conformations or in heptameric and hexameric assembly, was not carried out 
given the high number of possible combinations and the limited information gain.   





Figure 4.10: Analysis of PabMCM single ring heterogeneity by SAXS. Comparison of the 
experimental SAXS intensity curve of PabMCM in single ring assembly (purple) and theoretical 
SAXS curve calculated from the most abundant EOM models generated for PabMCM in single 
ring octameric (blue), heptameric (green) and hexameric (cyan) assemblies. Correspondent 
EOM models are shown in the figure. Red crosses highlight the conformations excluded from 













Figure 4.11: SAXS analysis of PabMCM octameric double ring assembly. Comparison of 
the experimental SAXS intensity curve of PabMCM in double ring assembly (blue) with the 
theoretical SAXS curves calculated from double ring assemblies generated using UCSF 
Chimera with PabMCM single ring octameric EOM models as input. Correspondent models 




4.3.4   DNA binding of y-shaped DNA induces conformational changes 
on PabMCM complex 
 
In order to dissect individual steps of MCM mechanism and provide deeper 
understanding of its role in DNA replication, we used distinct DNA molecules 
designed to mimic the shape adopted by genomic DNA during the different phases 
of replication. A long linear dsDNA substrate was used to examine whether a 
head-to-head double ring MCM complex performs the wrapping of the origin of 
replication. On the other hand, the configuration adopted by MCM during the 
process of origin melting could be studied using a “bubble”-shaped DNA and it 
could be compared to the one assumed during the progression of the replication 
fork by using a y-shaped DNA substrate which mimic the process of DNA 
unwinding. Preliminary experiments were performed using “bubble”-shaped DNA; 
however, the low-resolution information obtained with SAXS measurements failed 
in the detection of MCM rearrangements. For this reason, data for the complex 
between PabMCM and a “bubble”-shaped DNA substrate are not shown in this 
thesis and only results for a complex with dsDNA and y-shaped DNA are shown. 
Nickel-purified PabMCM was incubated with the different DNA substrates prior to 
size exclusion chromatography on a Superose6™10/300 GL column. Complex 
formation was monitored by A260/280 measurements and BN-PAGE analysis in a 4-
12% Bis-Tris NativePAGE gel.  
The comparison between the SEC traces of PabMCM in absence or presence of 
y-shaped DNA is shown in Figures 4.12A and 4.12C, respectively. As it can be 
seen from the chromatogram, the binding of the DNA substrate induces a change 
in the shape of the peak, as the left-hand side shoulder peak, likely to correspond 
to PabMCM in double ring assembly, seems to increase and to give rise to a non-
resolved double peak. However, when comparing the BN-PAGE analysis for 
PabMCM in absence or presence of y-shaped DNA (Figures 4.12B and 4.12D), it 
is possible to notice that the fractions corresponding to PabMCM in single ring 
assembly are shifted towards higher molecular weights when the DNA substrate 
is added to the mix, suggesting that PabMCM single ring binds y-shaped DNA. 
Moreover, a reduction of the number of fractions containing PabMCM in double 
ring assembly can be detected, suggesting that a portion of double rings 
dissociates in order to elicit DNA binding. On the other hand, PabMCM in double 
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ring assembly is still present and the distribution of the fractions containing this 
species suggests that it might become more compact, probably because of DNA 
binding. Interestingly, upon addition of DNA substrate, it is possible to observe the 
appearance of a new band, at ~300 kDa, in the elution fractions corresponding to 
the right-hand side part of the major peak, probably due to partial assembly and/or 
disassembly of the complex. 
 
	
Figure 4.12:	Heterogeneity analysis of PabMCM in absence or presence of y-shaped 
DNA. A: Size exclusion chromatography trace of PabMCM in SEC buffer (20 mM HEPES pH 
7.4, 150 mM NaCl) using a Superose6™10/300 GL column at 0.4 ml/min flow-rate. B: BN-
PAGE analysis of the elutions from SEC purification step of PabMCM in a 4-12% Bis-Tris 
NativePAGE, gel was run for 3 hour at 150 V and de-stained o/n in 30% ethanol and 10% 
acetic acid. C: Size exclusion chromatography trace of PabMCM in complex with y-shaped 
DNA in SEC buffer (20 mM HEPES pH 7.4, 150 mM NaCl) using a Superose6™10/300 GL 
column at 0.4 ml/min flow-rate. B: BN-PAGE analysis of the elutions from SEC purification 
step of PabMCM in complex with y-shaped DNA in a 4-12% Bis-Tris NativePAGE, gel was run 




Figure 4.13 shows the SAXS profiles of PabMCM in complex with different DNA 





Figure 4.13: SAXS curves of PabMCM in absence or presence of ATPγS and dsDNA or 
y-shaped DNA. A: Experimental SAXS intensity curves of PabMCM in single ring assembly 
(purple) and in presence of ATPγS (black). B: Experimental SAXS intensity curves of PabMCM 
in double ring assembly (blue) and in presence of ATPγS (black). C: Experimental SAXS 
intensity curves of PabMCM in single ring assembly (purple) and in presence of dsDNA (blue) 
or y-shaped DNA (green). D: Experimental SAXS intensity curves of PabMCM in double ring 
assembly (blue) and in presence of dsDNA (cyan) or y-shaped DNA (green). E: Experimental 
SAXS intensity curves of PabMCM in single ring assembly in presence of ATPγS (red) and in 
presence of dsDNA (blue) or y-shaped DNA (cyan) and ATPγS. F: Experimental SAXS 
intensity curves of PabMCM in double ring assembly in presence of ATPγS (red) and in 




Both PabMCM single and double rings adopt a more compact conformation when 
ATPγS is bound in the AAA+ domain. This effect is more dramatic for PabMCM 
in double assembly and a change in overall dimensions of the complex can be 
observed (Figure 4.14). In fact, in presence of ATPγS, the Rg calculated from the 
Guinier analysis drops from 110.46 Å to 96.12 Å (Rg  [p(r)] drops from 113.06 Å to 
96.19 Å), whereas the Dmax drops from 418 Å to 320 Å. In both cases, the C2 of 
the fitting are appropriate (0.53 vs 0.63) and the DAMMIN models obtained show 
an increased compactness and, consequently, a reduction of “extra density” when 






Figure 4.14: SAXS analysis of PabMCM double ring in absence or presence of ATPγS. 
SAXS intensity curve, real space fitting (in red), p(r) distribution, DAMMIN model and table 
with overall dimensions of the complex and statistical analysis. Beads size of the models 




For what concerns for PabMCM in single ring assembly a smaller change in 
overall dimensions of the complex can be observed (Figure 4.15). In fact, in 
presence of ATPγS, the Rg calculated from the Guinier analysis drops from 68.99 
Å to 64.95 Å (Rg  [p(r)] drops from 70.01 Å to 63.79 Å), whereas the Dmax drops 
from 283 Å to 210 Å. In both cases, the C2 of the fitting are appropriate (0.37 vs 
0.8) and the DAMMIN models obtained also show a reduction of extra density 





Figure 4.15: SAXS analysis of PabMCM single ring in absence or presence of ATPγS. 
SAXS intensity curve, real space fitting (in red), p(r) distribution, DAMMIN model and table 
with overall dimensions of the complex and statistical analysis. Beads size of the models 





Similarly, when PabMCM is bound to DNA substrates, the change induced by the 
binding of ATPγS is bigger for double ring assemblies (Figure 4.16) than for single 
rings (Figure 4.17). Moreover, the binding of dsDNA results in an increase of the 
Rg of the complex and in a decrease of its Dmax, while the binding of y-shaped 
DNA results in a overall more compact assembly, comparable to the one induced 
by the binding of ATPγS. 
More specifically, when PabMCM double ring binds dsDNA, its Rg changes from 
110.46 Å to 118.68 Å (Rg  [p(r)] increases from 113.06 Å to 116.94 Å), whereas 
the Dmax drops from 418 Å to 367 Å. Also in this case, the binding of ATPγS 
triggers the complex to adopt a more compact conformation and its Rg drops from 
118.68 Å to 107.02 Å (Rg  [p(r)] drops from 116.94 Å to 107.76 Å), whereas the 
Dmax decreases from 367 Å to 357 Å. In addition, when PabMCM double ring binds 
y-shaped DNA, its Rg changes from 110.46 Å to 96.84 Å (Rg  [p(r)] drops from 
113.06 Å to 98.43 Å), whereas the Dmax drops from 418 Å to 356 Å. However, in 
this case, the binding of ATPγS does not induce a more compact conformation of 
the complex and, instead, its Rg increases from 96.84 Å to 104.50 Å (Rg  [p(r)] 
increases from 98.43 Å to 103.86 Å) and the Dmax slightly decreases from 356 Å 
to 352 Å.  
On the other hand, when PabMCM in single ring assembly is bound to DNA 
substrates, an extremely small change in overall dimensions of the complex can 
be observed. In fact, in presence of dsDNA, the Rg calculated from the Guinier 
analysis slightly increases from 68.99 Å to 72.57 Å (Rg  [p(r)] changes from 70.01 
Å to 73 Å), whereas the Dmax decreases from 283 Å to 255 Å. As expected, the 
binding of ATPγS induces a more compact conformation of the complex and its 
Rg calculated from the Guinier analysis slightly decreases from 72.57 Å to 70.85 
Å (Rg  [p(r)] changes from 73 Å to 70.05 Å), whereas the Dmax drops from 255 Å to 
240 Å. Additionally, when PabMCM in single ring assembly is bound to y-shaped 
DNA, the Rg calculated from the Guinier analysis slightly increases from 68.99 Å 
to 70.12 Å (Rg  [p(r)] changes from 70.01 Å to 71.07 Å), whereas the Dmax 
decreases from 283 Å to 253 Å. Also in this case, as previously observed for 
PabMCM in complex with y-shaped DNA, the binding of ATPγS does not induce 
a change of the overall dimensions of the complex and its Rg calculated from the 




        
Figure 4.16: SAXS analysis of PabMCM double ring in presence of DNA substrates and 
in absence or presence of ATPγS. SAXS intensity curve, real space fitting (in red), p(r) 
distribution, DAMMIN model and table with overall dimensions of the complex and statistical 




         
Figure 4.17: SAXS analysis of PabMCM single ring in presence of DNA substrates and 
in absence or presence of ATPγS. SAXS intensity curve, real space fitting (in red), p(r) 
distribution, DAMMIN model and table with overall dimensions of the complex and statistical 
analysis. Bead size of the models increased post-analysis for clarity in figure. 
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4.3.5   Cryo-EM of PabMCM in complex with y-shaped DNA and ATPγS 
 
The architecture of PabMCM in complex with y-shaped DNA and ATPγS was 
studied by cryo-EM coupled to single particle analysis in order to assess 
conformational heterogeneity. 500 μl of nickel purified PabMCM protein (10 
mg/ml) were incubated with 100 μl of y-shaped DNA (50 μM) and 5 mM ATPγS 
for 1 hour at room temperature, prior to size exclusion chromatography using a 
Superose 6 Increase 10/300 GL column (Figure 4.18A). Fractions from the gel 
filtration were screened by negative staining TEM in order to identify the fraction 
containing a similar proportion of single and double ring assemblies, which 












Figure 4.18: Purification and negative staining TEM of PabMCM in complex with y-
shaped DNA and ATPγS. A: SEC trace of PabMCM+y-shaped DNA+ATPγS (continuous line), 
PabMCM (dashed line), and y-shaped DNA+ATPγS (dotted line) using a Superose 6 Increase 
10/300 GL column in SEC buffer. B: Negative staining TEM of fraction 12 of SEC of 
PabMCM+y-shaped DNA+ATPγS on a 400 mesh copper grid, using 2% uranyl acetate, where 




The cryo-EM data collection of fraction 12 of the SEC of PabMCM+y-shaped 
DNA+ATPγS was carried out at eBIC (Diamond Light Source, Harwell) under low-
dose mode at nominal magnification of 50,000x, at a final sampling of 1.06 Å/pixel, 
using a FEI Titan Krios microscope, equipped with a Gatan Quantum K3 Summit 
image filter/detector. Data was processed using RELION software by myself and 
Dr Laura Spagnolo, independently. The data processing pipeline, from manual 
picking to 3D classification, presented in this section derives from my single 
particle analysis. Higher-resolution refined 3D maps were generated and provided 
by Dr Laura Spagnolo. Further analysis on the cryo-EM density maps, such as 
superposition of the subunits, were performed by myself. From the CTF and 
motion corrected dataset (~2500 micrographs) (Figure 4.19A), ~3,000 single 
particles (SP) were manually picked using 250 Å masks; the single particle images 
were extracted into boxes 400x400 pixels and subjected to one round of 2D 
classification in order to generate reference images for auto-picking. ~543,000 
particles were autopicked, extracted into boxes 400x400 pixels and rescaled to 
100x100 pixels. The dataset was subjected to sequential rounds of alignments 
and 2D classification using a 300 Å mask, in order to initially clean up the dataset 
and then to improve the resulting class-average images. The polished dataset 
(~390,000 SP) was divided into sub-datasets on the basis of the class-averages 
obtained with the 2D classification. Two sub-datasets were created for PabMCM 
in single ring conformations (~206,000 SP) and in double ring conformation 
(~201,000 SP) (Figures 4.19B and 4.19C, respectively). Both the sub-datasets 
contain particles from the same top/bottom 2D class averages, while particles 
from 2D class averages that represent side views are sorted in the two sub-
datasets. Initial models for the single and double ring complexes were generated 
with EMAN2 without imposing any symmetry and checked by inspecting the 3D 
model and the correspondence between the class averages and the re-
projections of the models. Even though the addition of the y-shaped DNA seemed 
to decrease the level of asymmetry of the complex, we decided to avoid imposing 
symmetries at any stage of the analysis. An initial 3D classification was performed 
for each sub-dataset by generating five 3D classes. Representative 3D models 
are shown in (Figures 4.19B and 4.19C). However, at this stage, the individual 
classes were not further processed to obtain refined high-resolution density maps, 
because of the high computational power that was required and limited resources. 
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The final models of single and double ring assemblies were provided by Dr Laura 




Figure 4.19: Cryo-EM of PabMCM in complex with y-shaped DNA and ATPγS. A: 
Representative motion corrected micrograph of a cryo-EM dataset of fraction 12 of SEC of 
PabMCM+y-shaped DNA+ATPγS (low-dose mode, nominal magnification of 50,000x, final 
sampling of 1.06 Å/pixel, using a FEI Titan Krios microscope, equipped with a Gatan Quantum 
K3 Summit image filter/detector. B: 2D class averages of single ring assemblies and 
representative low-resolution 3D model. C: 2D class averages of double ring assemblies and 
representative low-resolution 3D model. 
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The cryo-EM density maps, obtained from single particle analysis of PabMCM in 
complex with y-shaped DNA and ATPγS, show the presence of two distinct single 
ring assemblies and two different double ring assemblies (Figure 4.20). The 
architecture of PabMCM, represented by the cryo-EM models obtained, will be 
discussed in more detail in the next paragraphs, with the exception of the one 
shown in Figure 4.20C. In fact, even though it appears clear that this model 
represents a double ring assembly where the two single rings are in closer 
contact, it is not possible to provide additional information, as the domain 
organization of the monomeric PabMCM, as well as individual subunits of the 





Figure 4.20: Cryo-EM models of PabMCM in complex with DNA and ATPγS. A: 3D 
reconstruction of PabMCM in single ring open assembly (~85,000 SP). B: 3D reconstruction 
of PabMCM in single ring close assembly (~30,000 SP). C: 3D reconstruction of PabMCM in 




The high-resolution cryo-EM density map obtained for PabMCM in single ring 
assembly show that the complex binds to y-shaped DNA as a hexamer, in an 
opened conformation. As shown in Figure 4.21A, a region of the y-shaped DNA 
is located in the middle of the complex but leans on one side of it, making contact 
with one of the subunits. Moreover, another part of the y-shaped DNA appears to 
twirl on the N-terminal part of the complex. The diameters of these DNA segments 
correspond to a single strand, for the region that can be found in the middle of the 
MCM complex, and to a double strand, for the one that sits on the surface of the 
ring where the N-terminal domains of each subunit make contact. Similarly, a 
recent study of the eukaryotic E.cuniculi MCM2-7, reporting the crystal structure 
of a near full-length MCM hexamer bound to ssDNA, shows that the open ring 
adopts a skewed conformation in order to accommodate the entrance of ssDNA 
through a spiral staircase (Meagher et al., 2019).  
Figure 4.21B shows top and side views of the open hexameric ring bound to y-
shaped DNA and the manual superposition of six identical copies of monomeric 
PabMCM, obtained by homology modelling using Phyre2. The six subunits do not 
reside on the same plane, resulting in a skewed open ring. Consequently, the two 
external subunits are extremely different when the ring is observed from the top. 
In fact, “PabMCM 1” appears to be smaller when compared to the other subunits, 
while “PabMCM 6” appears bigger because of their relative position down the view 
axis. Moreover, it is possible to observe that both the N-terminal and the AAA+ 
domains of “PabMCM 6” are visible from the top view. This is another 
consequence of the non-planar nature of the open ring and might be mistaken as 
indication of the presence of a seventh subunit, as previously shown in the 2D 
classification. Furthermore, in the cryo-EM map it is possible to detect a 
conformational change in the spatial organization of the winged helix-turn-helix 
domain of each PabMCM subunit. In fact, the linker between the AAA+ and the 
C-terminal domains triggers a rearrangement of the latter towards the centre of 
the MCM complex. As previously described, the C-terminal domain of MCM might 
play a role in DNA-stimulated ATPase activity. In our model it is possible to detect 
points of contact between the C-terminal domains of two subunits and the DNA 
substrate and further analysis could provide a deeper understanding of the 





Figure 4.21: Cryo-EM model of hexameric PabMCM single ring in complex with DNA and 
ATPγS. A: Side and top cut views of PabMCM single ring highlighting the DNA path in the 
middle channel of the ring. B: Side and top views of PabMCM single ring and superposition of 




The low-resolution cryo-EM density map obtained for PabMCM in single ring 
assembly shows that the complex can bind to y-shaped DNA as an heptamer. As 
shown in Figure 4.22A, the y-shaped DNA is located in the middle of the complex, 
leaning transversally. However, in this case, it appears that the double stranded 
region of the y-shaped DNA resides in the centre of the MCM complex, while the 
two single stranded segments stick out from the N-terminal side. Moreover, it is 
possible to observe that the N-terminal domains of several subunits mediate the 
contact with each single stranded portion of the y-shaped DNA, while some C-
terminal domains seem to interact with the double stranded region.  
Figure 4.22B shows top and side views of the heptameric ring bound to y-shaped 
DNA and the manual superposition of seven identical copies of monomeric 
PabMCM. As described for the open MCM hexamer bound to y-shaped DNA, and 
also for the octameric MCM in absence of DNA reported in section 4.3.2 of this 
chapter, the subunits do not reside on the same plane. The resolution of this 
model does not allow superposition of individual subunits on the basis of 
recognizable secondary structure elements, but only on lower resolution densities 
that can be associated to N-terminal and AAA+ domains. The superposition of the 
N-terminal domains in this map suggests that they adopt a different orientation in 
the heptameric assembly, when compared to the one observed in the open 
hexamer. This is consistent with the fact that the N-terminal domain of MCM plays 
a key role in protein oligomerization and therefore, different oligomeric states 
require a different organization of the N-terminal domains of each subunit. 
As described for the single hexameric ring in open conformation, the linker 
between the AAA+ and the C-terminal domains triggers a rearrangement of the 
latter towards the centre of the MCM complex. Interactions between the C-





Figure 4.22: Cryo-EM model of heptameric PabMCM single ring in complex with DNA 
and ATPγS. A: Side cut view of PabMCM single ring highlighting the DNA path in the middle 
channel of the ring. B: Side and top views of PabMCM single ring and superposition of seven 





The cryo-EM density map obtained for PabMCM in double ring assembly shows 
that the complex can bind to DNA also as a double octameric assembly.  
As shown in Figure 4.23A, the y-shaped DNA is buried inside the middle channel 
of the double ring complex. From our model, it appears that one of the PabMCM 
rings mediates the contact with the double stranded region of the y-shaped DNA, 
while the other interacts with the single stranded segments. In fact, the “bottom” 
ring of the complex seems to accommodate one of the single stranded regions in 
its central channel, while the other appears to enter one of the side channels 
between subunits or between the N-terminal rings, as proposed in Brewster and 
Chen (2010). Two recent cryo-EM structures of the yeast MCM2-7 double 
hexamer bound to DNA shows that the two rings are staggered to accommodate 
a kinked dsDNA molecule of 60-62 bp in length (Noguchi et al., 2017, Abid Ali et 
al., 2017). In particular, the model proposed by Noguchi et al. suggests a lagging 
strand DNA extrusion model, where the DNA strand separation is caused by 
torsion of the N-tier rings, which results in the extrusion of the lagging strand from 
the centre of the double ring and, consequently, in the activation of the helicase. 
Figure 4.23B shows top and side views of the double octameric ring in a head-to-
head conformation, bound to y-shaped DNA. The manual superposition of eight 
identical copies of monomeric PabMCM in each ring shows that the complex is 
not symmetrical, as all the subunits do not reside on the same plane. In fact, in 
our map it is possible to observe that the subunits 7, 8 and 9 of the two rings are 
more deeply interconnected through their N-terminal domains. This results in a 
more compact conformation of one side of the complex and therefore leads to the 
formation of an asymmetric complex.  
As previously described for the single hexameric ring in open conformation and 
for the single octamer, the rearrangement of the linkers between the AAA+ and 
the C-terminal domains results in a re-positioning of the C-terminal domains 
towards the centre of the MCM complex, where they mediate interactions with the 






Figure 4.23: Cryo-EM model of octameric PabMCM double ring in complex with DNA 
and ATPγS. A: Side cut view of PabMCM double ring highlighting the DNA path in the middle 
channel of the ring. B: Side and top views of PabMCM double ring and superposition of eight 




4.4   Conclusions 
 
Archaeal MCMs can form different assemblies in vitro, such as hexamers, 
heptamers, octamers -in single and double ring conformations- and filaments 
(Costa et al., 2006a, Costa et al., 2006b, Costa et al., 2008, Gomez-Llorente et 
al., 2005, Fletcher et al., 2003, Slaymaker et al., 2013, Cannone et al., 2017). 
Importantly, the question of whether hexamers, heptamers and octamers are all 
present in Archaeon cells and whether this polymorphism has a biological 
significance in vivo, still remain unsolved. With current knowledge, it is not 
possible to exclude that the presence of these diverse homo-multimers could be 
linked to artefacts driven by overexpression of these recombinant proteins and 
purification conditions.  
Here, we used the PabMCM protein as a functional tool to address advantages 
and limitations of different structural biology techniques, when dealing with a 
heterogeneous sample.  
As shown in this study, as well as in Cannone, et al. (2017), PabMCM binds DNA 
and has weak helicase activity in vitro. The limited activity of this protein could be 
linked to the absence of additional elements, such as GINS, Cdc6 and post-
translational modifications, which are all known to enhance helicase activity in 
other thermophilic MCMs (Cannone et al., 2017, Pan et al., 2011, Yoshimochi et 
al., 2008, Ogino et al., 2014, Xia et al., 2015).   
The polymorphism observed in archaeal MCM proteins adds an extra layer of 
complexity in the structural characterization of this complex. In particular, our cryo-
EM analysis of PabMCM, in isolation and bound to DNA, shows the presence of 
open hexamers, heptamers and octamers, both in single and double ring 
assemblies. Interestingly, only single ring and double ring species can be 
separated by size exclusion chromatography, suggesting that there might be an 
equilibrium between multimers within these two configurations. The dynamic 
behaviour of these complexes in solution was analysed by small angle X-ray 
scattering. However, the extreme complexity of this system, as well as the low-
resolution information that can be obtained with this technique, did not allow a 
quantitative measure of the heterogeneity observed. On the other hand, using 
small angle scattering methods (X-ray and neutron), we were able to detect a 
	
	 137	
change in overall dimension of the PabMCM complex when bound to y-shaped 
DNA, but not additional information on where the DNA is bound and on the 
conformation of the complex. Therefore, particular attention should be taken when 
interpreting these results. In fact, the difference in dimensions is likely to derive 
from an increase in the number of double ring assemblies, which results in 
augmented heterogeneity that might be difficult to detect. Nevertheless, these 
analyses allowed us to choose a y-shaped DNA molecule for further cryo-EM 
studies on PabMCM. Despite the different oligomeric state of PabMCM 
complexes, our cryo-EM data are in agreement with the models proposed by 
recent studies on the eukaryotic MCM2-7 complexes bound to different DNA 
molecules (Noguchi et al., 2017, Abid Ali et al., 2017, Meagher et al., 2019). In 
particular, our single hexameric ring in open conformation bound to y-shaped DNA 
resembles the recent crystal structure of a near full-length E.cuniculi MCM2-7 
hexamer bound to ssDNA. The mechanism proposed by this study is that the open 
ring adopts a skewed conformation in order to accommodate the entrance of 
ssDNA through a spiral staircase (Meagher et al., 2019). Similarly, we suggest 
that an open hexameric PabMCM ring can wrap single stranded DNA at the 
melted origin of replication and proceed towards the dsDNA to unwinding it, 





Figure 4.24: Model of the mechanism of action of PabMCM in ssDNA wrapping at a 




Additionally, our double octameric ring bound to y-shaped DNA resembles the 
recent cryo-EM maps obtained for yeast MCM2-7 double hexamer bound to 
dsDNA. The mechanism proposed by these studies suggests a lagging strand 
DNA extrusion model, where the DNA strands separation is caused by torsion of 
the N-tier rings, which results in extrusion of the lagging strand from the centre of 
the double ring and, consequently, in the activation of the helicase. 
Similarly, we suggest that a double octameric ring PabMCM complex can wrap 
double stranded DNA at the origin of replication and the tilted torsion of the two 
rings causes the DNA strands to separate, with one of them remaining in the 
central channel and the other one be extruded from the centre of the double ring. 
Upon activation, the two single octameric rings can proceed in 3’®5’ direction 








Figure 4.25: Model of the mechanism of action of PabMCM in DNA replication, from 







Conclusions and future perspectives 
 
In this thesis, I showed how an integrated structural biology approach can be used 
to study two extremely different nucleic acids binding proteins, the human 
Staufen1 protein and the archaeal PabMCM complex.  
These two proteins are examples of complicated systems, which cannot be fully 
characterized only by adopting one technique. In fact, the structural 
characterization of non-ideally behaving systems requires a multi-angle approach 
that provides information at different levels of detail. Adopting an integrative 
structural biology approach, by combining several biochemical, bioinformatical 
and biophysical techniques, allows to obtain an all-round model of the system of 
interest. 
In particular, the combination of hydrodynamic methods, homology modelling, 
small angle X-ray scattering and NMR allowed us to demonstrate that Staufen1 is 
a highly flexible protein, that recoils in solution from an elongated to a compact 
conformation in which the domains are in closer proximity but not interacting with 
each other. The information gathered using this multi-angle approach allowed us 
to propose a model in which flexible inter-domain loops possess a regulatory role 
in Staufen activity. We suggest that the high degree of flexibility of this protein 
could be functionally linked to the involvement of Staufen in many diverse aspects 
of RNA metabolism and regulation, by allowing a wide range of interactions with 
many RNA targets and protein partners. 
Additionally, the higher degree of polymorphism observed in PabMCM, compared 
to other archaeal and eukaryotic MCM proteins, adds an extra layer of complexity 
in the structural characterization of this complex. In this case, the use of small 
angle scattering could only provide a way to assess dynamic changes in overall 
dimensions of the assemblies and cryo-EM represents the best resource available 
to date to structurally address the polymorphism of archaeal MCM proteins and 
gain insights on its functional relevance in DNA replication.  
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The recent advances in electron microscopy led to a “resolution revolution” 
resulting with the establishment of this technique as a tool to obtain near-atomic 
resolution structures, previously achieved only by X-ray crystallography or NMR 
spectroscopy. Moreover, the development of the phase plate allowed to determine 
the architecture of small proteins (<100 kDa), which were not traditional targets of 
cryo-EM studies. In fact, we were able to directly visualise the monomeric 
Staufen1 protein, which is only 55 kDa and just below the limit of size of proteins 
that have been reported to be studied with cryo-EM. Additionally, cryo-EM is the 
tool that allows to study the structure of heterogeneous systems, such as archaeal 
MCM proteins. Advances in the cryo-TEM (tomography) field are making possible 
to visualize single enzymes inside the cells and this could allow us to address the 
question of the functional relevance of polymorphism in archaeal proteins in vivo. 
Finally, continuous and rapid improvements in direct detectors, phase plates and 
computational methods are likely to break many of the barriers that have been 
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ABSTRACT: Poly(2-methyl-2-oxazoline) (PMOXA) is an
alternative promising polymer to poly(ethylene glycol) (PEG)
for design and engineering of macrophage-evading nano-
particles (NPs). Although PMOXA-engineered NPs have
shown comparable pharmacokinetics and in vivo perform-
ance to PEGylated stealth NPs in the murine model, its
interaction with elements of the human innate immune
system has not been studied. From a translational angle, we
studied the interaction of fully characterized PMOXA-coated
vinyltriethoxysilane-derived organically modified silica NPs
(PMOXA-coated NPs) of approximately 100 nm in diameter
with human complement system, blood leukocytes, and mac-
rophages and compared their performance with PEGylated
and uncoated NP counterparts. Through detailed immuno-
logical and proteomic profiling, we show that PMOXA-coated NPs extensively trigger complement activation in
human sera exclusively through the classical pathway. Complement activation is initiated by the sensing molecule C1q,
where C1q binds with high affinity (Kd = 11 ± 1 nM) to NP surfaces independent of immunoglobulin binding.
C1q-mediated complement activation accelerates PMOXA opsonization with the third complement protein (C3) through
the amplification loop of the alternative pathway. This promoted NP recognition by human blood leukocytes and
monocyte-derived macrophages. The macrophage capture of PMOXA-coated NPs correlates with sera donor variability in
complement activation and opsonization but not with other major corona proteins, including clusterin and a wide range of
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The interaction of intravenously injected nanoparticles(NPs) with the host blood proteins has long beensuggested to modulate NP pharmacokinetics and their
extent of clearance from systemic circulation by macrophages of
the reticuloendothelial system (RES).1,2 The rapid clearance of
therapeutic NPs by macrophages of the RES, however, could
limit their delivery to target sites outside the liver and the
spleen.1−4 Steric stabilization of NPs with long-chain hydrophilic
polymers/copolymers has become a successful approach in
minimizing protein binding and modulating NP pharmacoki-
netics and biodistribution. Among many engineered polymers,
poly(ethylene glycol) (PEG) has widely been used for design and
surface engineering of long-circulating NPs and vesicular drug
carriers.5 A classic example is the regulatory-approved Doxil
(a PEGylated liposomal formulation of doxorubicin) and its
generic versions.6
Although PEGylation can successfully reduce adsorption of
blood proteins to NPs, numerous studies have shown that
opsonization of PEGylated NPs by the third protein of the
complement system (C3) and its cleavage products (C3b/iC3b)
may still occur, and this could lead to their efficient capture by
human macrophages.7,8 It is also crucial to consider that some
individuals may have antibodies that could recognize the PEG
moiety of PEGylated nanopharmaceuticals. This may initiate
macrophage recognition of PEGylated NPs through comple-
ment opsonization.9−13 Furthermore, PEG can undergo
oxidative degradation, and this may increase its complement acti-
vation property.14 A number of animal and clinical studies have
also indicated that PEGylated NPs may induce cardiopulmonary
disturbances and distress. Earlier studies postulated that
complement activation and subsequent release of C3a and C5a
anaphylotoxins induced by PEGylated NPsmay play a causal role
in initiating such reactions.7,8,15,16 However, a recent study has
demonstrated a transitional link between robust NP clearance
from the blood by strategically placed macrophages in vascu-
lature and adverse hemodynamic reactions independent of
complement activation.17 This further indicates that PEGylated
NPs may not necessarily behave as stealth entities depending on
microenvironmental conditions.
In line with the above-mentioned issues, alternative strategies
are being considered for design and engineering of long-
circulating and macrophage-evading NPs.18 Among many
approaches in NP surface engineering is surface functionalization
with polyoxazoline polymers and their derivatives, which has
generated promising outcomes.19−27 For instance, polyoxazo-
line-coated NPs show considerable resistance to protein binding
and are more amenable to further chemical modifications
compared with PEGylated NPs.28−30 Furthermore, polyoxazo-
line-coated NPs exhibit prolonged circulation profiles on
intravenous injection in the murine model with comparable
pharmacokinetic profiles to PEGylated NPs.27,31,32 Murine
models and murine- and bovine-derived materials are widely
used in nanomedicine evaluations. However, there are
considerable species differences (e.g., mouse versus human) in
innate immune responses to particulate invaders, including
complement activation, C3 opsonization processes, and
phagocytic clearance. For instance, although the uptake of
superparamagnetic iron oxide nanoworms by both murine and
human leukocytes is C3-dependent, there are major differences
in pathways of complement activation and the extent of C3
fixation between these species.33 Accordingly, species differences
in innate immune system function and performance can modu-
late NP pharmacokinetics and responses differently. Therefore,
prior to translational and clinical studies, it is necessary to con-
firm stealth characteristics of engineered nanopharmaceuticals, at
least with respect to the human complement system, blood
leukocytes, and macrophage responses. Here, we have tested
stealth characteristics of poly(2-methyl-2-oxazoline)-coated
vinyltriethoxysilane-derived organically modified silica NPs
(PMOXA-coated NPs) in human sera from different individuals
against complement activation, complement opsonization, and
dysopsonization processes and capturing efficacy by human
blood leukocytes and monocyte-derived macrophages. Our
approach has considered interindividual responses and highlights
important insights into the mechanisms of compatibility of
nanomaterials with elements of the human innate immunity and
disparity with the murine system.
RESULTS AND DISCUSSION
Synthesis and Physicochemical Properties of NPs.
Polymeric NPs were prepared by ammonia-catalyzed micro-
emulsion polymerization of vinyltrietoxysilane (VTES) (Figure 1A
and Figures S1−S3).34 Fluorescent labeling and surface function-
alization with PEG (Mw = 2000Da, degree of polymerization = 44)
and PMOXA (Mw = 4000 Da, degree of polymerization = 40)
were achieved by copolymerizing VTES with Rhodamine B
triethoxysilane and, when needed, with the trimethoxysilane
derivatives of the polymers. 1H NMR confirmed reaction
completion and the absence of byproducts. Broadening of the
1H NMR polymer signals (with respect to their corresponding
linewidth in solution), as well as diffusion filter experiments,
confirmed NP grafting with designated polymers (Figure S4). All
NP types exhibited spheroidal morphology (determined by
transmission electron microscopy, Figure S4) with calculated
diameter (mean ± SD) of 115 ± 23, 90 ± 10, and 70 ± 6
(n = 400) for uncoated, PEGylated, and PMOXA-coated species,
respectively. NP hydrodynamic size distribution and concen-
tration were also measured by nanoparticle tracking analysis
(NTA). This modality overcomes intrinsic problems observed
when DLS is applied to heterogeneous samples because it is
based on video tracking of the Brownian motion of single NPs.35
The NTA results revealed mean hydrodynamic diameters (mean
± SD) of 144± 5 (mode 124± 8), 117± 4 (mode 103± 2), and
86 ± 4 (mode 83 ± 2) for uncoated, PEGylated, and PMOXA-
coated species (n = 3 measurements in all cases), respectively.
Size distributions were almost symmetrical, with a ±D50% of
20−25 nm for all NPs. Dynamic laser light scattering yielded
results comparable to those with NTA for all NP preparations
with polydispersity indices <0.04, thus confirming near
monodisperse NP suspensions. The small differences found in
nanoparticle sizes are likely the result of the different additives
(i.e., the alkoxysilane derivatives of the coating polymers) present
apolipoproteins. In contrast to these observations, PMOXA-coated NPs poorly activated the murine complement system and
were marginally recognized by mouse macrophages. These studies provide important insights into compatibility of
engineered NPs with elements of the human innate immune system for translational steps.
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in the reaction mixtures. Thermogravimetric analysis indicated
approximately 13 000 PEG molecules and 16 000 PMOXA
molecules per designated NP. These values correspond to
surface footprints of 2.8 and 2.2 nm2 for PEG and PMOXA,
respectively, and to a distance between grafting points of 1.9 and
1.7 nm, respectively, which indicate that both the NP types
feature a dense brush shell and that differences in their interfacial
properties are solely due to their diverse shell composition
(Table S4). Calculated ζ-potential values of all engineered
polymer-coated NPs (−4 mV) were comparable with those of
uncoated NPs (−6 mV). All NP types exhibited comparable
UV−visible spectra (Figure S4), and Rhodamine B loadings were
in the 0.1−0.3% w/w range.
Complement Activation Studies. NP-mediated comple-
ment activation in human serum (HS) was followed through
measurement of a number of established complement activation
products bound to NP surfaces as well as in the aqueous phase
(see scheme in Figure 1B). Based on Western blot analysis,
PMOXA-coated NPs were more effective in liberating C3a (the
anaphylatoxin released on C3 cleavage) than both PEGylated
and uncoated NPs (Figure 1C). The potency of PMOXA-coated
NPs in activating the human complement system was further
confirmed by showing the abundant presence of C3c α′ chain
fragment 2, which is generated after conversion of C3b into the
inactive C3b (iC3b), confirming C3 convertase activity as well as
Bb generation (confirming the involvement of the alternative
pathway of the complement system) compared with other NP
species (Figure 1C). In addition to these, ELISA studies showed
that PMOXA-coated NPs are far more efficient in liberating two
markers of the terminal pathway of the human complement
Figure 1. Complement activation by engineered NPs in human serum. (A) Schematic representation of NP structure. (B) Simplified scheme of
complement activation pathways (CP, classical pathway; LP, lectin pathway; AP, alternative pathway). The scheme depicts C3 conversion into
C3b through assembly of pathway-dependent C3 convertases and generation of measurable complement activation products such as C3a, Bb,
C5a, and sC5b-9. (C) Western blot analysis of complement activation products by NPs. The panel shows detection of C3a (Mw ∼ 9 kDa) in the
fluid phase and surface-bound C3 α (Mw ∼ 110 kDa), C3 β (Mw ∼ 70 kDa) chains, C3c α′ chain fragment 2 (a fragment of C 3d,Mw ∼ 39 kDa),
factor B (Mw ∼ 85 kDa), and Bb (Mw ∼ 55 kDa) from washed NPs. StC3 represents purified human C3. (D) Determination of NP-mediated
complement activation as a function of NP surface area by ELISA. Complement activation was monitored through measurements of fluid phase
C5a and sC5b-9. Data are mean ± SE (n = 3). Statistical analyses were performed with student’s t test to calculate significance (*p < 0.05,
**p < 0.01) compared with corresponding controls. Zymosan (200 μg/mL) was used as the positive control for monitoring complement
activation, resulting in formation of 249 ng/mL serum of C5a and 35707 ng/mL serum of sC5b-9. The maximal effect of PMOXA NPs
correspond to 67% (C5a) and 35% (sC5b-9) of the Zymosan activity.
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system (the anaphylatoxin C5a and sC5b-9, which is the soluble
form of the membrane attack complex) than PEGylated and
uncoated NPs on the basis of equivalent surface area (Figure 1D).
Complement Activation Pathways Triggered by
PMOXA-Coated NPs. PMOXA-coated NP-mediated Bb
liberation confirms a role for the alternative pathway; however,
it is not clear whether complement activation is solely arising
from this pathway or if there is a role for both classical and lectin
pathways and/or the amplification loop of the alternative pathway.
It is well-known that the activation of the classical and lectin
pathways of the complement system is Ca2+-dependent, whereas
Mg2+ is essential for the operation of the alternative pathway.36,37
We found that selective chelation of serumCa2+ (ethylene glycol-
bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA)/
Mg2+ treatment) strongly reduces PMOXA-coated NP-mediated
C3a release, whereas chelation of both Ca2+ and Mg2+
(ethylenediaminetetraacetic acid (EDTA) treatment) abolishes
anaphylatoxin release (Figure 2A). Consistent with these
observations, PMOXA-coated NP-induced generation of both
C5a and sC5b-9 is dramatically reduced on Ca2+ chelation.
On the other hand, prevention of the alternative pathway con-
vertase stabilization by a neutralizing antiproperdin antibody
abolished Bb generation and dramatically reduced C5a release and
sC5b-9 formation on PMOXA-coated NP treatment. Further-
more, dot immunoblot studies (Figure 2B) showed that the
binding of both C3 and properdin to PMOXA-coated NPs is
affected by EGTA/Mg2+ and essentially eliminated by EDTA.
Collectively, these observations indicate that complement acti-
vation by PMOXA-coated NPs is predominantly initiated through
Ca2+-sensitive pathways. Subsequently, this increases the turnover
of the amplification loop of the alternative pathway to maximize
C3 opsonization through assembly of the alternative pathway C3
convertase. In contrast to PMOXA-coated NPs, complement
activation by uncoated and PEGylated NPs is marginal.
Proteomic Analysis of Complement Protein Deposi-
tion on NPs. Next, we performed shot-gun proteomics after
treatment of NPs with normal and chelated HS to gain more
insights into complement activation processes (Figure 3A,
Figures S5 and S6, and SI files 1−3). Among many deposited
species, we detected several effector and regulatory components
of the complement system (predominantly C1q, C1r, C1s, C3,
C4, C5, C6, C7, C8, C9, B, P, C4Bp, CFAH, and related
isoforms) on PMOXA-coated NPs. The surface presence of
complement proteins was more prominent on PMOXA-coated
NPs than PEGylated and uncoated NPs and in line
with functional complement activation studies (Figure S6).
Figure 2. Effect of divalent cation chelation and antiproperdin antibodies on complement activation by engineered NPs in HS. (A) Western blot
representation (repeated three times) of C3a generation by PMOXA-coated NPs in normal HS and after serum treatment with chelating agents
(top left panel). Control lanes include untreated HS (negative control) and HS incubated with Zymosan (100 μg/mL; positive control). Other
panels show NP (119 cm2/mL)-mediated C5a, Bb, and sC5b-9 release (determined by ELISA) before and after serum treatment with either
chelating agents or antiproperdin antibodies. Data are the mean ± SE (n = 3). (B) Densitometric quantification (arbitrary units) of dot blot
analysis of C3 and properdin binding to engineered NPs on incubation with untreated, chelated, and antiproperdin antibody-treated HS. Values
are mean ± SE (n = 3); *statistical significance (p < 0.05) compared with respective controls.
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However, there was a discrepancy between shot-gun and func-
tional studies. Whereas functional studies confirmed a role for
calcium-sensitive pathways, the second complement protein (C2)
was not detectable by shot-gun profiling. Nevertheless, the general
trend of shot-gun proteomics is in agreement with functional
studies involving chelators as binding of the majority of comple-
ment proteins is dramatically reduced (>90%) on calcium chela-
tion and further inhibited on EDTA treatment of serum
(Figure 3A and Figures S5 and S6). In contrast to complement
proteins, other predominantly deposited species such as
clusterin, lipoproteins (LPs), serum albumin, and immunoglo-
bulins (Igs), are marginally affected on divalent cation chelation,
regardless of NP type (Figure 3A and Figures S5 and S6).
MS spectrometry analysis, after in-gel digestions of major
electrophoretic bands obtained by separation of the NP-bound
HS polypeptides by SDS-PAGE, further agreed with shot-gun
analysis (Figure 3B, Figure S7, and SI files 4−7). Notably, the
bands corresponding to C3 β chain (Mw ∼ 65 kDa) and C3c α′
chain fragment 2 (Mw ∼ 39 kDa) were only detected under
reducing conditions, which confirms C3 cleavage and covalent
association of C3b with NP surfaces. Densitometry analysis of
samples incubated in the presence of chelating agents, once
again, showed that only the binding of complement proteins to
PMOXA-coated NPs is strongly reduced on Ca2+ chelation and
further inhibited on EDTA treatment (Figure 3B).
Role of Human Serum and Complement Fixation on
PMOXA-Coated NP Uptake by Human Phagocytes.
Circulating blood phagocytes (monocytes and PMNGs
(polymorphonuclear granulocytes)) and human macrophages
showed preferential tendency to capture PMOXA-coated NPs
and PEGylated NPs, compared with uncoated NPs, pretreated
with HS (75% v/v) for 15 min at 37 °C in the absence of cells and
then incubated with cells after a 10-fold dilution in protein-free
culture medium (Figure 4A,B). Confocal fluorescent microscopy
confirmed internalization of all preopsonized NPs and their
localization to the acidic endosomal−lysosomal compartments
(Figure 4C). Cell viability was further confirmed on NP uptake
studies (Figure S8). Preopsonized NP uptake by both blood
phagocytes and human macrophages, however, was dramati-
cally reduced with Ca2+ chelation of serum (Figure 4B).
Figure 3. Proteomics analysis of complement proteins on engineered NPs. (A) Shot-gun and label-free quantification of complement proteins
from protein corona of PMOXA-coated NPs after incubation in untreated and chelated HS. The iBAQ values (left axis) of identified polypeptides
were plotted in order of abundance in control samples. Right axis indicates approximate stoichiometry per NP for each polypeptide. Complement
proteins are indicated by blue arrows. Clusterin is shown in red. (B)Mass spectrometry after SDS-PAGE, in-gel digestion, and densitometry. The
representative panel shows the identification of major complement proteins and their fragments (in blue) in the corona of PMOXA-coated NPs
(exemplified in the pictogram on the left). NP-bound proteins are highlighted by densitometry after nonreducing (−βme) and reducing (+βme)
electrophoresis and silver staining. Peaks corresponding to complement proteins (and their fragments) are indicated by blue arrows. The
clusterin band is indicated in red.
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This observation may suggest a likely role for complement acti-
vation and surface C3 fixation inNP recognition by human phago-
cytic cells. In contrast to human phagocytes, PMOXA-coated NPs
were not only poor activators of the mouse complement system
but also poorly recognized by mouse monocyte-derived
macrophages compared with uncoated NPs (Figure 4D).
Next, we investigated whether complement activation and
surface C3 fixation play a critical role in NP recognition by
human phagocytes. Proteomic studies did not show significant
surface association of collectins and associated proteases
(e.g., mannose binding lectin (MBL), ficolins, collectin 11, and
MBL-associated serine proteases, MASPs)38,39 with NPs. First,
this observation excludes the potential involvement of these
molecules and hence the lectin pathway in complement
activation and C3 fixation. However, on the basis of the observed
C2 discrepancy between shot-gun proteomics and functional
complement activation studies, we sought to further investigate
whether the lectin pathway of the complement plays a role in NP
recognition by macrophages. There was no effect of mannose
and N-acetyl glucosamine (which compete with the binding
of MBL and ficolins to their substrates)8,39 on NP uptake
(Figure S9). Furthermore, aprotinin (a MASP inhibitor)40 did
not affect the capture of PMOXA-coated NPs by macrophages
(Figure S10). Following these studies, we measured macrophage
uptake of NPs after incubation with HS depleted of various
complement proteins (Figure 5). The results showed that the
recognition of polymer-coated NPs by macrophages is blocked
by >95% on C3 depletion, thereby suggesting a role for C3b/
iC3b as the major opsonic molecule and of cellular complement
receptors 3 and 4 (Figure 5A). In addition, depletion from HS of
either C1q or C4 (which are required for assembly of the classical
pathway C3 convertase) or factor B (which is required for
Figure 4. Capture of PMOXA-coated NPs by human phagocytes. (A) Uncoated and polymer-coated NPs were treated with HS and incubated at
designated concentrations with primary human bloodmonocytes and PMNGs. After being incubated for 3 h at 37 °C, cells were washed with PBS
and their mean fluorescence intensity (MFI) was measured by FACS as a read out of NP−cell association (instrumental setting was constant to
ensure cell−cell quantitative comparison). Data are mean ± SE (n = 3; samples in triplicate in each experiments). (B) NP uptake by human
macrophages and blood leukocytes following NP treatment in untreated or chelated HS. NP concentration was 80 μg/mL (n = 4; samples in
duplicate in each experiments); *statistical significance (p < 0.05) compared with respective controls (HS). (C) Fluorescent microscopy images
of NP internalization by human monocyte-derived macrophages. NP concentration was 80 μg/mL. Green and red correspond to NPs and
Lysotracker-labeled acidic endolysosomes, respectively. Insets are magnified views of selected fields. (D) Species difference in PMOXA-coated
NP-mediated complement activation and macrophage uptake. PMOXA-coated NPs were incubated for 30 min at 37 °C with either 75% (v/v)
human serum or mouse serum. Fluid-phase C3a was measured by Western blot (top panels), indicating NP-mediated complement activation.
Negative controls (sera with no NPs) and positive controls (Zymosan-treated sera) were also run and analyzed as indicated. After sera
incubation, NPs were diluted 10-fold in RPMI medium and further incubated for 3 h at 37 °C with human or mouse primary macrophages
(as indicated). Uncoated NPs were also used in this assay for comparison. NP capture was estimated by FACS and expressed asMFI. Data are the
mean ± SE (n = 3, samples run in triplicate); *p < 0.05.
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increasing the turnover of the alternative pathway, and the
amplification loop) strongly inhibited (77−86%) capture of
PMOXA-coated NPs by macrophages (Figure 5A). Addition of
depleted factors to respective sera restored macrophage
capabilities in capturing polymer-coated NPs and comparable
to levels seen in intact serum (Figure 5A). These observations
confirm the role of complement activation and C3 surface
fixation in NP capture by macrophages. Indeed, the results in
Figure 5B confirm the notion that restoration of C1q in C1q-
depleted serum triggers complement activation through the
classical pathway and subsequent C3 cleavage.
Antibodies of both IgG and IgM classes are known to trigger
activation of the classical pathway by facilitating C1q docking.
Accordingly, complement activation by PMOXA-coated NPs
may have been initiated through binding of either nonspecific or
putative “PMOXA-specific” antibodies in human serum.
Selective depletion of either IgM or IgG from HS did not
significantly affect macrophage capture of PMOXA-coated NPs
(Figures 5C and S11). Therefore, C1q-mediated complement
activation by PMOXA-coated NPs is apparently antibody-
independent. Subsequently, we showed that purified human
C1q binds directly to PMOXA-coated NPs but not to uncoated
NPs (Figure S12) with nanomolar affinity (Kd = 11 ± 1 nM;
maximal binding = 12 ± 1 C1q molecules/NP). This is
rather comparable with the affinity of C1q for some of its
natural ligands such as DNA (Kd = 22 nM), histones, annexins,
and IgG (Kd range = 1−2 nM)
41 and phosphatidylserine
(Kd = 37−70 nM).
42 For a comparative purpose, we also showed
low affinity of pooled human IgG and lipoproteins (e.g., HDL)
for PMOXA-coated NPs (Table 1 and Figure S13).
The globular head of C1q is predominantly basic, which makes
C1q function as a charge pattern recognition molecule.43 Indeed,
direct binding of the highly cationic C1qA chain to anionic
Figure 5. Mechanism of complement-mediated PMOXA-coated NP macrophage capture. (A) Macrophage uptake (3 h, 37 °C) of uncoated and
polymer-coated NPs treated with control HS (full HS) or sera depleted of selected complement proteins (C1q, C3, C4, and factor B). Uptake was
further monitored on restoration of the depleted factor; *statistical significance (p < 0.05) compared with corresponding uncoated NPs;
§statistical significance (p < 0.05) compared with corresponding incubations in complement factor-depleted and complement factor-restored
sera. (B) PMOXA-coated NPs were treated as in (A) with control HS (full HS), C1q-depleted HS, and C1q-depleted HS plus purified C1q
(100 μg/mL) for 30 min at 37 °C in the absence or the presence of EGTA/Mg2+ or EDTA, as indicated. C3a was then measured in the incubation
media by Western blot (a representative blot is shown in the top panel, whereas densitometric evaluation is depicted in the bottom panel);
*statistical significance (p < 0.05) compared with HS in each condition; §statistical significance (p < 0.05) compared with C1q-depleted HS
serum as well as with C1q restoration. (C) Efficacy of PMOXA-coated NP uptake by macrophages after incubation with normal HS (full HS) and
with the same HS after IgM or IgG depletion. Purified autologous IgM and IgG were added to the respective depleted sera for comparison.
Macrophage uptake was measured as mean fluorescent intensity (mean± SE, n = 3, incubations in duplicate). Differences were not statistically
significant (p > 0.05).
Table 1. Binding Constants (Kd) and Maximal Binding
Stoichiometry (Bmax) of the Indicated Purified Human
Purified Proteins to PMOXA-Coated NPsa
species Kd ± SE (nM) Bmax (number/NP)
C1q 11 ± 1 12 ± 1
IgG 1671 ± 224 48 ± 4
HDL 612 ± 344 226 ± 58
aKd was calculated by nonlinear fitting, based on free protein
determination in the presence of PMOXA-coated NPs at equilibrium
(C1q and HDL) or on NP-recovered protein after washings (IgG).
Values are the mean ± SE (n = 3; samples run in triplicate).
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liposomes (e.g., cardiolipin-containing vesicles) was demonstrated
previously, which led to complement activation.44 In addition to
this, C1q was also suggested to bind cardiolipin-containing lipo-
somes and PEGylated vesicles through hydrophobic interactions
and hydrogen bonding.44 Given the fact that the ζ-potential of
PMOXA-coated NPs is close to neutrality, it is most likely that
direct C1q association with these NPs could arise from hydropho-
bic interactions and/or hydrogen bonding by considering that in
each PMOXA molecule there are about 40 CO and 2 SO
functionalities, and that SO groups are buried close to NP
surfaces, whereas CO groups are distributed along the chains.
It is also plausible that in serum/plasma, C1q may also function
as a charge pattern recognition molecule by binding to exposed
anionic domains of protein corona on PMOXA-coated NPs.
Effect of Sera Variability on Complement Activation,
Protein Corona, andNPUptake byMacrophages.Next, we
compared the effect of sera from 8 individual donors on NP
uptake by human phagocytes to account for interindividual
variations in complement opsonic activities. The results in
Figure 6A show that all 8 sera promoted efficient uptake of
PMOXA-coated NPs by macrophages compared with uncoated
NPs. In the case of PEGylated NPs, macrophage uptake was
more variable and translated either to smaller, equal, or higher
values than that of uncoated NPs, depending on serum donor.
C3 β chain densitometry analysis of NPs incubated with different
sera (Figure 3B and Figures S7 and S14) also mirrored
macrophage captures efficacies (Figure 6B). Comparative shot-
gun proteomics further confirmed the above-mentioned
observations, which correlated with C3 and properdin deposition
on NPs, when tested in three representative sera displaying
different macrophage capturing efficiency [(i) a serum that
showed low macrophage capture of PEGylated NPs but high
Figure 6. Interindividual variability of HS onNP capture bymacrophages and complement protein association. (A) Capture intensity of uncoated
and polymer-coated NPs (80 μg/mL) by human macrophages was measured by FACS after 3 h incubation at 37 °C. NPs were previously
incubated with HS obtained from eight different donors (A−H) or with an independent commercially available pooled HS (CompTech, HS).
The results aremean± SE (n = 5; duplicate incubations); *statistical significance compared with uncoatedNPs in the sameHS sample (p < 0.05).
The inset represents the data from different donors as a whisker plot (bold symbol = mean; box =±SE; whiskers = max and min values) to show
the general trend and the statistical variability (*p < 0.05). HS was ranked in three groups based on their efficacy to mediate PEGylated NP
capture compared with uncoated NPs: PEGlow (PEGylated NPs capture statistically lower compared with uncoated NPs); PEGintermediate
(PEGylated NPs capture statistically not different from uncoated NPs); PEGhigh (PEGylated NPs capture statistically higher than that of
uncoated NPs). The red-boxed HS donors represent these three categories and were used for shot-gun proteomics. (B) Comparison of
macrophage capturing efficacy of NPs after preincubation with HS from four donors (A, B, F, and G), measured by FACS after 3 h of incubation
and represented as MFI (mean ± SE; n = 4, samples in duplicate). The quantity of βme-released corona C3 β subunit (arbitrary units) was
determined by densitometry following SDS-PAGE. (C) Stoichiometry of C3 and properdin based on iBAQ analysis following NP incubation with
HS from the indicated donors and shot-gun proteomics. (D) Macrophage capture efficacies of polymer-coated NPs preincubated in sera of three
donors (A, D, and F) were normalized to that of uncoated NPs one (macrophage capture ratio) and plotted against the amounts of C3 and
properdin [estimated from the intensity parameter after shot-gun analysis, as well normalized to uncoated NPs values (protein ratio)]. Pearson
correlation index (R) and the slope ± SE of the linear regression interpolation for both proteins are indicated (*p < 0.05; **p < 0.01).
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levels of PMOXA-coated NPs (donor A; PEGlow/PMOXAhigh),
(ii) a serum promoting moderate/intermediate capture of
PEGylated NPs, yet high levels of PMOXA-coated NPs
(donor D; PEG intermediate/PMOXA high), and (iii) a serum
promoting high capture of both coatedNP types bymacrophages
(donor F; PEGhigh/PMOXA high)] (Figure 6C).
Furthermore, based on the label-free quantification parameter
iBAQ, we observed no major quantitative differences in the
protein corona for all NP types in the three sera (Figure S15,
SI files 1−3 and 8−12). Subsequently, we compared the
polypeptide composition of the corona (Figure S16, SI files 1−3
and 8−12). Clusterin and lipoproteins constituted major corona
proteins from all sera. Although clusterin showed no clear
preference for any specific NP type, Apo-AIV and Apo-E were
consistently enriched on PEGylated NPs, whereas Apo-CI, CII,
CIII, and Apo-AII were preferentially associated with PMOXA-
coated NPs. Uncoated NPs effectively bound all indicated
apolipoproteins but with no clear selectivity. Finally, we
statistically correlated the macrophage capture efficacy of
polymer-coated NPs and the amount of those major protein
classes consistently found in their corona through normalization
(Figure 6D). As expected, the analysis showed a significant
positive correlation between macrophage capture efficacy and
the quantity of deposited C3 (Pearson’s R = 0.9, p < 0.05) and
properdin (Pearson’s R = 0.93, p < 0.01). On the contrary,
macrophage capturing efficacies of polymer-coated NPs did not
significantly correlate with surface IgG (Pearson’s R =−0.17, p =
0.75) and IgM binding (Pearson’s R = 0.57, p = 0.24). These
observations corroborate with immunoglobulin depletion
studies of HS and complement activation profiling. We also
found no significant correlation between NP surface enrichment
of clusterin, a protein reported to exhibit dysopsonic activity,45
and NP recognition by macrophages (Pearson’s R = −0.62, p =
0.18). Clusterin is a regulator of complement activity and is
incorporated stoichiometrically into terminal complement
complex,46−48 thereby inhibiting its lytic activity and proin-
flammatory effects.49 In accordance with complement activation
properties of the tested NPs, and clusterin-mediated regulation
of the complement by accelerating sC5b-9 formation, clusterin
deposition on NP surfaces seems physiologically relevant. It is
therefore possible that a fraction of surface-bound clusterin is in
complex form with terminal complement C7, C8 α, and C9b
proteins.49 Furthermore, it is also known that clusterin circulates
in plasma as a HDL complex with ApoA-I.50 Because clusterin
deposition on NPs still occurs when the complement is inhibited
(Figure 3 and Figures S5−S7), this may indirectly support the
notion of direct HDL binding to NPs and/or clusterin-ApoA-I
transfer from HDL to NP surfaces. Nevertheless, our data show
that human macrophages can efficiently capture NPs on efficient
C3 opsonization, despite NP surface enrichment with clusterin.
CONCLUSIONS
We demonstrated that NP coating with PMOXA, which confers
“stealthing” properties in the murine environment, effectively
activates the human complement system through C1q binding
independent of initial antibody deposition. C1q-mediated
complement activation, in turn, enhanced C3 opsonization
through the amplification loop of the alternative pathway. The
extent of both C3 and properdin deposition on PMOXA-coated
NPs correlated with human macrophage capture efficacy.
We further showed that efficient C3 opsonization supersedes
the proposed dysopsonic effect of clusterin and other corona
proteins onNP surfaces. At large, our data show good correlation
between proteomics and functional immune studies (with the
exception of C2 protein) and further draw attention to the
importance of testing nanomaterial immune compatibility with
human materials, rather than relying on non-human sources
(animal sera, cells, and in vivo studies in the murine model). Such
disparities in immune handling of nanomaterials have also been
observed among rodents. For example, in mice, intravenously
injected ganglioside GM1-incorporated liposomes avoid rapid
interception by macrophages of the RES,51 whereas in rats, such
vesicles are not long-circulating.52 Rats, but not mice, produce
natural anti-GM1 antibodies which, by triggering the classical
complement pathway, likely mediate the clearance of GM1-
containing liposomes by liver macrophages. Another example is
the porcine model, which has been suggested for evaluating the
safety (infusion reactions) of nanopharmaceuticals under
development.16 However, a large body of evidence suggests
that the porcine reactions are related to robust NP clearance by
pulmonary intravascular macrophages (PIMs) and rapid release
of arachidonate metabolites from these cells.17,53 Normal human
lungs, however, do not have PIMs. Accordingly, testing of
nanomedicine safety in porcine (and other animals with resident
PIMs) will most likely induce cardiopulmonary distress, and
therefore, global nanomedicine safety assessment in such species
is perhaps inappropriate.
Finally, given the versatility of oxazoline-based polymers to
further chemical modifications, future attempts may be directed
to synthesize derivatives with no affinity for C1q binding and
push the path toward engineering of oxazoline-coated NPs that
evade recognition by elements of the human innate immune
system.
METHODS
Nanoparticle Preparation and Characterization. Details of all
NP preparation and characterizations steps are provided in the
supplementary files (S1−S4). For NTA, NPs were diluted in purified
water (182 MΩ· cm) and tracks analyzed with Nanosight 2.3 software
after acquisition with a LM20NanoSight mounted with a blue (405 nm)
laser (Malvern Instruments, UK). A minimum of five different videos of
individual NPs were pooled to define size distribution in three
independent experiments per NP type.
Cells. Blood was drawn from healthy volunteers and provided by the
Blood Transfusion Centre of the Padova Hospital (Padova, Italy)
complying with local regulations. Blood leukocytes were purified from
buffy coats. Buffy coats were centrifuged (800g, 10 min, RT) and then
treated twice with 155 mM NH4Cl, 10 mM KHCO3, and 100 mM
Na2EDTA at pH 7.4 for 5 min at room temperature to lyse erythrocytes.
Leukocytes were then washed twice with PBS and used immediately.
Forward versus side scatter gating in FACS allowed separation and
analysis of the three different cell populations (lymphocytes, monocytes,
and PMNGs). Human macrophages were derived from blood
monocytes incubated for 7 days with 100 ng/mL of macrophage
colony-stimulating factor (M-CSF, Peprotech, UK) in RPMI 1640
(Invitrogen, CA, USA) supplemented with 20% (v/v) fetal calf serum
(Euroclone, Italy, endotoxin <0.3 EU/mL), 100 U/mL penicillin, and
100 μg/mL streptomycin).54 Human PMNGs were purified from
healthy donors as previously described using dextran sedimentation,
centrifugation through Ficoll-Paque, followed by hypotonic lysis of
contaminating erythrocytes and washing with PBS.55 To obtain mouse
bone marrow macrophages, femurs and tibiae of Balb/c animals,
previously subjected to cervical dislocation, were flushed with Iscove’s
modified Dulbecco’s medium (IMDM, Thermo Fisher Scientific, MA,
USA). After lysis of red blood cells with ammonium−chloride−
potassium lysis buffer (5 min at room temperature), leukocytes were
recovered from the obtained cell suspension, and mononuclear
phagocytic precursor cells were propagated in suspension in IMDM
containing 10% v/v FBS (Thermo Fisher Scientific), 100 U/mL
ACS Nano Article
DOI: 10.1021/acsnano.8b01806
ACS Nano 2018, 12, 5834−5847
5842
penicillin, 100 μg/mL streptomycin (Thermo Fisher Scientific), and
10 ng/mLM-CSF (Miltenyi, Germany).56 After being cultured at 37 °C
in a humidified incubator with 5% CO2 for 3 days, one-half of the
medium was replaced with a fresh one, and cells were further incubated
for 4 days to obtain their differentiation into macrophages.
Human and Mouse Sera. Venous blood from healthy human
donors was collected into BD Vacutainer clot activator tube (Becton
Dickinson, NJ, USA). Experiments with human sera were per-
formed under local guidelines. After clotting at room temperature,
blood samples were centrifuged at 1250g for 5 min to obtain sera.
Collected sera were aliquoted and stored at −80 °C. Before use, serum
was thawed at 37 °C.57 Independent commercially pooledHSpreparations
from at least six donors were provided by CompTech (TX, USA) and used
when indicated. C1q-, C3-, C4-, and factor-B-depleted sera and purified
C1q, C3, C4, and factor B were purchased from CompTech. For IgM
depletion, HS was incubated with anti-human IgM agarose beads
(Sigma, MO, USA).58 Prechilled agarose beads (0.2 mL packed)
equilibrated in cold PBS were mixed with 0.2 mL of HS and 0.5 mM
EDTA, and the suspension was mixed at 4 °C for 60 min. Agarose beads
were pelleted by centrifugation, and the incubation step was repeated
with fresh resin. IgM-depleted serum was then recovered and
immediately frozen in liquid nitrogen. On the day of the experiment
with macrophages, physiological Ca2+ and Mg2+ levels were restored
during incubation with cells. To recover bound IgM, beads were treated
with 500 μL of 100 mM glycine, pH 2.8 (Sigma), for 5 min and
centrifuged. To the recovered supernatant was added 50 μL of 1MTris-
HCl (Sigma) to restore physiological pH; this procedure was repeated
three times and then dialyzed overnight at 4 °C against PBS. Finally, IgM
was concentrated in Microcon tubes (Millipore, MA, USA), and protein
concentration was measured by Bradford assay (Biorad, CA, USA).
For the depletion of IgG antibodies, HS was incubated with protein A
sepharose (Amersham, UK). To 200 μL of HS (supplemented with
0.5 mMEDTA) was added and mixed 200 μL of packed protein A beads
at 4 °C for 60 min. Sepharose beads were removed by centrifugation,
and the follow-up treatments and IgG recovery procedures were the
same as those for IgM. Depletion of IgM and IgG from sera was
confirmed by immunoblotting. Here, 0.5 μL of designated serum was
mixed with 50 μL of PBS, and then 12 μL of sample containing loading
buffer was loaded onto a 6 or 8% gel. Following SDS-PAGE, proteins
were blotted onto nitrocellulose paper (Biorad) for 1 h. The membrane
was blocked with TBS-T (50 mM Tris-HCl, pH 7.5, 100 mM NaCl,
0.1% w/v Tween 20) containing 3% w/v nonfat milk overnight at 4 °C.
Finally, the membrane was incubated with anti-IgM-HRP antibodies
(Sigma) or anti-IgG-HRP antibodies (Merck, Germany) for 1 h at room
temperature, and proteins were detected by a Huvitec (Eppendorf,
Germany) image analyzer. Pooled mouse serum was prepared from the
blood of 12 adult healthy male and female BALB/c mice. Blood clotting
and retraction was allowed to take place spontaneously at room
temperature following procedures outlined by Lachmann.59 The initial
centrifugation was carried out at 3000g for 5 min at room temperature to
obtain serum. A second high-speed centrifugation was performed to
remove contaminated blood cells at 20 000g for 2min. Fresh serum from
the second centrifugation was not frozen but was used immediately for
biological experiments.
NP Binding to Cells. Intracellular distribution of fluorescent NPs
was assessed by confocal microscopy. Macrophages (2× 106) seeded on
glass slides were washed with PBS (Invitrogen) and incubated for 3 h at
37 °C with NPs, preincubated with 75% (v/v) HS for 15 min at 37 °C,
and then diluted in RPMI. Following incubation, the medium was
removed, and cells were washed with PBS and incubated for 30min with
75 nM LysoTracker Green DND-26 (Invitrogen) for endolysosomal
staining and then directly analyzed by confocal microscopy (Leica SP2,
Germany). Images were processed using ImageJ software. For FACS
analysis, NPs (200−800 μg/mL) were preincubated with 75% v/v for
20 min at 37 °C. For control experiments, NPs were incubated in PBS.
NPs were then diluted with RPMI medium and incubated with cells
(106 cells/well for leukocytes and macrophages) for 3 h at 37 °C. Cells
were than washed with PBS, resuspended in FACS buffer (1% FBS in
PBS), and analyzed by cytofluorimetry (FACSCantoII, Becton
Dickinson). Data were analyzed by FACSDiva software (BD) and
expressed as MFI (mean fluorescence intensity) values, normalized
based on intrinsic quantum yield of different NPs types and batches.
In some experiments, the incubation of NPswithHS was performed in the
presence of 10 mM EGTA/2 mM MgCl2 or 10 mM EDTA to chelate
Ca2+ or both Ca2+ and Mg2+, respectively, before dilution as above in
culture medium for cell uptake measurements. In some experiments,
samples were incubated in the presence of 25 mM D-mannose,
N-acetylglucosamine (inhibitors of lectin complement pathway) or
D-galactose (as control), and 5 μMaprotinin (Sigma) and further diluted
in cell culture medium in the presence of the same inhibitors.
NP Protein Corona Determination by Shot-Gun Proteomics.
Uncoated, PEGylated, or PMOXA-coated NPs (800 μg/mL) were
incubated under stirring at 37 °C for 15 min in RPMI 1640
supplemented with 100 μL of 75% (v/v) HS. NPs were washed three
times with 1 mL of ice-cold PBS (pH 7.4) and then recovered by
centrifugation (30 min, 21 000g at 4 °C). NP−protein pellets were
resuspended in 8 M urea/50 mM NH4HCO3 (Sigma). Disulfide bonds
were reduced with 5 mM TCEP (Sigma) for 30 min and alkylated with
40 mM iodacetamide (Fluka, Mexico) at room temperature in the dark.
The content of urea was brought to 6 M with 50 mM NH4HCO3, and
1−100% (w/w) of LysC (Promega) was added to each sample for 6 h at
37 °C. Samples were diluted five times with 50mMNH4HCO3 to obtain
a urea concentration of 1.2 M during trypsin digestion. A 1−50% (w/w)
of sequencing-grade-modified trypsin (Promega) was added to the
protein sample, and digestion was carried out at 37 °C overnight.
Samples were then centrifuged at 18 000g for 30 min at 4 °C to remove
NPs and desalted using C18 cartridges (Sep Pak, Waters, France)
according to manufacturer’s instructions. All samples were treated
simultaneously and exactly in the same way to allow a quantitative
comparison of the MS data. Samples were then dried under vacuum and
suspended in 24 μL of 3% (v/v) acetonitrile/0.1% (v/v) formic acid.
Next, 2 μL of each sample was analyzed by LC-MS/MS on a LTQ-
Orbitrap XL mass spectrometer (ThermoFisher Scientific) coupled
online to a nano-HPLC Ultimate 3000 (Dionex−ThermoFisher
Scientific) as described earlier.60 Peptides bound to pico-frit columns
(New Objective, NJ, USA) packed with C18 material (Aeris Peptide
3.6 mmXBC18; Phenomenex, CA, USA, flow rate = 8 μL/min)
were separated with an acetonitrile/0.1% (v/v) formic acid gradient
(from 3 to 40% in 45 min, flow rate = 250 nL/min). Ion source capillary
temperature was 200 °C, and spray voltage was set to 1.2−1.3 kV.
The instrument operated in a data-dependent mode with a full scan
at 60 000 resolution on the Orbitrap followed byMS/MS fragmentation
in the linear trap of the four most intense ions.
Protein Identification. Raw data files were processed using the
software Proteome Discoverer 1.4 (ThermoFisher Scientific) interfaced
to a Mascot server (version 2.2.4; Matrix Science, MA, USA) and the
software MaxQuant (version 1.5.1.2)61 integrated with the Andromeda
search engine.62 Protein identification was performed against the human
section of the Uniprot database (version 20150401; 9411 sequences).
Enzyme specificity was set to trypsin with a maximum of two missed
cleavages allowed. Precursor and fragment mass tolerances were set to
10 ppm and 0.6 Da, respectively. Carbamidomethylation of cysteine
residues and methionine oxidation were set as a static and dynamic
modification, respectively. For data obtained with Proteome Discoverer,
the algorithm Percolator was used to assess peptide and protein
identification confidence.63 Data were filtered to account only for
proteins identified with at least two independent unique peptides with
high confidence (q ≤ 0.01). Proteins were grouped into protein families
according to the principle of maximum parsimony. Label-free
quantification was obtained with the precursor ion area detector node,
which extracts and integrated the area under the peak for each identified
peptide and estimates the amount of protein by averaging the area under
the peak of identified peptides for each protein (intensity). Therefore,
quantitative intensity data are associated only with proteins identified
with at least three independent peptides. For data obtained with the
software MaxQuant, the intensity of each peptide and the intensity-
based absolute protein quantification (iBAQ) parameter (described in
ref 64) were automatically calculated by the software. Data were
manually filtered to keep into account only proteins identified with at
least four unique peptides per identified proteins.
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Estimation of Polypeptide Stoichiometry and Mass in NP
Corona. The approximate polypeptide composition of the NP corona
was calculated by taking into account the size and density of NPs (mean
diameter of 100 nm and density around 1.5 g/mL, leading to a Mw of
∼5× 108 Da for all NPs) and then using proteomics label-free parameter
iBAQ (4 peptide cutoff). Based on the above information, a ratio of
1 clusterin molecule (49 000 Da) per NP would lead to a weight ratio
of 0.01 μg clusterin/100 μg of NPs. Hence, using values of the
experimentally determined percent amount of total protein (associated
with 100 μg of NPs) (% w protein), we used the following equation to











The stoichiometry of other polypeptides was derived by their respective
iBAQ values, compared to that of clusterin (polypeptiden/NP = number
of clusters/NPs × (iBAQn/iBAQclusterin). The mass amount was
determined based on the molecular weight of a given polypeptide and
the Avogadro number using the equation
= × −Mweight of one polypeptide [ (KDa)/6.022] 10 grn nw,
20
SDS-PAGE and Staining. Uncoated, PEGylated, and PMOXA-
coated NPs (800 μg/mL) were incubated under stirring at 37 °C for
15 min in RPMI 1640 supplemented with 100 μL of 75% (v/v) HS. NPs
were washed three times with 1 mL of ice-cold PBS, pH 7.4, and
recovered by centrifugation (30 min, 21 000g at 4 °C). The NP−protein
pellet was dissolved in 25 μL of loading sample buffer (62.5 mM Tris-
HCl, pH 6.8, 2% w/v SDS, 25% v/v glycerol, 0.01% w/v bromophenol
blue, with or without β-mercaptoethanol). After being heated at 95 °C
for 5 min, equal volumes (12 μL) of samples were subjected to SDS-
PAGE in 8 or 12% acrylamide gels. After being heated at 95 °C for 5min,
equal volumes (12 μL) of samples were subjected to SDS-PAGE (8 or
12% acrylamide). NP-independent protein recovery was assessed by
running mock samples in protein media. Silver or Coomassie G-250
staining (for mass spectrometry) was used to reveal separated
polypeptides. For silver staining, gels were fixed for 30 min in 50% v/v
methanol 10% v/v acetic acid and then incubated for 15 min in
5% v/v methanol, 1% v/v acetic acid, washed three times with water, and
exposed for 90 s to thiosulfate solution (200 μg/mL Na2S2O3
pentahydrate). After extensive washing with water, gels were incubated
in the dark for 30 min with 0.2 g/L AgNO3, rinsed, and developed for
5−15 min with a solution containing 60 mg/mL Na2CO3, 4 μg/mL
Na2S2O3 pentahydrate, and 0.01875% v/v formaldehyde. Reaction was
stopped with 6% v/v acetic acid. For colloidal Coomassie G-250
staining, gels were fixed for 18 h in 50% v/v methanol and 2% v/v
H3PO4, rinsed three times for 30min with water, and incubated for 1 h in
a solution containing 34% v/v methanol, 2% v/v H3PO4, and 17% w/v
(NH4)2SO4. Staining was performed for 3 days in 34% v/v methanol,
2% v/v H3PO4, 17% w/v (NH4)2SO4, and 0.066% w/v Coomassie
G-250, and it was followed by destaining in water for an additional
3 days. Band densitometry was performed using ImageJ software, after
background subtraction. In separate experiments, the protein content
after corona formation was determined by Bradford assay after washings.
Bovine serum albumin (Sigma) was used as the reference protein.
Protein Identification after In-Gel Digestion. Bands from
SDS-PAGE were washed with 50% v/v acetonitrile (ACN) in 0.1 M
NH4HCO3, vacuum-dried, treated for 30 min at 56 °C with 10 mM
DTT in 0.1 MNH4HCO3, cooled at 25 °C, and further incubated in the
dark for 20 min with 55 mM iodacetamide in 0.1 M NH4HCO3 to
alkylate thiols. After being washed with 50% ACN in 0.1 M NH4HCO3,
the dried gel pieces were swollen and treated overnight at 37 °C with
15 μL of digestion buffer (12.5 ng/μL trypsin, Promega, in 25 mM
NH4HCO3). The obtained peptides, extracted as detailed by Kim et al.,
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were analyzed by LC-MS/MS on a 6520 Q-TOF mass spectrometer
(Agilent Technologies) coupled to a chip-based chromatographic
interface. Large capacity chips (C18, 150 μm × 75 μm) and enrichment
columns (C18, 9 mm, 160 nL volume, 0.3 μL/min) were employed for
peptide separation. Eluting solutions A (water/formic acid 0.1% v/v)
and B (acetonitrile/formic acid 0.1% v/v) were used. A gradient of
solution B from 5 to 50% in 20 min allowed effective chromatographic
resolution. Raw data, converted into mascot generic format with
MassHunter qualitative analysis software version B.03.01 (Agilent
Technologies), were analyzed with Mascot Search Engine version 2.2.4
(Matrix Science). MS/MS spectra were screened versus SwissProt
database (June 2014 version, Taxonomy Mammalia, 66370 peptide
entries). Enzyme specificity was set to trypsin/P with two missed
cleavage (mass tolerance 20 ppm for parent mass and 0.6 Da for
fragment ions). Cysteine carbamidomethylation and methionine
oxidation were set as fixed or variable modifications, respectively.
Positivity cut off: more than 1 peptide per protein (p < 0.05).
Western Blot, Dot Blot, and ELISA Assays of Complement
Proteins and Fragments. Western Blot. To control complement
activity, 25 μL of HS was treated with 6.25 μL of Zymosan (25 mg/mL,
Sigma, prepared as described by manufacturer’s instructions) at 37 °C.
The reaction was terminated after 30 min with 25 mMEDTA. To assess
complement activation induced by NPs, 25 μL of HS was incubated with
800 μg/mL of different NP preparations for 30 min at 37 °C. Then
1.6 μL of each sample was mixed with 38.4 μL of water and 6.7 μL of
loading buffer without β-mercaptoethanol, and 15 μL of sample was
loaded onto an 8 or 12% gel. Polypeptides were then transferred to nitro-
cellulose membranes (Biorad) which, after saturation with TBS-T
containing 1% nonfat milk at room temperature for 1 h, were further
treated in the same solution with antibodies against C3a or B factor
(Calbiochem, 1:2000) overnight at 4 °C.Membranes were washed three
times with TBS/0.1% v/v Tween 20 and treated with secondary HRP-
(Calbiochem) or FITC (Millipore)-conjugatedAbs. Proteins were detected
by Huvitec (Eppendorf) or Odissey CLx (Li-cor) imaging systems.
Dot Blot. For the binding assay of complement proteins, NPs were
treated with HS at a 1:3 (v/v) ratio (routinely mixing 10 μL of NPs 3
mg/mL and 30 μL of HS) with or without 10 mM EDTA, 10 mM
EGTA/Mg2+, or antiproperdin antibodies (10 folds diluted). NP
concentrations were quantified with NanoSight (Malvern Instruments).
After being washed three times by centrifugation in PBS plus Ca2+/Mg2+
at 4 °C (Beckman Optima TLX ultracentrifuge, 150 000g), NP pellets
were resuspended in 20 μL of PBS, and bound proteins were detached
by 2% SDS and quantified. Two microliter triplicate sample aliquots
were blotted on a 0.2 μm pore nitrocellulose membrane (Bio-Rad)
which was then saturated with 5% (w/w) nonfat dry milk in PBS-T (1×
PBS with 0.1% Tween 20) for 1 h at room temperature. Membranes
were incubated with anticomplement protein specific antibodies for 1 h
at room temperature, washed three times with PBS-T, and eventually
challenged for 1 h with IRDye 800CW-labeled secondary antibodies.
Intensities of scanned bot images, obtained with an Odyssey infrared
imager (Li-COR Biosciences, Lincoln, NE, US), were measured using
ImageJ software.
ELISA. Complement activation in HS was quantified by testing the
NP-induced rise of complement activation products C5a, Bb, and sC5b-
9 with Quidel (Quidel, CA, USA) kits as detailed.17,66 NPs were added
to 75% (v/v) HS in Eppendorf tubes (in triplicate) in a shaking water
bath at 37 °C for 30 min. Reactions were terminated by addition of
“sample diluent” provided with the assay kit or saline containing 25 mM
EDTA. NP-induced rises of serum complement activation products
were then measured following reaction termination with “sample
diluent” from kits or saline supplemented with 25 mM EDTA and NP
removal. Background complement activation was estimated by
incubating HS with saline. In some cases, the assay was performed in
the presence of 10 mM EGTA/2.5 mM MgCl2 or antiproperdin
antibodies or of Zymosan as a positive control.
Statistical Analysis.Mean difference significances (0.05 level) were
assessed by two samples or paired t test, when appropriate, using the
Microcal Origin 8 software, after checking the Gaussian distribution
(Shapiro-Wilk test, 0.05 level). Pearson correlation coefficient, R, its
significance (t test), and linear regression analysis parameters were
calculated using the Excell2000 software statistics package. The number
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Structure of an octameric form of 
the minichromosome maintenance 
protein from the archaeon 
Pyrococcus abyssi
Giuseppe Cannone1,2,3, Silvia Visentin1,2,4, Adeline Palud5,6,7, Ghislaine Henneke5,6,7 & 
Laura Spagnolo1
Cell division is a complex process that requires precise duplication of genetic material. Duplication is 
concerted by replisomes. The Minichromosome Maintenance (MCM) replicative helicase is a crucial 
component of replisomes. Eukaryotic and archaeal MCM proteins are highly conserved. In fact, 
archaeal MCMs are powerful tools for elucidating essential features of MCM function. However, while 
eukaryotic MCM2-7 is a heterocomplex made of different polypeptide chains, the MCM complexes 
of many Archaea form homohexamers from a single gene product. Moreover, some archaeal MCMs 
are polymorphic, and both hexameric and heptameric architectures have been reported for the same 
polypeptide. Here, we present the structure of the archaeal MCM helicase from Pyrococcus abyssi in its 
single octameric ring assembly. To our knowledge, this is the first report of a full-length octameric MCM 
helicase.
Mini-chromosome maintenance (MCM) proteins are oligomeric enzymes that unwind the DNA double helix 
in an ATP-dependent manner. Homologues of eukaryotic MCM protein complex have been identified in all 
sequenced archaeal genomes, most of which have a single gene encoding for one MCM-like protein1. Among 
the exceptions, there are some Methanococcales, which possess between two and eight genes coding for MCM 
proteins2,3. In eukaryotes and archaea, MCM monomers are organized in three structural domains. The MCM 
amino-terminal domain (NTD) plays a role in higher order structure assembly and in the regulation of the 
ATPase activity, helicase activity and substrate specificity4. The AAA + module is needed to catalyse DNA 
unwinding5. Adjacent to the AAA + domain, the winged helix (WH) motif is proposed to have a regulative role. 
Many eukaryotic MCM2-7 subunits possess amino- or carboxy-terminal extensions involved in the regulation 
or recruitment of MCM2-74. Important information on MCM helicases has been gathered from structural and 
functional studies of archaeal assemblies, as well as from the crystal structures of distantly related helicases (SV40, 
LTAg, and E1 helicase of bovine papilloma virus)5. A recent study of the human MCM helicase showed how this 
heterohexameric complex exhibits both ATP hydrolysis and DNA unwinding activities, and highlighted confor-
mational changes on DNA binding6. A significant step forward in understanding the molecular organization and 
mechanism of the eukaryotic replicative helicase comes from the near-atomic resolution of the yeast MCM2-7 by 
cryo-electron microscopy. This model highlights the twisted and tilted single hexamers features of the MCM2-7 
double rings and suggests a concerted mechanism for the melting of origin DNA that requires structural defor-
mation of the intervening DNA7.
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Archaea can provide a simplified model for understanding complex molecular machinery involved in DNA 
metabolism8. However, the differences between archaeal and eukaryotic replication machines should also be 
studied to provide additional information to our knowledge about this fundamental biological process, as well 
as to offer insights for possible biotechnological applications of unusual archaeal enzymes. The first structural 
observation of a multimeric assembly of MCM came from electron microscopy studies of M. thermautotrophicus 
MCM9. These studies showed a double hexameric structure with the two hexamers joined in a head-to-head man-
ner, similar to the yeast MCM2-7 assembly observed later10. The human MCM helicase is a heterohexamer that 
exhibits intrinsic DNA unwinding activity6. MCM proteins were shown to assemble in several oligomeric states, 
including single hexamer, single heptamer, double heptamer and filaments11–18. Recently, a double octameric 
assembly has been reported for the ATPase domain of Pyrococcus furiosus19.
Here, we describe the structural analysis of a MCM-like protein, encoded by Pyrococcus abyssi (Pab) genomic 
ORF PAB2373. We cloned, overexpressed and purified PabMCM, and we analysed it by single particle electron 
microscopy. We also tested its helicase activity in vitro. Our data show that PabMCM is mainly arranged as a sin-
gle octameric ring, with some degree of compositional heterogeneity, and its helicase activity is weaker compared 
to that of SsoMCM. This octameric assembly is different from the other full-length MCM helicases known to date, 
which are mainly hexameric and sometimes heptameric.
Results
Sequence analysis of the PabMCM’s AAA+catalytic domain. The sequence alignment of the 
archaeal MCM proteins from S. solfataricus (Q9UXG1), M. thermoautrophicus (O27798) and P. furiosus (Q8U3I4) 
with the predicted one from P. abyssi reveals high sequence homology (Figure S1) as well as showing the presence 
of two insertions that are predicted to be inteins. The first intein is inserted into the C-terminal of the Walker A 
motif, the second one is inserted at the N-terminus of the H2I-hp motif. SsoMCM and MthMCM have no intein 
domains, while PfuMCM has just one inserted before the H2I-hp motif. The N-terminal domain of PabMCM 
reveals low sequence similarity with previously reported S. solfataricus and M. Thermoautrophicus MCM pro-
teins (Figure S1). Biochemical and biophysical characterization demonstrated that the N-terminal domain plays 
a regulatory role in MCM function20–22 as well as being involved in the formation of single and the double ring 
assemblies9,23. The low sequence similarity of the N-terminus of the A and B domains could represent a form 
of adaptation to the extreme environment while the higher conservation of the C domain and the NCL linker a 
similar role in the ring formation and inter-subunits interaction, as previously seen for other MCM protein com-
plexes. The AAA+ catalytic domain of PabMCM is better conserved compared to the N-terminus (Figure S1). In 
PabMCM, the active site (AAA+ domain) is ~250 residues long, and it is organized in Walker A, Walker B, sensor 
1 (S1) and sensor 2 (S2) motifs. Sequence alignment shows that these motifs are well conserved in PabMCM 
although polymorphisms are present in functional motifs such as EXT-hp, Walker A, H2I-hp, PS1-hp. These 
differences could represent mutations evolved as a form of adaptation to the extreme habitats in which P. abyssi 
thrives.
Cloning of the intein-free PabMCM gene. The ORF PAB2373 (3336 bp) deposited at the NCBI data 
bank (http://www.ncbi.nlm.ni.gov) encodes a protein of 1112 amino acid residues, predicted to be a PabMCM 
protein. The ORF contains two intein domains (Figure S1), whose insertion in the sequence cause the isolation of 
a fragment of the 27 amino acid residues. As result of this insertion, serine 499 is isolated from the adjacent lysine 
525 of the predicted Walker A domain, while the predicted H2I-hp is not affected (Figure S1). According to the 
sequence alignment (Figure S1), the putative active full-length PabMCM is devoid of inteins. In order to recon-
struct the full-length gene, we used a PCR-based approach, in which fragments of the putative coding sequence 
were amplified separately and fused by PCR (Fig. 1A).
Production, DNA binding and DNA Unwinding Activity of a Soluble PabMCM Complex. 
PabMCM was purified by heat denaturation, followed by nickel affinity and size exclusion chromatographies 
(Fig. 1B). To ensure that no DNA contaminant was present in the sample, fractions eluted from the nickel affinity 
purification step were pooled and their A260/280 ratio measured spectrophotometerically. Only fractions with an 
A260/280 between 0.51 and 0.68 (99% protein) were concentrated and loaded onto a Superose 6 10/300 GLTM size 
exclusion column. The apparent molecular weight of PabMCM, estimated as in ref. 24, was 575 kDa, indicating 
an octameric assembly.
Structural studies on archaeal MCM proteins have shown a positively charged central channel large enough 
to accommodate dsDNA25,26. In addition, biochemical studies reported that MCM proteins bind DNA through 
two types of structural motifs, which include a zinc finger and a beta-hairpin motif at the N-terminus and a 
beta-hairpin located in the AAA+ catalytic domain22,27,28. Bioinformatic analysis of the PabMCM sequence 
shows strong sequence homology and well-conserved structural motifs, with well-known archaeal MCM pro-
teins (Figure S1).
Full-length PabMCM binds dsDNA (Fig. 1C). The helicase activity of PabMCM octamer complex has been 
examined by using a Y-shaped substrate. In the conditions tested PabMCM had a mild (10% fork unwound) 
helicase activity, while our positive control SsoMCM exhibited maximal helicase activity (30% fork unwound) as 
previously shown29 (Fig. 1D). Similarly, P. furious MCM (PfuMCM) shows weak helicase activity. However, it is 
stimulated upon interaction by GINS complex29. On the other hand, the unwinding activity of the thermophilic 
M. thermoautotrophicum MCM (MthMCM) is stronger than the hyperthermophilic PfuMCM and PabMCM 
enzymes8. Moreover, it can unwind DNA substrates despite the presence of DNA-bound proteins30. Like 
MthMCM, the thermophilic Thermoplasma acidophilum MCM (TacMCM) displays significant helicase activity31. 
Studies carried out on the mesophilic D. melanogaster indicated that MCM2-7 has no activity in the absence of 
GINS and Cdc4528. Based on these comparative results, we conclude that PabMCM is an active helicase.
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Electron microscopy Structure of Recombinant PabMCM. We used EM coupled to single particle 
analysis to glean insights into the three-dimensional architecture of the PabMCM complex. We calculated a 
three-dimensional structure of the octameric assembly using single particles acquired in negative staining condi-
tions. A typical micrograph is shown in Fig. 2A. ~45,000 molecular images (320 × 320 pixels, 1.51 Å/pixel) were 
pre-processed to a final size of 80 × 80 pixels at 6.04 Å/pixel. A first round of MSA classification was performed 
to calculate reference-free class averages and build a first catalogue of views present in the dataset. The resulting 
eigenimages, calculated by MSA, are shown in Figure S2. The eigenimages are normally presented in the order of 
their significance32. In this respect, eigenimage 2 reflects the characteristic of the main shape, which is a ring, in 
the dataset. Additionally, the strong black ring encircling the white ring is likely to be related to the size variation 
between particles into the dataset32,33. Eigenimages 3 and 4 have two-fold symmetry, which is likely to be related 
to a different oligomeric states (single/double ring)33. Eigenimages 5 and 6 reflect size variation for the tilted 
views. Eigenimage 7 shows a black and a white rings, probably still related to the different particles size within 
the dataset32. To check if this interpretation was correct, molecular images were classified using the first seven 
eigenimages. 100 class-averages were calculated (Figure S2). Analysis of these class-averages showed three types 
of class-averages: one of elongated shape and two ring-shaped (Figure S2B). The validity of the interpretation of 
the 2nd and 7th eigenimages was tested as in White, H.E. et al.32. Rotational averages of the circular and elongated 
class averages were calculated and then images were compared by subtraction. As shown in Fig. 2B, both eigenim-
ages are representative of the size variation in the dataset. Based on this observation, the dataset was partitioned 
into two sub-datasets: the one containing elongated particles and the one with ring-shaped ones. Further rounds 
of MSA classification and alignment, with a subset of ~5,000 molecular images (10% of the total) classified as 
elongated, revealed their features. The elongated class averages show a two-fold symmetry and a four-tier organ-
isation, which is the typical feature of a double ring assembly of MthMCM, with the top and bottom tiers corre-
sponding to the C-termini, and the two middle tiers corresponding to the N-termini13,15.
Analogous analyses were carried out for the 45,000-image subset of ring-shaped molecular images (90% of 
the total images). Further rounds of MSA classification led to classify two types of top-end views of PabMCM: 
a small ring showing 7-fold symmetry and a bigger ring with 8-fold symmetry. The difference in size between 
Figure 1. Cloning, purification and functional assay of PabMCM. (A) Reconstruction of the full-length 
PabMCM devoid of inteins. (a) PCR-amplified N and C-terminus. (b) PCR-amplified fragment Ser499-
Leu525. (c) PCR-amplified of the joined N-term/Ser499-Leu525. (d) PCR-amplified of the joined N-term/
Ser499-Leu525. (e) PCR-amplification of the PabMCM full-length. (f) PCR performed in order to check 
that the fragment was successfully joined into the MCM sequence.(B) Size-exclusion chromatography. Gel-
filtration was performed in 20 mM HEPES pH 7.4, 150 mM NaCl at 0.3 ml/min flow-rate. (a) Size-exclusion 
chromatography trace of PabMCM. The black arrow indicates the molecular weight of gel-filtration standards 
(BioRad). (b) SDS-PAGE analysis of eluted fractions. (C) DNA binding assay. The gel shows the PabMCM 
complex can bind dsDNA. A 59-mer dsDNA was used in this experiment. Size was chosen in order to avoid 
multi-MCMs loading on the same dsDNA and thus force a 1:1 stoichiometry. L, DNA ladder. D, dsDNA only 
used has control. M, PabMCM only used as control to avoid artefacts due to ethidium bromide staining. Lines 
1–5 all contain 24 pmol (calculated on the monomeric MCM) of PabMCM with increasing amount of dsDNA 
(10, 20, 30, 40, 50 pmol). Lines 6–10 all contain 10 pmol of dsDNA with increasing amount of PabMCM (24, 48, 
72, 96, 120 pmol). The band-shift experiment was performed as shown in Fletcher et al.26. (D) Helicase activity 
of PabMCM. Reactions contained helicase buffer with either no MCM (lanes 1 and 6, positive control or lanes 
2 and 7, negative control) or increasing amounts of PabMCM (150, 300, 600 nM) lanes (3–5) and SsoMCM (50, 
100, 150, 200, 300 nM) lanes (8–12).
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the two rings was 8%. MSA classification also allowed sorting two types of side views, small and large side views. 
More difficult was the sorting of the tilted views since the difference in size was not always clear. From this 
dataset, ~10,000 molecular images belonging to the ‘large’ PabMCM assembly were taken forward for calcu-
lating the initial 3D model of the full-length PabMCM using EMAN234,35 (Figures S3). The initial model was 
calculated with e2initial_model.py, which calculates a random blob model, from pure noise images, to seed a 
single particle reconstruction and refinement35. For this purpose, nine class averages were used for the 3D recon-
struction of the initial model (Figure S3) and ten initial models were calculated. For each 3D reconstruction, the 
Figure 2. Electron microscopy and 3D refinement of the full–length PabMCM. (A) Characteristic negatively 
stained electron micrograph of PabMCM. Micrography recorded at 50,000x nominal magnification in low–dose 
mode (20–25 e−/Å2). White circles are used to show single particles. (B) Refined 3D model of the full-length 
PabMCM single octamer. Volumes were rendered with Chimera48. (C) Class averages and re-projections for the 
refined 3D reconstruction. (D) Fourier shell correlation of the refined PabMCM model.
www.nature.com/scientificreports/
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e2initial_model.py program calculates a set of re-projections, which can be used to estimate the quality of the 
3D reconstruction. Each 3D reconstruction was checked by inspecting the 3D model and the correspondence 
between the class averages and the re-projections. The model with the best matching between class averages 
and re-projections was refined by projection matching with e2refine.py35. Re-projections and class-averages were 
checked at each iteration. Particular care was taken for the tilted views. The final refined model is shown in Fig. 2. 
Projections of the maps matched with 2D class-averages assigned the same Euler angles highlighting the validity 
of the map (Fig. 2C). The overall shape of the refined model PabMCM exhibits similarity with 3D-EM models 
previously reported archaeal MCMs. However, the PabMCM complex exhibits an octameric assembly and has 
overall dimensions of 170 Å × 170 Å × 110 Å. The resolution of the map is 22 Å, calculated at 0.143 Fourier Shell 
Correlation (FSC) (Fig. 2D).
To test that the conditions used for negative staining did not affect the assembly of PabMCM, we carried 
out preliminary cryo-EM experiments (Figure S4, panels A and B). We confirmed that single PabMCM octam-
ers also exist in cryo conditions. ~33,000 particles (Figure S4C) were manually picked and used to feed a 2D 
classification experiment in a semi-automated manner, using the Relion software36 without imposing symmetry 
at any stage. The classes calculated for the whole dataset clearly show the coexistence of single ring as well as 
higher-order assemblies (Figure S2E). Among the single ring assemblies, we identified a majority of rings bearing 
8-fold symmetry. Particles belonging to these classes were extracted from the full dataset and used as an input for 
reference-free 2D classification (Figure S4). These classes have features that are in excellent agreement with the 
ones obtained in the negative staining structure, showing that the octameric assembly is not an artifact of negative 
staining experiments (Fig. 2C).
Interpretation of the PabMCM 3D-EM structure. To interpret the 3D-EM reconstruction of the 
full-length PabMCM, we docked the crystal structure of the C-terminally truncated SsoMCM25; the crystal struc-
ture of the full-length MkaMCM16 and the NMR structure of the C-terminal domain of SsoMCM37. The fitting of 
the 3D structure of the full-length PabMCM complex (Fig. 3) was performed manually using Chimera38 and then 
optimised with Situs39. 3D volume and fitted model were rendered in Pymol40. The crystallographic structure of 
the C-terminally truncated SsoMCM fitted well into the electron density corresponding to the bottom and top 
tier, although a C-terminal extra density was observed (Fig. 3A and B). The orientation resulting from docking 
of SsoMCM into the map shows PS1 and HP2 β -hairpins pointing into the central channel, while Ext β –hairpin 
is pointing toward the side channel between the subunits composing the ring (Fig. 3C and D). Ext β -hairpin 
locates on the exterior side of the side channel (close-up Fig. 3D). The crystallographic structure of the full-length 
MkaMCM monomer fitted better into the electron density corresponding to the bottom and top tier (Fig. 3E and F). 
Docking resulted in PS1 and HP2 β –hairpins of MkaMCM pointing into the central channel of the 3D-EM map 
of the full-length PabMCM (Fig. 3G and H).
The structural superposition of one octameric PfuMCM AAA ring (PDB 4R7Z)19 on the middle layer of the 
octameric PabMCM shows that the diameter of the central cavities is very similar in both structures (Fig. 4A). 
Despite their different oligomeric state, the diameter of the N-terminal tier of the hexameric PfuSsoMCM chi-
mera (PDB 4R7Y)19 also almost fits the top density, however it is slightly wider. On the other hand, the compari-
son with another octameric AAA assembly involved in DNA metabolism, the human Dmc1 recombinase (PDB 
1V5W)41 highlights that in this case the upper tier of the PabMCM channel is slightly wider than that of the 
recombinase (Fig. 4A). The best fit for symmetry and cavity dimension could therefore be represented by a pos-
sible octameric ring of eight full-length MkaMCM subunits, that crystallised as monomers in 3F8T16. The milder 
activity of PabMCM compared to that of SsoMCM could be related to structural differences such as the broader 
end of the cavity, possibly due do the octameric arrangement of the subunits in the ring. It should however be 
noted that the length of each individual subunit in the octamer is not more extended than that of each of the eight 
modeled full-length subunits of MkaMCM (PDB 3F8T)16. The comparison of the hexameric SsoMCM and the 
octameric PabMCM channels (Fig. 4B) shows two very different overall shapes. This different arrangement could 
be one explanation for the different activities of the two helicases.
Conclusions
The structural observation of archaeal MCM proteins by electron microscopy showed that several oligomeric 
states could be adopted by MCM proteins, including single hexamer, single heptamer, double heptamer and 
filaments9–19.
In this study, we report the structure of a homo-octameric MCM protein. Electron microscopy coupled to 
SPA revealed that PabMCM is a mixture of at least three molecular species: single heptamer, single octamer and 
double rings. A subset of ~10,000 particles, showing characteristic 8-fold symmetry, were classified and sorted by 
MSA. This subset was homogeneous enough for a subsequent 3D reconstruction. The final 3D-EM map at 22 Å 
(calculated by FSC) showed similarity with previously reported 3D-EM reconstruction of similar archaeal MCM 
proteins, however this is the first non-chimeric MCM helicase reported to assemble as an octamer.
PabMCM binds to dsDNA (Fig. 1C), and has weak helicase activity compared to SsoMCM (Fig. 1D). Studies 
of another hyperthermophilic archaeal MCM, PfuMCM, demonstrated that the helicase activity of MCM is stim-
ulated by the GINS complex42. Like other hyperthermophilic MCM such as Thermococcus Kodakaraensis MCM12 
or PfuMCM, the helicase activity seems to be reduced. Additional replication factors like the GINS complex 
and cdc642,43 or post-translational modifications44 are described to further enhance the helicase activity. Hence, 
similar mechanisms of activation could be involved in PabMCM functionality. The structure for the full-length 
PfuMCM assembly is not yet available, however it is noteworthy that the octameric arrangement of PabMCM is 
very reminiscent of that of the PfuMCM AAA ring, suggesting an interesting similarity between two Pyrococcal 
proteins. The weak helicase activity could be due to the conformation of the bell-shaped inner cavity (Fig. 4B) 
which is broader than that of hexameric helicases such as SsoMCM (Fig. 4B).
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Figure 3. Model fitting of the full–length PabMCM 3D EM structure. (A,B,C,D) Fitting of the atomic 
coordinates of the C–terminally truncated SsoMCM (PDB 3F9V)25 and C–terminal domain of SsoMCM 
(PDB 2M45)37. (E,F,G,H) Fitting of the atomic coordinates of full-length MkaMCM (PDB 3F8T)16. In blue is 
shown the fitting of the NMR structure of SsoMCM. In red, the AAA + module while in orange the N-terminal 
domain of both SsoMCM and MkaMCM. In light blue, EXT β -hairpin; in yellow, H2I β -hairpin; in green, PS1 
β –hairpin; in dark blue, NT β –hairpin (only in panel D).
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Experimental Section
Cloning. The cloning was performed from Pab genomic DNA (kind gift of P. Forterre). The primers oligo1 and 
oligo4 were used to PCR-amplify the N-terminus of MCM, the primers oligo5 and oligo6 were used to amplify the 
fragment Ser499-Leu525 and the primers oligo3 and oligo2 were used to amplify the C-terminal fragment of MCM 
(Supplementary Table 1). The full-length PabMCM was reconstructed in three PCR reactions (Fig. 1). In each reac-
tion, the PCR to join the fragments was performed in two steps. In the first step, two fragments were incubated in 
the reaction mixture for 5 cycles, in absence of primers, in order to fill the 5′ ends. In the second step, primers were 
added and PCR was performed for 35 cycles. In the first PCR, the N-terminal fragment was fused with the fragment 
Ser499-Leu525 and then amplified by the Oligo1 and Oligo6 pair. In the second PCR, the fragment Ser499-Leu525 
was fused with the C-terminal fragment of MCM and then amplified by the pair of oligos 5 and 2. The reconstructed 
full-length MCM fragment was cloned into a modified pET vector and the sequence was confirmed by sequencing.
Figure 4. Structural superposition. (A) One octameric PfuMCM AAA ring (PDB 4R7Z)19, the N-terminal 
tier of the hexameric PfuSsoMCM chimera (PDB 4R7Y)19 and the human Dmc1 recombinase (PDB 1V5W)41 
superposed on PabMCM highlights the similarity with the symmetry and AAA ring subunits orientation of 
the crystallographic structure for PfuMCM. (B) Comparison of the central channel of the hexameric SsoMCM 
(47RY) and the octameric PabMCM (EMD-3487).
www.nature.com/scientificreports/
8SCIentIFIC REPORTS | 7:42019 | DOI: 10.1038/srep42019
Protein overexpression and purification. PabMCM was overexpressed in Rosetta (DE3) pLysS grown 
in terrific broth (TB). Cells were grown to Abs600 = 0.4–0.6 before induction with 0.2 mM IPTG for 16 hours at 
30 °C. PabMCM was purified by heat–denaturation (20′ at 70 °C), followed by nickel affinity chromatography and 
size-exclusion chromatography. Fractions eluted from the nickel affinity purification step were pooled and tested 
for DNA contaminations by measuring the Abs260/280 ratio. Only fractions with Abs260/280 ratio between 0.51 and 
0.68 (99% protein) were concentrated by ultra-filtration using a 15 R Vivaspin (30,000 MWCO), to a final concen-
tration of 15 mg/ml. Finally, the sample was loaded onto a Superose6TM10/300 GL size-exclusion chromatography 
column. The apparent molecular weight of PabMCM, estimated as in Andrews24, was ~575 kDa.
DNA binding assay. DNA binding assays were carried out as described in ref. 25. Oligos 3 and 4 were 
annealed in annealing buffer (50 mM Tris, 50 mM NaCl, pH 8.8) to a final concentration of 10 μ M. Annealing was 
achieved by incubating the tube containing the oligo mixture in a beaker with boiling water and letting it cool 
overnight. Reactions were carried out at 50 °C for 30 minutes. Annealing was checked by electrophoresis onto 
1.5% agarose gels.
Helicase assay. The fluorescent-labeled Y-shaped substrate is obtained by mixing oligos A and B 
(Supplementary Table 2) as described in DNA binding assay and followed by PAGE purification.
The helicase assays (20 μ l) were performed by mixing 5 nM fluorescent-labeled Y-shaped substrate, 10 mM 
ATP, and increasing amounts of enzyme in reaction buffer containing 20 mM Tris-acetate pH 7.9, 50 mM 
potassium-acetate, 10 mM magnesium-acetate, and 1 mM DTT. Reactions were initiated by the addition of ATP, 
and the mixtures were incubated at 65 °C for 45 minutes. Reactions were terminated by the addition of 11 μ l of 
chilled stop solution (0.5 mg/ml Protéinase K, 0.5% [wt/vol] SDS, 5 mM EDTA, and 250-fold molar excess of 
unlabeled DNA trap oligonucleotide C to minimize reannealing of the unwound oligonucleotides. Followed by 
incubation at room temperature for 15 minutes, 4 μ l loading buffer are added to the samples. As a positive con-
trol, DNA substrates were heat denatured at 95 °C for 15 min in the absence of helicase. As a negative control, the 
substrates were incubated in the reaction mix in the absence of helicase. Samples were resolved in a 8% (vol/vol) 
polyacrylamide gel in 1 × Tris-borate-EDTA. The fluorescent-labeled bands were visualized using a Typhoon 
9400 (GE healthcare) and quantified with ImageQuant 5.2 software (Molecular Dynamics).
Electron Microscopy. PabMCM was studied both by negative staining and cryo electron microscopy (EM) 
and single particle analysis (SPA). The protein sample was added to glow-discharged grids, blotted and washed 
twice before staining using 1% uranyl acetate. Data were collected on a FEI F20 FEG microscope, equipped with 
a TemCam-F816 (8kx8k) CCD camera. Images were collected under low dose mode at nominal magnification 
of 50,000x, at a final sampling of 1.51 Å/pixel at the specimen level. Negatively stained single particle images 
were selected interactively using the e2boxer.py program from the EMAN2 single particle analysis package and 
extracted into boxes. Image processing was performed using the IMAGIC-545 and Eman35,46 packages. The data-
set was re-sampled at 6.04 Å/pixel. ~45,000 images with homogeneous staining were band-pass filtered with a 
high pass cutoff of 110 Å and a low pass cutoff of 18 Å. The single particle images were analysed by Multivariate 
Statistical Analysis with IMAGIC-5. The dataset was subjected to successive rounds of alignment and classifica-
tion in order to improve the resulting image class-averages. Three-dimensional reconstruction was performed 
using Imagic and Eman2 protocols. The map was deposited in the PDB with accession code EMD-3487. The 
cryoEM data collection was performed on Quantifoil grids covered with a thin layer of carbon, plunge-frozen 
into liquid ethane using a Vitrobot instrument. Data collection was performed at the same magnification of the 
negative staining study (50,000x), in low-dose mode. The single particle analysis was performed using the Relion 
software36 according to instructions. Figures were prepared with UCSF Chimera38 and Pymol47.
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